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Summary 
Fibronectin (FN), a major adhesive glycoprotein ubiquitously present in the 
extracellular matrix and in blood plasma of vertebrates, is secreted by cells as a 
disulfide-bonded dimer. FN requires cell surface expressed integrins to assemble into a 
functional fibrillar network, which in turn orchestrates the assembly of other ECM 
components to promote cell adhesion, cell migration and a large variety of signaling 
events.  
The most prominent integrin binding site of FN is located in the 10
th
 type-III repeat 
(FN-III10) and consists of an Arg-Gly-Asp (RGD) motif. This motif is considered to be 
essential for the initiation and assembly of a fibrillar FN matrix through its capability to 
bind to a variety of different members of the integrin family. Gene ablation studies 
confirmed that two RGD-dependent FN assembly mechanisms either induced by 
integrin α5β1 or αv integrins exist in vivo, and that each of them can compensate for the 
absence of the other (Yang, Bader et al. 1999). In order to specifically test how FN-
RGD binding integrins compensate for each other during development and FN 
fibrillogenesis, a mouse strain was generated in which the Asp (D) of the RGD motif 
was substituted with a Glu (E). This mutation resulted in an integrin-binding-deficient 
RGE motif. FN-RGE homozygous mice die around embryonic day 10 (E10) of 
development with shortened posterior trunk, absent tail-bud derived somites and severe 
defects of the cardiovascular system. All these defects are similar to those observed in 
α5 integrin-null mice. Surprisingly, the absence of a functional RGD binding site did 
not abolish assembly of a FN matrix in mutant embryos or on cells derived from 
mutants. Matrix assembly assays and solid-phase binding assays performed in this study 
reveal that αvβ3 integrin assembles FN-RGE by binding to an isoDGR-motif in FN-I5, 
which is generated by the non-enzymatic rearrangement of Asn (N) into iso-Asp (isoD). 
This study unravelled a novel motif for integrin binding and fibril formation in FN 
whose activity is controlled by amino acid modification.     
The dimerization of FN is facilitated by two cysteines at the C-terminus which are 
forming a pair of disulfide-interchain bonds. Fibronectin dimerization has been shown 
to be essential for the assembly of a fibrillar FN matrix network in vitro. To directly test 
the function of the dimerization in vivo, a mouse strain was generated that is exclusively 
expressing a monomeric form of FN by exchanging the two cysteines (C) against two 
serines (S). This study shows that FN-monomer homozygous mice die around E11.0, 
displaying severe cardiovascular defects and a growth arrest commencing around E9.0 – 
E9.5. Interestingly, these defects are similar to those observed in mouse models with 
compromised TGF-β signaling. Moreover, monomeric FN was assembled into a FN 
matrix in mutant embryos. Matrix assembly assays and biochemical analyses revealed 
that FN-monomer is also assembled in vitro, but fails to orchestrate assembly of other 
ECM proteins such as LTBP-1 leading to an impaired targeting of latent TGF-β to the 
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ECM. This in turn leads to altered TGF-β signaling underlying the cardiovascular 
defects. This study demonstrates that dimeric FN is not required for FN fibril assembly 
in vivo, but is essential for sequestration and activation of TGF-β and normal FN 
fibrillogenesis in vitro.  
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1 Introduction 
1.1 The extracellular matrix (ECM) 
The extracellular matrix (ECM) is a heterogeneous meshwork of fibrillar and non-
fibrillar components. The ECM plays crucial roles in development, tissue homeostasis 
and disease by providing a structural scaffold for cell adhesion and migration, by acting 
as a repository to store various growth factors and control their bioavailability, and by 
regulating numerous cell functions through activating multiple signaling pathways at 
cell adhesion sites. The ECM fibrillar network is a highly dynamic structure that is 
subjected to constant reorganization mediated by cells and tissue motion.  
The major constituents of the ECM are different proteoglycans, glycosaminoglycans 
and glycoproteins. The most abundant glycosaminoglycan in the ECM is hyaluronan, 
which is a carbohydrate polymer (Laurent and Fraser 1992). Proteoglycans such as 
perlecan, aggrecan, biglycan and decorin are highly glycosylated proteins that support 
cell adhesion and bind various growth factors (Timpl 1993; Iozzo 1998). 
A major fraction of the ECM is composed of glycoproteins, such as collagens, laminins, 
fibrillins and fibronectin, which serve as substrates for different adhesion molecules 
including integrins (Humphries, Travis et al. 2004; Dallas, Chen et al. 2006). A 
comprehensive introduction of all constituents of the ECM would be far beyond the 
scope of this introduction. Therefore, only a selection of the most important ECM 
glycoproteins will be briefly introduced within this section. 
The more than 30 members of the collagen-family represent the major proteinaceous 
component of the ECM in most organs. The triple-helical proteins provide a scaffold for 
the organization of cells in a given tissue. Collagens can be roughly divided into two 
classes; the fibril forming collagens (Col I, II, III, V and XI) and the more 
heterogeneous class of non-fibrillar collagens, including the typical basement 
membrane collagens IV, Col VIII and Col X. Some collagens are almost ubiquitously 
expressed, while others are found only in distinct tissues, such as for example, Col X in 
cartilage (Aumailley and Krieg 1996; Kadler, Hill et al. 2008).  
The fibrillin-family of ECM proteins including fibrillin-1, -2, -3 and the latent 
transforming growth factor binding proteins (LTBPs) 1 trough 4, form microfibrils and 
regulate growth factor activity. Fibrillins are found in various connective tissues in 
association with elastin with which they form the so-called elastic fibers (Kielty, 
Sherratt et al. 2005).  
The heterotrimeric laminins are abundant glycoproteins in basement membranes. 
Laminins polymerize into sheet-like supramolecular structures which interact with the 
collagen network via entactin or perlecan and with receptors on the cell surface such as 
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integrins and dystroglycans. Mammals possess at least 15 different laminin isoforms, 
two of which have been reported to be essential for development (Laminin-1 and -10), 
whereas the other laminins play tissue and cell-type specific roles required for 
specialized organ functions (Miner and Yurchenco 2004).  
Fibronectin is an abundant constituent of the ECM. FN exhibits multiple sites that 
interact with integrins, other cell surface receptors and ECM components. As one of the 
earliest ECM components to be assembled, it is thought to act as an orchestrator for the 
assembly of multiple ECM proteins (Schwarzbauer and Sechler 1999; Pankov and 
Yamada 2002).  Since FN is in the focus of this study, it will be introduced in more 
detail in one of the following sections (see 1.3). 
Importantly, these ECM components are all secreted by cells as non-functional building 
units, which are assembled into functional supramolecular structures in a highly 
regulated manner (Larsen, Artym et al. 2006; Vakonakis and Campbell 2007). Integrin 
cell surface receptors play a key-role in many of these assembly processes and are 
therefore introduced in the following chapter. 
1.2 The integrin cell surface receptor family 
1.2.1 Integrins   
Integrins represent a family of cell adhesion receptors that are ubiquitously expressed in 
all metazoan tissues. The heterodimeric cell surface receptors recognize numerous 
ligands, among which are ECM-molecules, cell-surface receptors and soluble proteins, 
such as latency-associated protein (LAP) or the milk fat globule-EGF factor 8 
(MFGE8). Integrins exhibit large extracellular domains, transmembrane domains and 
cytoplasmic domains, which connect to the actin-cytoskeleton via numerous 
cytoplasmic adaptor proteins. Thus, integrins link the cytoskeleton with the ECM, 
which facilitates bi-directional signaling across the cell membrane and enables cells to 
mechanically and chemically integrate with their extracellular environment. This is 
important for executing integrin functions such as cell adhesion, migration, survival, 
gene expression and differentiation (Sheppard 2000; van der Flier and Sonnenberg 
2001; Hynes 2002; Legate, Wickstrom et al. 2009). 
1.2.2 The integrin family and ligands 
Integrins are heterodimeric proteins, consisting of α and β transmembrane type I protein 
subunits, which are non-covalently linked to each other. The number of different 
integrin subunits encoded in the genome correlates with the complexity of the organism. 
Mammals express 18α and 8β subunits which can form 24 known combinations of 
different heterodimers. Splicing of some subunits increases the diversity (van der Flier 
and Sonnenberg 2001). The ligand-specificity of each heterodimer is determined by the 
types of α and β subunits associated with each other (Hynes 2002). While some 
integrins exhibit a stringent ligand-specificity, others are promiscuous. In general, 
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integrins can be assigned to distinct subgroups regarding their ligand recognition 
specificity (see Fig 1.1); the RGD-binding integrins, which recognize ECM molecules 
containing RGD motifs such as FN, vitronectin (VN), thrombospondin, osteopontin and 
tenascin; the laminin-binding integrins; the collagen binding; integrins which recognize 
the LDV motif present in FN, in vascular cell adhesion molecule-1 (VCAM-1) and 
Mucosal addressin cell adhesion molecule-1 (MAdCAM-1); and integrins expressed on 
cells of the haematopoietic system, which mediate cell-cell interactions by binding 
counter-receptors of the IgG-superfamily (Humphries, Byron et al. 2006; Legate, 
Wickstrom et al. 2009). 
 
Fig 1.1. Mammalian integrin heterodimers. Integrins can be classified in subgroups regarding 
their ligand specificity. RGD receptor integrins recognize the RGD motif, which is present in 
FN and vitronectin (VN). FN is also recognized by another subgroup of integrins (α4β1, α4β7 
and α9β1) that are additionally capable to interact with VCAM-1 (vascular cell adhesion 
molecule). Two further integrin subgroups mediate interactions with ECM proteins of the 
collagen- and laminin-family. A group of leukocyte-specific integrins mediates cell-cell 
adhesions in the haematopoietic system to Ig-superfamily counter receptors. (Based on Hynes, 
2002). 
1.2.3 Integrins structure 
Integrins are approximately 28 nm long. Their α and β subunits have a size of 150-180 
kDa and ~100 kDa, respectively. The large extracellular domain of each subunit is 
linked to the cytoplasmic tail via a single α-transmembrane helix. A hallmark of almost 
all integrin subunits is their rather short cytoplasmic tail, which is made up of only 
about 10-70 amino acids. The β4 subunit is an exception with a much larger 
cytoplasmic tail composed of 1072 amino acids (Wegener and Campbell 2008). Both 
integrin subunits consist of modules. The ectodomain of α subunits consists of a N-
terminal β-propeller domain, an Ig-like domain (thigh) and two β sandwich domains 
(calf-1 & -2). The ectodomain of β subunits comprises a N-terminal β I domain 
followed by a Ig-like domain (“Hybrid”), a PSI (plexin, semaphorin and integrin) 
Introduction 
4 
domain, four tandem repeats of epidermal growth factor-like (EGF-like) domains and a 
β-tail domain (Zhu, Luo et al. 2008) (See fig. 1.2). Structural data of integrin 
ectodomains indicate that both subunits assemble into a “head on two tails”-like 
structure. The β-propeller of the α subunit, together with the β I and Hybrid domain of 
the β subunit form the headpiece, which contains the ligand binding pocket. An 
important structural property required for ligand binding are the metal ion coordinating 
sites located in the β I domain, which consist of an Mg2+/Mn2+ binding site (Metal ion-
dependent adhesion site, MIDAS) and two flanking Ca
2+
 (synergistic metal ion binding 
site, SyMBS and adjacent to MIDAS, AdMIDAS site) binding sites (Hynes 2002; 
Wegener and Campbell 2008).  
It is widely recognized that integrins can switch between two conformational states; a 
bent, closed conformation which characterizes inactive integrins with low ligand 
affinity, and an extended, open conformation representing active integrins with high 
ligand affinity (Xiong, Stehle et al. 2001; Takagi, Petre et al. 2002; Zhu, Luo et al. 
2008). The bent conformation is achieved by bending of the ectoplasmic “tails” between 
the thigh and calf-1 domain of the α subunit and bending of the β integrin subunit 
between the I-EGF domains 1 & 2. In order to obtain the active conformation, the 
ectoplasmic tails need to switch to an extended conformation. The extension is believed 
to be initiated by separation of the cytoplasmic and transmembrane domains upon 
binding of proteins to β integrin cytoplasmic domains. This model of long range 
conformational changes is referred to as “switchblade” model (see Fig 1.2). However, it 
is still disputed whether integrins can adopt different bent conformations which are also 
capable to bind ligands with varying affinities (“deadbolt” model) (Carman and 
Springer 2003; Arnaout, Mahalingam et al. 2005). 
 
Fig 1.2. The “switchblade” model of integrin activation. A. Integrin in the bent conformation 
with low affinity for the ligand. B. Binding of cytoplasmic proteins to the β subunit leads to 
separation of the cytoplasmic tails (opening) and extension of the ectodomains. The binding 
pocket in the headpiece is now accessible for the ligand. C. Ligand-bound integrin in the 
extended, active conformation. (modified from Zhu et al., 2008). 
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1.2.4 Regulation of integrin activation and “inside-out” signaling 
Integrin activation is a process that requires tight regulation, since many cellular 
processes, such as for example platelet aggregation in response to injury, are 
fundamentally dependent on localized and accurately timed integrin activation (Bennett 
2005). Integrins cytoplasmic tails are small compared to the extracellular domains and 
are devoid of enzymatic activity but have been shown to play a central role in integrin 
functions. Numerous studies demonstrated that integrin activation and integrin mediated 
signal transduction is facilitated by direct interactions between intracellular proteins and 
conserved motifs in integrins cytoplasmic tails (Calderwood 2004; Legate and Fassler 
2009). Hydrophobic interactions and a proposed salt-bridge formed between the Asp 
residue in the β-tail HDRK motif and the Arg residue in the α-tail GFFKR motif result 
in a close association of both subunits in integrins inactive state. Upon intracellular 
stimuli, specific FERM-domain containing proteins, such as talin and kindlin, bind to 
conserved motifs in β integrins cytoplasmic tail, which leads to disruption of the weak 
tail-tail interactions and integrin activation (Vinogradova, Velyvis et al. 2002; Wegener, 
Partridge et al. 2007; Moser, Nieswandt et al. 2008; Wegener and Campbell 2008). 
Besides talin and kindlin, several other proteins have been reported to activate integrins 
by direct interaction with the cytoplasmic tail, such as cytohesin I, calcium and integrin 
binding protein (CIB) and β3 endotoxin (Travis, Humphries et al. 2003; Legate and 
Fassler 2009). The regulation of integrin activity through interaction with intracellular 
proteins is referred to as “inside-out” signaling. 
Up to now, more than 20 different proteins have been shown to directly interact with 
integrins cytoplasmic tails, most of which bind to the β subunit. These include actin-
binding proteins (e.g. Talin, α-actinin, Myosin), kinases (FAK), adaptor proteins (i.e. 
kindlin, paxillin, ILK), transcriptional co-activators (JAB1), transmembrane proteins 
(CD98) and guanine nucleotide exchange factors (Cytohesin-1, -3) (Liu, Calderwood et 
al. 2000). The diversity of this group of interaction partners highlights the complexity of 
integrin signaling, which is far from being fully understood and can not be exhaustively 
introduced here. Instead, the reader is referred to some outstanding reviews about 
integrin signaling (Schwartz and Ginsberg 2002; Guo and Giancotti 2004; Legate and 
Fassler 2009; Moser, Legate et al. 2009). 
1.2.5 Integrin-actin interaction at cell adhesion sites 
One of the major functions of cytoplasmic integrin binding proteins is to facilitate the 
linkage of integrins to the actin cytoskeleton. The actin binding protein talin is known to 
play a pivotal role for this interaction, since it is not only required for integrin 
activation, but also provides a direct physical link between integrins and actin 
(Tanentzapf, Martin-Bermudo et al. 2006; Zhang, Jiang et al. 2008). Upon integrin 
binding, talin recruits and activates phosphoinositol-phosphate kinase type I gamma 
(PIPkγ) which catalyses the local production of phosphatidylinositol (4,5) bisphosphate 
(PIP2). At sites of cell adhesions, PIP2 serves two functions: Firstly, it enhances the 
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interaction of talin with integrins β subunit. Secondly it recruits other PIP2 binding 
proteins, such as vinculin, to integrin cell adhesion sites. The talin binding protein 
vinculin strengthens the indirect integrin-actin interaction in various ways: It probably 
acts as a cross-linker of the talin-actin interaction (owing to its capability to bind to both 
proteins), and enhances talins capability to cluster integrins (Giancotti and Tarone 2003; 
Gallant, Michael et al. 2005; Humphries, Wang et al. 2007). Moreover, vinculin 
undergoes a conformational change upon PIP2 binding which leads to its increased 
affinity for actin, resulting in enhanced recruitment of F-actin to sites of integrin 
mediated cell adhesion (see Fig 1.3). This process provides an example, how tight 
integrin-actin interactions are established. The total number of interactions increases 
gradually, starting out with only few ECM-bound integrins clustered in so called 
nascent adhesions (Choi, Vicente-Manzanares et al. 2008). These unstable adhesion 
structures may increase in size, as more and more ECM-bound integrins cluster, and 
mature into larger multiprotein adhesion structures with gradually increasing size and 
complexity, such as dot-shaped focal complexes (FCs), focal adhesions (FAs) and, 
finally, streak-like fibrillar- (Geiger, Bershadsky et al. 2001) and 3D-matrix adhesions 
(Cukierman, Pankov et al. 2001). Particularly the larger, more advanced structures such 
as FAs and fibrillar adhesions mediate the interaction of integrins with thick F-actin 
bundles called stress fibers in a highly dynamic fashion (Zamir and Geiger 2001). The 
creation of a tight integrin mediated ECM-cytoskeleton linkage finally paves the way 
for further cytoskeletal rearrangements which facilitate the transmission of cytoskeletal 
pulling- and traction-forces required for cell migration and cell shape modulations 
during differentiation and proliferation. 
 
Fig 1.3. Indirect integrin – F-actin interconnection via talin and vinculin. Binding of talin and 
kindlin to the cytoplasmic tail of the β integrin subunit is necessary to synergistically induce 
integrin activation through tail separation. Active integrin binds to extracellular ligands on the 
ectoplasmic face and recruits PIPkγ to the cytoplasmic face. Local PIP2 production by PIPkγ 
attracts PIP2 binding vinculin. The PIP2-bound vinculin is capable to interact with talin and 
facilitates the recruitment of F-actin. (Modified from Giancotti and Tarone, 2003). 
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1.2.6 Integrins role in FN assembly 
The assembly of elongated FN fibrils is a cell dependent process termed FN 
fibrillogenesis. This process requires a dynamic, directional integrin movement to 
stretch integrin-bound fibronectin on the cell surface, and is found to coincide with the 
assembly of streak-like adhesion structures called fibrillar adhesions. These elongated 
structures are characterized by a high content of FN binding α5β1 integrins and tensin, 
and typically lack other integrins, paxillin, vinculin and tyrosine-phosphorylated 
proteins (Zamir, Katz et al. 2000). Fibrillar adhesions are considered to be emerging 
from FAs; upon FN binding, α5β1 integrins are pulled out from sites of FAs and move 
towards the cell center to form fibrillar adhesions, in which integrin-bound FN fibrils 
are aligned with F-actin and multiple signaling molecules (Pankov, Cukierman et al. 
2000; Zamir, Katz et al. 2000; Ohashi, Kiehart et al. 2002). 
The traction forces required for fibrillar adhesion assembly are generated by myosin II-
dependent contraction of the F-actin cytoskeleton, which is linked to integrins via the 
actin and integrin-binding protein tensin (Lo, Weisberg et al. 1994). Translocation of 
FN-bound integrin facilitates the mechanical stretching of the FN molecule (see Fig 
1.4), resulting in the exposure of cryptic self assembly sites which results in FN self 
assembly (Yamada, Pankov et al. 2003).  
Interestingly, loss of α5β1 integrin in cells and ablation of the α5 integrin gene in mice 
revealed, that FN can still be assembled by the remaining FN binding integrins, most 
notably the αv integrin subfamily (Yang, Rayburn et al. 1993; Wu, Keivens et al. 1995; 
Wennerberg, Lohikangas et al. 1996). However, FN fibrils produced by αv-class 
integrins appear short and thick and often resemble the shape and dynamics of αv 
integrin containing FAs that may be attributed to the inability of these integrins to move 
out from FAs (Wennerberg, Lohikangas et al. 1996; Wu, Hughes et al. 1996). The 
crucial role of α5 and αv integrins for FN assembly have been confirmed by a double 
knock out of both genes, which ablates FN fibril formation (Yang, Bader et al. 1999). 
An interesting but still unanswered question is whether αv mediated thick and short FN 
fibrils co-exist with the fine and thin α5-mediated FN fibrillar meshwork in vivo. The 
co-existence of different types of FN fibrils would provide tissues with qualitatively 
different FN matrices and different functional properties. 
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Fig 1.4. Integrin translocation facilitating FN fibrillogenesis. A. Cells use focal adhesions as 
anchors. Strong adhesion is mediated e.g. to Vitronectin (VN) using αvβ3 integrin. Intracellular 
contractility leads to directional movement of FN-bound α5β1 integrin along actin-filaments 
from FAs towards the cell center. As a result, FN is stretched. B. Stretching of the FN molecule 
leads to unfolding of cryptic self-assembly sites, resulting in the assembly of a linear FN fibril. 
This process requires intracellular actomyosin contractility and the cytoskeletal protein tensin. 
Note that the translocation of integrins during formation of fibrillar adhesions is restricted to 
α5β1 integrins. (Modified from Yamada et al., 2003). 
1.2.7 “Outside-in” signaling   
Integrin activation through “inside-out” signaling increases the affinity of individual 
integrins for their ECM ligands. However, strong cell-ECM interactions foremost 
require increased avidity which is only achieved through clustering of several hundred 
integrins at sites of adhesion, so that individual weak interactions add up to a tightly 
bound cell adhesive site. Dense clustering of ECM-bound active integrin induces the 
recruitment of cytoplamic tail binding proteins to adhesion sites which in turn initiate 
numerous intracellular signaling cascades in a process that has been termed “outside-in” 
signaling (see Fig 1.5). These regulate the activity of signaling proteins, including 
members of the Rho GTPase family, focal adhesion kinase (FAK), extracellular 
regulated kinase (ERK), cyclic AMP (cAMP) dependent kinase, protein kinase C 
(PKC), tyrosine phosphatases as well as phosphate inositol metabolism (Lee and Juliano 
2004). As a result of all these complex signal transduction processes, a large signaling 
hub is assembled at sites of cell adhesion which affects cell cycle progression, 
differentiation, cell shape, survival and cell migration (Lee and Juliano 2004). 
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Fig 1.5. Bi-directional integrin mediated signaling. A. Regulation of integrin activity by 
intracellular proteins, termed “inside-out” signaling. Note that the inactive integrin is bent with 
both subunits associated, while the active integrin exhibits an extended conformation with 
separated subunits (“switchblade” model). B. ECM bound active integrins recruit complex 
intracellular signaling platforms to adhesion sites, resulting in “outside-in” signaling. 
(Modified from Askari et al., 2009). 
One of the earliest events in integrin mediated “outside-in” signaling is the activation of 
Src family kinases (SFKs), tyrosine phosphatases and focal adhesion kinase (FAK). 
FAK acts as a central scaffold and activator for multiple signaling proteins in integrin- 
and receptor tyrosine kinase (RTK) dependent signaling. It is composed of an N-
terminal FERM-homology domain which facilitates integrin binding, a central kinase 
domain and a C-terminal FA targeting domain. Once recruited to nascent focal 
adhesions or focal adhesions (FAs), FAK is activated in response to integrin ligation by 
autophosphorylation on tyrosine residue Y397, which creates a docking site for a 
number of SH2 domain containing proteins including PI-3-kinase, PLCγ and SFK 
family members, including Src and Fyn (Schaller 2001). FAK recruits SFK family 
members to sites of cell adhesion and positions them in close proximity to their target-
effectors which in turn become activated and mediate numerous signaling events (Sieg, 
Hauck et al. 2000). FAK-Src interaction, for instance, stabilizes active Src, which then 
fully activates FAK by phosphorylation of five other sites on FAK (Schlaepfer and 
Hunter 1996). Active SFK-FAK complexes trigger, amongst others, the Ras-MEK-
MAPK pathways, resulting in activation of ERK1/2, c-JUN kinase (JNK) and p38 
MAPK which affect the regulation of cell proliferation, cell growth and differentiation 
(Giancotti and Ruoslahti 1999; Miranti and Brugge 2002). Activation of FAK also leads 
to the recruitment of PI-3-kinase to FAs, leading to activation of downstream effectors 
such as Akt and Gsk3β which regulate cell differentiation and survival. Other sites on 
FAK, such as the C-terminal Proline rich sequence, can serve as binding sites for SH3 
domain containing proteins such as p130Cas and GRAF. Once p130Cas becomes 
phosphorylated by the FAK-Src complex, it is capable to recruit further adaptor proteins 
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such as Crk and Nck. Crk recruitment by active p130Cas initiates the engagement of the 
adaptor protein ELMO and the guanine exchange factor (GEF) Dock180, leading to 
activation of the small GTPase Rac1, which promotes Arp2/3 mediated F-actin 
polymerization (Schaller 2001; Chodniewicz and Klemke 2004). Alternatively, the 
small Rho GTPases Rac1 and Cdc42 can be regulated through the PIX/GIT pathway, 
both of which get targeted to FAK associated paxillin (Hoefen and Berk 2006). The 
latter signaling pathways exemplify that integrins do not only act as important signaling 
receptors and cell anchorage proteins, but also mediate – along with growth factor 
receptor signaling - a number of cytoskeletal remodelling processes via regulation of 
small Rho GTPases. These include master regulators of cell-migration and cell-
contractility such as RhoA, Rac1 and Cdc42 (see Fig 1.6) (Price, Leng et al. 1998; Ren, 
Kiosses et al. 1999).  
To date, more than 156 molecules have been found to form intracellular integrin 
signaling complexes (Zaidel-Bar, Itzkovitz et al. 2007). This enormous number of 
signaling proteins recruited to sites of cell adhesion reflects the vast complexity of 
possible signaling events, which might be even higher when cell-type specific 
expression or different isoforms of the signaling molecules are taken into account. 
 
Fig 1.6. Examples of integrin “outside-in” signaling pathways. Combined integrin and 
growth-factor receptor signaling regulates a huge repertoire of signaling pathways which 
allows the cell to respond to extracellular cues. (Modified from Legate et al., 2009).  
Integrins can also regulate the responses to other cell-surface receptors and vice versa. 
A dense network of crosstalks between multiple signaling pathways downstream of 
integrins and other cell-surface receptors provides a multilevel coordinated control of 
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cell responses to the extracellular environment. Coordinated signaling through α5β1 
integrin and the heparin proteoglycan cell surface receptor syndecan-4 in response to 
FN binding, for instance, has been reported to promote the assembly of FAs and actin-
stressfibers in a Rho dependent manner (Saoncella, Echtermeyer et al. 1999). The 
crosstalk between integrins and receptor protein tyrosine kinases (RTKs), which bind to 
cytokines and soluble growth factors, is yet another extensively studied field of 
coordinated integrin-cell surface receptor signaling. Prominent examples are 
represented by the integrin dependent transactivation of epithelial growth factor 
receptor (EGFR), platelet derived growth factor receptor (PDGFR), vascular endothelial 
growth factor receptor (VEGFR) (Sundberg and Rubin 1996; Soldi, Mitola et al. 1999) 
which in turn are capable to amplify integrin signals. This applies for instance to the 
ERK/Shc pathway, which is triggered in response to combined signals from integrins 
and integrin activated EGF receptors (Moro, Venturino et al. 1998). Another type of 
integrated co-signaling of RTKs and integrins is characterized by integrin induced 
clustering of RTKs which has been demonstrated for EGFR, PDGFR and FGFR 
(Plopper, McNamee et al. 1995; Miyamoto, Teramoto et al. 1996; Sundberg and Rubin 
1996), which is initiated by active integrins organizing signaling platforms, which can 
be subsequently shared with clustered RTKs for combined signal propagation. All these 
examples only represent a small selection of possible crosstalks between integrin and 
RTK triggered signaling pathways. For detailed information about the RTK-integrin 
cross-talk, the reader may be referred to the following review: (Giancotti and Tarone 
2003). 
1.2.8 Integrins role in development 
The analysis of genetically engineered mice provides a powerful tool to study integrin 
function during development. Up to now, all β subunits and all but two α subunits (αD, 
αX), have been knocked out in mice. The ablation of integrin genes leads to various 
phenotypes, ranging from apparently normal mice to early embryonic lethality (see Fig 
1.7). 
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Fig 1.7. Integrin knock out phenotypes. The diversity of different phenotypes emphasizes the 
important functions of integrins in development as well as in maintaining tissue integrity. V/F, 
viable / fertile; (Modified from Bouvard et al., 2001).   
Targeted inactivation of genes encoding for the α5 integrin results in a severe phenotype 
with embryonic lethality around E10-11. Pronounced defects in the posterior trunk and 
the yolk sac vasculature demonstrate the essential role of α5β1 integrin in mesoderm 
function, formation or migration. Interestingly, α5-null mice progress much further than 
FN-null mice, suggesting a compensatory role for other FN-binding integrins in FN 
activation and fibril assembly (Yang, Rayburn et al. 1993). Indeed, mice carrying 
deletions of both the α5 and the αv integrin gene exhibit an even more severe phenotype 
than FN-null mice and display a severly compromised FN matrix assembly, which 
proved that αv integrins facilitate FN assembly in absence of α5β1 (Yang, Bader et al. 
1999).  
The development of conditional, tissue-specific knock out techniques helps to overcome 
the problem of recessive embryonic lethality of most integrin-null mice (α4, α5, α8, αv) 
and facilitates the analysis of integrins role for adhesion and signaling processes in a 
tissue specific manner. Integrins are still object of extensive studies, particularly since 
integrin mutations seem to be involved in the progression of various diseases. 
1.3 Fibronectin (FN) 
1.3.1 Fibronectin - Structure and distribution 
FN is a widely distributed high-molecular weight ECM glycoprotein of about 250 kDa, 
which can be found in connective tissue matrices, basal laminae and plasma of 
vertebrates (Kornblihtt, Pesce et al. 1996). It is one of the earliest ECM proteins to be 
assembled and regulates numerous processes including cell attachment, migration, 
survival, proliferation, differentiation (Ffrench-Constant and Hynes 1988; Smith, Symes 
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et al. 1990). FN is a modular organized protein that consists of an array of type I, II and 
III domains which are later found also in a wide range of other vertebrate proteins (see 
Fig 1.8). The type I and II domains contain two intra-chain disulfide bridges, while type 
III domains lack disulfide bonds. Type I domains contain highly conserved aromatic 
amino acid residues and disulfide bridges building a hydrophobic core which is 
enclosed by stacked β-sheets (Baron, Norman et al. 1990). The type II domains are 
made up of two anti-parallel β-sheets that are linked via the disulfide bridges in a 
perpendicular orientation to each other (Constantine, Brew et al. 1992). FN’s type III 
domain structure has been extensively studied by means of nuclear magnetic resonance 
spectrometry (NMR) and X-ray crystallography. These data demonstrate that type III 
domains are composed of seven β-strands that form a sandwich of two anti-parallel β-
sheets which are connected to each other through flexible loops (Dickinson, 
Veerapandian et al. 1994).  
The FN molecule is characterized by several specific features: It is secreted as a 
disulfide-bonded dimer, and the dimerization seems to be required to assemble FN into 
a fibrillar matrix (see Fig 1.8) (Schwarzbauer 1991; Leiss, Beckmann et al. 2008). 
 
Fig 1.8. Schematic depiction of the modular structure of fibronectin. FN consists of three 
different modules (type I, blue; type II, brown; type III, green). The alternatively spliced 
extradomains B, A, and the variable region (v) are shown in ochre. The dimer forms via two 
disulfide-bonds at the C-terminus. Integrin binding sites, as well as binding domains for FN, 
collagen, fibrin, heparin and bacteria are indicated. Note that the α5β1 as well as the αIIbβ3 
integrins require the synergy region in domain III9 to bind to the RGD motif located in domain 
III10. (Modified from Leiss et al.)   
Furthermore, the FN gene can be alternatively spliced allowing the expression of up to 
20 monomeric isoforms in man and up to 12 in mouse which may result in an even 
larger variety of FN dimers (Pankov and Yamada 2002). Finally, FN exists in two 
forms; cellular FN (cFN), which is present in tissues where it is assembled into a 
fibrillar matrix, and hepatocyte produced plasma FN (pFN), which is secreted at high 
concentrations (300 µg/ml in man) into the blood where it remains in a non-fibrillar, 
soluble form (Pankov and Yamada 2002) and is implicated in blood clotting, skin 
wound healing, atherosclerosis and liver fibrosis (Kornblihtt, Pesce et al. 1996). 
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1.3.2 FN assembly – a cell mediated process 
The existence of fibrillar cFN and soluble pFN largely results from the fact that the 
assembly of the FN fibrils is a cell-driven process, in which integrin cell-surface 
receptors play a central role. Integrins shift between a low affinity (also called inactive) 
and a high affinity (active) conformation (Luo, Carman et al. 2007). In tissues, cells 
express activated integrins that immediately bind cFN. In blood, haematopoietic cells 
express their integrins in an inactive conformation, which prevents cells from binding 
pFN and assembling fibrils. As soon as the blood cell integrins, however, shift into the 
high affinity conformation, for example when platelets are activated in response to a 
vascular injury, pFN is bound and assembled into fibrils, which in the case of platelets 
are required for thrombus stability (Ni, Yuen et al. 2003; Cho and Mosher 2006). A 
recent report showed that pFN can also diffuse into tissues where it is incorporated into 
the fibrillar matrix (Moretti, Chauhan et al. 2007). 
The assembly of a FN matrix is a complex process involving interactions between 
various self assembly sites along the length of the molecule, which facilitate the 
elongation and stabilization of the fibrils. During assembly, FN is initially organized 
into arrays of fine, cell-associated fibrils, which accumulate and become gradually 
converted into a dense network of detergent-insoluble fibrils. The differential solubility 
of the FN matrix in the detergent deoxycholate (DOC) underlies the principle for its 
biochemical fractionation (Wierzbicka-Patynowski, Mao et al. 2004). The mechanisms 
of FN self-assembly and fiber organization are still poorly understood but are probably 
determined by intermolecular interactions involving several FN domains 
simultaneously. Up to now at least six FN self-binding sites have been identified. The 
site located in the first five type I modules (I1-5) of the N-terminus is considered to be 
the most important one, since fragments containing these N-terminal domains can 
completely inhibit FN-fibrillogenesis without affecting FN-integrin interactions 
(Wierzbicka-Patynowski and Schwarzbauer 2003; Mao and Schwarzbauer 2005). A 
further self assembly site is made up of domains III1-2 and seems to promote FN 
assembly through the interaction between III1 and C-terminal modules, which in turn 
unmasks additional FN assembly sites (Xu, Bae et al. 2009). There is a number of 
conflicting reports about other regions along the FN molecule implicated in FN self-
binding. For a review, the reader may be referred to (Mao and Schwarzbauer 2005). 
1.3.3 Fibronectins cell binding motifs 
FN fibrils provide structural support for cell adhesion at the same time as the adhesion 
receptors, most notably integrins, transduce signals that promote actin dynamics, cell 
migration, cell proliferation and apoptosis (Larsen, Artym et al. 2006; Vakonakis and 
Campbell 2007). Cell adhesion to FN is mainly dependent on the RGD motif located in 
the 10
th
 type III domain (III10) (see Fig 1.8 and Fig 1.9). This RGD motif is bound by 
α5β1 integrin (Pierschbacher and Ruoslahti 1984), all members of the αv subfamily, 
α8β1, α9β1 and the platelet specific αIIbβ3 integrin (see Fig 1.8) (Hynes 2002; Liao, 
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Gotwals et al. 2002). Among FN binding integrins, however, α5β1 integrin is 
considered of major importance for the formation of an elaborate meshwork of FN 
fibrils.  
α5β1 integrins require a second FN-binding site in addition to RGD, called synergy 
region, to obtain maximum binding affinity. This binding site comprises the PSHRN 
minimal sequence and is located in the ninth type III module (III9) adjacent to the RGD 
motif (see Fig 1.8 and 1.9); (Nagai, Yamakawa et al. 1991; Bowditch, Hariharan et al. 
1994; Aota and Yamada 1997; Chada, Mather et al. 2006). A combination of electron 
microscopy and surface plasmon resonance analyses demonstrated that the synergy 
region is not in contact with the α5β1 integrin bound to FN, and propose an indirect 
function of the synergy region for the high affinity binding of α5β1 to FN by optimally 
exposing the flexible RGD motif, or by inducing long range electrostatic steering 
(Baron, Main et al. 1992; Takagi, Strokovich et al. 2003). More recently it was reported 
that the α5 integrin subunit engages FN’s synergy site in response to increased 
cytoskeletal forces tensioning the α5β1-FN bond. This study proposes a “catch-bond” 
model in which FN-bound integrin α5β1 is capable to switch between two states of 
activation; an active state, facilitating binding to RGD, and a tensed active state, which 
results in simultaneous binding of synergy region and RGD motif. The additional 
interaction strengthens integrin-ECM interactions and switches on specific integrin 
mediated signaling pathways in a force-dependent manner (Friedland, Lee et al. 2009). 
Mutations in the synergy region reduce α5β1 integrin-mediated FN matrix assembly 
(Sechler, Corbett et al. 1997), which could result from a shift from α5β1 to αv integrin 
engagement, as the latter does not require the synergy region for optimal FN binding. 
 
Fig 1.9. Schematic representation of FN domain pair type III9-10. The RGD motif extends in a 
loop-like structure from domain III10. The synergy region, encoded by the minimal sequence 
PHSRN, is located in domain III9, adjacent to the RGD motif (Modified  from Leiss et al., 2008). 
Some integrin interaction sites within the FN meshwork can be regulated by alternative 
splicing. One alternatively spliced domain is the variable-region (v-region), which can 
give rise to five different splice variants in man. Rodents possess two variants of the v-
region, named V120 and V95 according to their molecular weight (Schwarzbauer 
1991). cFN harbours a v-region in both subunits, while pFN contains only one subunit 
with a v-region. Biosynthetic analyses of intracellular FN dimer formation revealed, that 
at least one v-region is essential for formation and secretion of native FN dimers 
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(Schwarzbauer, Spencer et al. 1989). The v-region, particularly the V120 isoform, can 
associate with two non-RGD-binding integrins, α4β1 and α4β7, both of which bind the 
minimal sequences LDV and REDV (Wayner, Garcia-Pardo et al. 1989; Guan and 
Hynes 1990). Recruitment of FN by α4β1 is able to induce FN assembly in vitro, which 
is independent of the interaction of α5β1 with the RGD-motif (Sechler, Cumiskey et al. 
2000). It is unclear, however, whether α4β1-mediated FN fibrillogenesis is relevant in 
vivo. The alternatively spliced extra domain A (EDA) and extra domain B (EDB) are 
both exclusively present in cFN (see Fig 1.8), and the EDGIHEL sequence of the EDA 
is thought to facilitate binding to α4β1 and α9β1 integrins  (Liao, Gotwals et al. 2002; 
Shinde, Bystroff et al. 2008). While the in vivo role of the integrin binding site in EDA 
has not been determined yet, ablation of either the entire EDA or EDB allows normal 
development, while ablation of both extradomains (EDA and EDB) results in early 
embryonic lethality with multiple cardiovascular defects (Fukuda, Yoshida et al. 2002; 
Muro, Chauhan et al. 2003; Astrof, Crowley et al. 2007). Since deposition of FN fibrils 
in mutant mice constitutively lacking the EDA domain was not affected, it is likely that 
the integrin binding site in EDA is not essential for assembling a FN matrix.  
In addition to the previously mentioned integrin binding sites, FN also exhibits two 
heparin binding domains that mapped to the first five type I domains (I1-5) and the three 
type III domains preceding the v-region (III13-15) (see Fig 1.8) (Pankov and Yamada 
2002). Both domains facilitate the binding of non-integrin cell surface receptors, most 
notably members of the syndecan family. Although it has been shown that syndecan-2 
and syndecan-4 promote FN assembly (Klass, Couchman et al. 2000; Woods, Longley 
et al. 2000; Morgan, Humphries et al. 2007) via distinct mechanisms, it has not been 
examined whether the interaction of syndecans with FN by itself is sufficient to induce 
FN fibril formation. 
1.3.4 Fibronectin - a “master organizer” of ECM biogenesis 
The functional properties of the FN fibrillar matrix are diverse and represent a prime 
example of how ECM protein assembly functions. FN fibrils possess binding sites for 
multiple ECM components (Fig 1.1), which are used to orchestrate the assembly of 
several other ECM proteins. Up to now, the presence of extracellular FN fibrils has 
been shown to be essential for the assembly of fibrillins (Kinsey, Williamson et al. 
2008; Sabatier, Chen et al. 2009), collagen I, III and thrombospondin-1 (McDonald, 
Kelley et al. 1982; Sottile and Hocking 2002; Velling, Risteli et al. 2002; Li, Van Den 
Diepstraten et al. 2003), fibulin-1 (Godyna, Mann et al. 1995) and fibrinogen (Pereira, 
Rybarczyk et al. 2002). Moreover, it has been reported that a continuous assembly and 
supply of FN is a prerequisite for continued assembly and matrix stability of collagen I, 
thrombospondin-1 and fibrillin-1 (Sottile and Hocking 2002; Dallas, Sivakumar et al. 
2005).  
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1.3.5 TGF-β  
Deposition into the ECM is a major mechanism known to regulate bioavailability and 
activity of growth factors. Within the ECM, growth factors can be either stored in an 
inactive state, or activated to carry out critical functions in situ during tissue 
morphogenesis and repair. The activity of numerous growth factors, including fibroblast 
growth factor (FGF), vascular endothelial growth factor (VEGF), bone morphogenic 
protein (BMP) and transforming growth factor β (TGF-β) is regulated through their 
association with the ECM (Flaumenhaft and Rifkin 1992; Taipale and Keski-Oja 1997; 
Gregory, Ono et al. 2005). A well characterized example of how ECM regulates growth 
factor activity is transforming growth factor β1 (TGF-β1), a prototypic member of a 
large family of secreted cytokines that plays a crucial role in multiple processes during 
development, including vascular development, hematopoiesis and ECM production, and 
in the maintenance of tissue homeostasis in adult life (for a review, see (ten Dijke and 
Arthur 2007). Most cells secrete TGF-β as an inactive complex containing the TGF-β 
precursor, the so called latency-associated protein (LAP) linked to various latent TGF-β 
binding proteins (LTBPs) (see Fig 1.10; (Dallas, Miyazono et al. 1995)). LTBPs are 
members of the fibrillin superfamily and are well established as extracellular key-
regulators of TGF-β actions reviewed in (Hyytiainen, Penttinen et al. 2004). They 
facilitate the secretion of latent TGF-β from cells and target the growth factor to the 
ECM. Finally, they provide mechanisms to activate TGF-β from ECM associated latent 
complexes either through proteolytic cleavage or via a αvβ6 integrin dependent 
mechanism (Annes, Rifkin et al. 2002; Dallas, Sivakumar et al. 2005; Fontana, Chen et 
al. 2005). Recent studies have shown that the continuous assembly of LTBP-1, similarly 
to fibrillin-1, is critically dependent on the continual presence of a fibrillar FN matrix, 
highlighting the fact that FN does not only act as an orchestrator for assembly of 
multiple ECM proteins, but also modulates growth factor signaling events by regulation 
of the growth factors bioavailability. 
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Fig 1.10. Integrin-mediated activation of ECM anchored latent TGF-β. Latent TGF-β is 
comprised of TGF-β (magenta), latency associated protein (LAP, orange) and latent TGF-β 
binding protein (LTBP, black). Once latent TGF-β is fixed to the ECM, integrin αvβ6 on an 
adjacent cell may bind to LAP and transmit an actomyosin generated retractile force which 
releases biologically active TGF-β (Based on Annes et al., 2002).  
TGF-β superfamily members utilize a variety of type I and II Ser/Thr kinase cell surface 
receptors. The vast majority of cell-types express the activin receptor like kinase-5 type 
I receptor (ALK5) and TGF-β type II receptors (TGF-βRII). One of the best 
characterized mechanisms of TGF-β initiated signal transduction is mediated via ALK-
mediated phosphorylation of Smad effector proteins. They can be grouped in three 
classes based on their functions; the receptor-activated Smads (R-Smad 1, 2, 3, 5 and 8), 
the common mediator Smad (Co-Smad 4) and inhibitory (I-) Smads 6 and 7. ALK5, for 
instance, mediates the activation of the R-Smads 2 and 3, whereas the endothelial 
specific ALK1 mediates the activation of the R-Smads 1 and 5. Upon activation, R-
Smads are capable to associate with Co-Smads resulting in the formation of a 
heteromeric complex that accumulates in the nucleus and triggers gene transcription 
(see Fig 1.11) (reviewed in (Rahimi and Leof 2007; ten Dijke and Arthur 2007)). 
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Fig 1.11. Canonical pathway of TGF-β induced Smad activation. In most cells, TGF-β signals 
via TGF-βRII and ALK5, resulting in activation of R-Smad 2 and 3 mediator proteins. 
Endothelial cells additionally express the ALK1 receptor, which activates R-Smad 1 and 5 in 
response to TGF-β binding. Activated R-Smads associate with Smad 4, translocate in the 
nucleus, where they regulate the expression of target genes (Modified from ten Dijke et al., 
2007). 
Genetic ablation of TGF-β pathway components impressively underscored the 
importance of TGF-β signaling for proper yolk sac angiogenesis and hematopoiesis 
during embryonic development (Goumans, Liu et al. 2009). 
1.3.6 FNs role in development 
The expression of FN in mice sets in at the blastocyst stage where it is involved in 
parietal endoderm migration and trophoblast outgrowth during implantation (Armant, 
Kaplan et al. 1986). Later in gastrulation, FN expression is mainly localized to the 
ectodermal-mesodermal interface, where it may promote the migration of mesodermal 
cells (Smith, Symes et al. 1990). Experiments utilizing anti-FN antibodies injected into 
embryos during gastrulation inhibited lateral migration of mesodermal cells and the 
migration of ectoderm derivatives such as neural crest cells (Lallier, Artinger et al. 
1990). In addition, FN has been reported to promote the migration of primordial germ 
cells; it is implicated in heart development, somitogenesis and vasculogenesis (Linask 
and Lash 1986; Risau 1991; Icardo, Nakamura et al. 1992). The initiation of epithelial 
branching, a process taking place during the development of organs including salivary 
gland, lung and kidney has also been shown to depend on FN as an inducer of cleft 
formation (Sakai, Larsen et al. 2003).  
Targeted inactivation of the FN gene in mice leads to early embryonic lethality around 
E8.5 due to severe defects in the development of the mesoderm and mesoderm-derived 
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structures. Very early occurring developmental processes, such as implantation and 
initiation of gastrulation, which is accompanied by extensive mesodermal movement, 
proceed normally in FN-null embryos. Until E7.5, mutant homozygous embryos appear 
largely normal with respect to their number of germlayers and the morphology of 
extraembryonic membranes. Abnormalities are first visible by E8.0 and are manifested 
in a shortened anterior-posterior axis, a deficient head and trunk mesoderm, a 
disorganized notochord and a complete absence of somites (see Fig 1.12). Additionally, 
the ectoderm of FN-null embryos at this stage shows multiple bends and distortions, 
whereas allantois and yolk sac including red blood islands appear to be normal 
compared to wild-type controls.  By E8.5, the shortened anterior-posterior axis is even 
more pronounced between mutants and wild-type littermates at this stage. The head-
folds have arrested development and appear distorted. Some FN-null embryos exhibit a 
kinked neural tube and only a fraction possesses a primitive heart bulge, while none of 
the mutant embryos has initiated turning. In contrast to the 8-12 somite pairs present in 
wild-type control embryos at this stage, FN-null embryos lack somites (George, 
Georges-Labouesse et al. 1993; Georges-Labouesse, George et al. 1996). In summary, 
the observed defects are proving the essential requirement of FN for normal 
development and in particular for the development of mesoderm-derived tissues.  
 
Fig. 1.12. Whole mount images of wild-type and FN-null
-
 embryos. Side (top) and dorsal view 
(bottom) of E8.0 embryos. FN-null embryos exhibit a notably shortened anterior-posterior axis 
(A-P axis) as compared to the wild-type littermate. Note that all mutants lack somites and that 
some of the FN
-/-
 embryos lack a primitive heart (right). al, allantois; h, heart; s, somite; Scale 
bar: 500 µm. 
1.3.6.1 FNs role in somitogenesis 
Somites are mesoderm-derived structures, which are formed transiently during 
vertebrate development and give rise to the prospective skeletal muscles, dermis and 
vertebra in the adult organism. Somites are budding off as regular shaped segments in a 
head-to-tail manner from the anterior end of the presomitic mesoderm (PSM), which is 
located paraxially to the neural tube demarcating the A-P axis of the embryonic midline 
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(see Fig 1.13). In terms of their position, somites can be divided into anterior and 
posterior groups, each of which exhibits individual gene regulation and growth rate. The 
mechanism of pre-patterning and formation of epithelialized somite-blocks with defined 
boundaries is dependent on a plethora of temporally exactly defined signaling events, 
which are mainly represented by a cyclic signaling network involving the Notch, 
fibroblast growth factor (FGF), Wnt, and retinoic acid pathways (reviewed in (Pourquie 
2001; Chong and Jiang 2005; Gridley 2006; Aulehla and Pourquie 2008)). A crucial 
role for FN-integrin signaling in somite formation has been suggested by the 
observation, that FN-deficient mouse embryos completely lack somites, whereas mice 
lacking the FN receptor integrin α5β1 develop only anterior somites and completely 
lack posterior somites (George, Georges-Labouesse et al. 1993; Yang, Rayburn et al. 
1993). Targeted inactivation of the fibronectin1 and α5 integrin genes in zebrafish 
revealed that the FN-α5 integrin interaction is indeed indispensable for somite 
epithelialization and the maintenance of intersomitic boundaries of the anterior somites 
(Julich, Geisler et al. 2005; Koshida, Kishimoto et al. 2005). The restriction of the 
observed defects to the anterior somites is probably due to a functional redundancy of 
FN binding integrins exclusively expressed in the caudal located presomitic mesoderm 
of the zebrafish. Despite the converse orientation of somites groups affected by integrin 
α5β1-FN signaling in zebrafish and mice, somitogenesis provides a telling example on 
how FN-integrin interactions affect the mesodermal development.   
 
Fig 1.13. Formation of somites from the presomitic mesoderm (PSM). A. Pairs of somite 
blocks bud off simultaneously from the anterior end of the presomitic mesoderm on both sides of 
the neural tube. Anterior somites differentiate, giving rise to dermatome, myotome and 
sclerotome (depicted in blue, red and orange). B. Side view of an E9.5 embryo. Note the somite 
blocks marked with black dots along the A-P axis.  a, anterior somite; p, posterior somite; Scale 
bar: 500 µm 
1.3.6.2 FNs role in neovessel formation 
The cardiovascular system is the first organ to develop and to become functional during 
embryogenesis. A characteristic trait of FN-null embryos is the severely impaired 
development of the cardiovascular system.  
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The first step in neo-vascularization is the formation of the so called primitive vascular 
plexus by in situ differentiation of mesodermally derived angioblasts - vascular 
endothelial cell precursors that have not yet formed a lumen (see Fig 1.14). This 
process, termed vasculogenesis, is largely dependent on vascular endothelial growth 
factor (VEGF) and fibroblast growth factor (FGF), and results in the generation of 
primitive blood vessels, which basically consist of endothelial-lined capillaries. Once 
the primitive vascular plexus has formed, more endothelial cells are generated in a 
second step, which leads to formation of new capillaries. These can be either formed by 
sprouting or splitting (intus-susception) of pre-existing capillaries, in a process termed 
angiogenesis (see Fig 1.14). During angiogenesis, some capillaries are further 
remodelled into larger vessels and recruit several layers of smooth-muscle cells to the 
vessel walls in a platelet derived growth factor (PDGF)-dependent manner. While 
vasculogenesis is restricted to early developmental stages, angiogenesis starts during 
development and lasts throughout post-natal life (Flamme, Frolich et al. 1997; Pepper 
1997; Risau 1997).  
Studies of mutant mice revealed that endothelial, ECM-bound integrins trigger 
numerous signaling pathways crucial for vasculogenesis and angiogenesis. Both 
processes of neovessel formation seem to require the interaction of fibrillar FN with its 
integrin receptors α5β1 and αvβ3 (Zhou, Rowe et al. 2008) for a review, see (Stromblad 
and Cheresh 1996). This finding may also explain the severe vascular phenotype 
observed in FN-null embryos. Similarly, TGF-β was shown to be essential for these 
neo-vessel formation processes, since mice with compromised TGF-β signaling exhibit 
severe vascular defects, characterized by a stalled angiogenesis in yolk sacs (see Fig 
1.13; for a review, see (ten Dijke and Arthur 2007). 
 
Fig 1.14. Processes of neovessel formation. Endothelial progenitor cells (angioblasts) 
differentiate to endothelial cells that form the primitive vascular plexus in a process called 
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vasculogenesis. Angiogenesis leads to formation of new vessels from pre-existing capillaries in 
two different ways: Either through sprouting of capillaries or through splitting of a capillary 
resulting in formation of two capillaries. Growth factors including VEGF, TGF-β, FGF and 
PDGF, as well as integrin interactions with a fibrillar FN matrix, in which the endothelial cells 
are embedded, are required for these processes (Modified from ten Dijke et al., 2007).  
1.4 Aims of the projects 
Part I 
It is thought that FN assembly is induced by α5β1 integrin binding to the RGD motif 
located in FN’s 10th type III domain along with the synergy motif located in the adjacent 
9
th
 type III domain. Additional RGD binding integrins, including αvβ3 and αIIbβ3 can 
partially substitute for α5β1 integrin in FN matrix assembly. Gene ablation studies in 
mice confirmed that these two RGD dependent FN matrix assembly mechanisms 
induced by either α5β1 or αv integrins exist in vivo and that each of them can 
compensate for the absence of the other. To test how FN binding receptors compensate 
for each other during development and FN fibril formation, it would be necessary to 
generate double, triple or even higher order combinations of FN cell-surface receptor 
knock out mice. However, the necessary intercross combinations can not be performed 
since most integrin-null mice are recessive lethal (α4, α5, αv, α8). Moreover, FN cell-
surface receptors, including integrins and syndecans, interact with multiple ECM 
components and vice versa, which would further complicate the interpretation of the 
phenotypes. In order to specifically test the role of FN-RGD binding integrins in vivo, a 
mouse strain was generated in which the aspartic acid residue (D) of FN’s RGD motif 
was exchanged against glutamate (E), resulting in a complete inactivation of this motif 
for cell adhesion. One goal was to investigate the consequences of this knock in 
mutation in vivo with a particular emphasis on the development of the mesoderm and 
mesoderm-derived structures. A second goal was to characterize the effects of the FN-
RGE mutation on FN matrix assembly in vivo and in vitro.  
Part II 
FN is a dimeric glycoprotein, and several studies reported that the dimerization is 
essential for the assembly of a fibrillar FN matrix. All these studies were performed in 
vitro and with truncated FN polypeptides. In order to test this function with full length 
FN in vivo, a genetically modified mouse strain was generated which exclusively 
expresses a monomeric form of FN. The second goal of this study was to investigate the 
consequences resulting from this mutation on the physiological and molecular level. 
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2 Materials and Methods    
2.1 Common chemicals 
Unless further specified, all chemicals used in this study were purchased from: Sigma 
Aldrich (Munich, Germany), Riedel de Haen (Seelze, Germany), Carl Roth GmbH 
(Karlsruhe, Germany), Merck (Darmstadt, Germany), Serva (Heidelberg, Germany) and 
Roche Diagnostics GmbH (Mannheim, Germany).   
2.2 Animals 
All mouse strains used in this study were maintained and bred in the animal facility of 
the Max-Planck-Institute of Biochemistry (Martinsried, Germany). The strains were 
backcrossed to C57BL6 for at least 7 generations. 3-4 weeks after birth, the pups were 
weaned, separated according to gender and marked with ear tags. For genotyping, tail- 
tip biopsies were taken and immediately subjected to DNA isolation (2.8.1.1). For 
matings, female mice of at least 6 weeks of age, and male mice older than 9 weeks were 
used. All experiments were carried out according to the German Animal Protection 
Law.  
2.2.1 Breeding scheme 
In order to generate mice homozygous for the FN knockin mutations, heterozygous 
mice were intercrossed overnight. Successful mating was indicated by a female vaginal 
plug whose presence marks the day 0.5 of gestation (also: 0.5 dpc or E0.5). Embryos 
were harvested and dissected at indicated days of gestation. 
2.2.2 Dissection of mouse embryos 
Both mutations in FN analysed in this study represented a recessive embryonic lethal 
trait. Therefore it was necessary to analyse mouse embryos at defined post-implantation 
stages. In order to dissect embryos, the pregnant mother was euthanized and laid supine 
on a Styrofoam pad. Subsequently, the animal was fixed on the pad with needles and 
soaked with 70% ethanol to reduce the risk of contaminating the dissection. Using 
surgical scissors, a lateral incision along the midline was made to expose the abdominal 
cavity. The female reproductive organs, two uterine horns, the oviduct and the ovaries, 
are located at the dorsal region of the body cavity. The uterine horns containing the 
embryos were grasped below the oviducts and were removed by cutting them free along 
the mesometrium. Dissected uteri were transferred into ice-cold PBS and each embryo 
was separated by cutting between implantation sites along the uterine horn. All further 
dissection steps were performed under a stereomicroscope (2.9.5) using watchmaker’s 
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forceps. At each embryo, the muscle layer lining the decidual tissue was removed and 
the embryo was carefully shelled out of the decidua. Finally, the yolk sac and amnion 
were removed and little pieces of the yolk sac were collected for genotyping (2.8.1.2). 
Dependent on the further histological application, the bare embryo was either stored in 
ice-cold PBS or fixed overnight at 4°C in the appropriate fixative. 
10 x PBS: 80 g NaCl, 14.4 g Na2HPO4, 2.4 g KH2PO4, 2 g KCl filled up to 1 l 
with ddH2O and adjusted to pH 7.4 with HCl 
2.3 Histological analysis of Fibronectin (FN) knockin mice 
2.3.1 Material Histology 
Embedding machine: Shandon, HistoCentre 2 
Microtomes: Microm, Vacutome HM5000M, HM355S 
Cryomold: Sakura, Tissue-Tek, #4566 
Cryomatrix: Thermo Scientific, Shandon Cryomatrix
TM
, #6769006 
Microscope slides: Thermo Scientific, Menzel-Gläser Superfrost®Plus, #J1800AMNZ 
Entellan mounting medium: Merck, #1.07960 
Meyers hemalaun: Merck, #1.09249 
Eosin G: Merck, #1.09844 
2.3.2 Histological methods 
The performance of a significant histological analysis strongly depends on the best 
possible conservation of the specimen’s morphology and its biological activity. Both 
properties of the specimen are negatively affected by fixation and embedding, which are 
crucial steps in the histological workflow. Therefore it is necessary to choose the most 
suitable from a variety of fixation and embedding protocols for each particular 
experiment. Paraformaldehyde (PFA) and alcohols (ethanol, methanol) are among the 
most widely used fixatives. PFA – and alcohol to a lesser extent - preserves the 
morphology very well but may compromise the biological activity of the specimen. In 
contrast, unfixed tissue is prone to morphological disaggregation, but features a 
maximum of biological activity. If a histological assay is rather unsusceptible for PFA 
treatment, PFA fixation and paraffin embedding is the method of choice. Paraffin 
embedding preserves the morphology of the specimen very well and allows cutting of 
thin sections of around 6 µm thickness (2.3.2.1). Freezing of the specimen in cryomatrix 
was the second embedding method used in this study (2.3.2.2). This procedure does not 
require fixation and thus optimally maintains the biological activity, but results in a 
limited conservation of the morphology. 
PFA fixing solution: 3.7% PFA in PBS, boiled briefly and cooled on ice 
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2.3.2.1 Preparation of Paraffine sections 
Pregnant mice were sacrificed at selected days of gestation, embryos were dissected 
(2.2.2) and fixed in freshly prepared, ice-cold paraformaldehyde (3.7% PFA in PBS) 
overnight at 4°C. Next day, the embryos were washed with ice-cold PBS and then 
dehydrated by sequential incubation in ethanol solutions with ascending concentrations 
(70%, 80%, 90%, 95% and 100%) for 1 h each. Subsequently, the embryos were 
incubated in fresh xylene for 2 x 10 min and then transferred in 5 ml of melted paraffin–
wax for 2 h at 65°C. The paraffin was changed further two times, followed by 2 h 
incubation at 65°C each time. Next, the embryos were embedded in a paraffin block 
using an embedding machine and were then stored at 4°C until cutting. For cutting, the 
paraffin block was mounted in a microtome and cut into 6 µm thick sections. During the 
process, the quality of each section was routinely checked under a light microscope 
(2.9.4). Finally, sections were air-dried overnight at 37°C and subsequently stored at 
4°C. 
2.3.2.2 Preparation of Cryo-sections 
Embryos were sequentially incubated in sucrose solutions with ascending 
concentrations (0.5%, 1%, 2%, 5%, 10%, 20% sucrose in PBS) for 1 h each step. 
Subsequently, the embryos were orientated on the bottom of a small tissue tek plastic 
container under a stereomicroscope (2.9.5) and all residual liquids were carefully 
removed using the tip of a facial tissue. Next, the embryos were covered with 
Cryomatrix
TM
 and subsequently frozen by placing the whole container on a copper plate 
situated on dry-ice. Frozen blocks were stored at - 80°C until cutting. For cutting, the 
tissue tek container was removed, the frozen block mounted on a cryo–microtome and 
cut into 8 µm sections at a maintained temperature of –17°C. The sections were 
transferred to glass microscope slides and dried for ~ 20 min at RT before they were 
stored at -80°C.   
2.3.2.3 Hematoxylin/Eosin (H&E) staining of sections 
H&E staining is a commonly used histological technique to demonstrate the 
morphology of a broad variety of different tissue structures. Haematoxylins major 
oxidation product Hematein stains basophilic molecules, such as DNA, RNA and acidic 
proteins in blue, whereas Eosin stains cytoplasmic components and connective tissues 
in pink. In order to perform an H&E stain, paraffin sections were de-paraffinised for 2 x 
5 min in xylene.  Afterwards, sections were re-hydrated in 100%, 95%, 90%, 80% and 
70% ethanol for 2 min each. Next, the slides were stained for 1 min in a Hematoxylin 
solution, followed by a washing step in tap water. After the Hematoxylin stain was 
completed, the slides were stained for 1 min in Eosin solution. The staining was again 
terminated by a washing step in tap water. In order to allow the final mounting step of 
the slides, the sections had to be dehydrated by subjecting the slides to ethanol and 
xylene in the reverse order as mentioned above. Finally, slides were mounted with 
Entellan and stored at 4°C. 
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2.4 Immunological Methods 
2.4.1 Material Immunological Analysis 
Antibody Company Cat. No. species 
dilutions 
special treatments 
IF IHC WB 
FACS / 
MACS 
α4 integrin-
PE BD 557420 rat - - - 1:200   
α5 integrin-
PE PharMingen 557447 rat 1:50 - - 1:200   
α6 integrin-
PE PharMingen 555736 rat - - - 1:200   
αv integrin-
PE BD 551187 rat - - - 1:200   
β1 integrin-
PE BioLegend 102207 rat - - - 1:200   
β3 integrin-
PE eBioscience 12-1106 rat - - - 1:200   
cCasp 3 
Cell 
signaling #9661 rabbit - 1:200 - - 
boil sections 15 min in 10 
mM Citrate pH 6.0 
Endomucin Santa Cruz sc-53941 rat 1:300 1:300 1:500 -   
pERK1/2 
Cell 
signaling #4376 rabbit - - 1:1000 - 
WB: block and incubate in 
5% BSA/PBS 
ERK1/2 
Cell 
signaling #9102 rabbit - - 1:1000 - 
WB: o/N at 4°C in 5% 
BSA/PBS 
FAK Abcam ab71563 rabbit - - 1:1000 - 
WB: block and incubate in 
5% BSA/PBS 
pY397FAK Biosource #44-624G rabbit - - 1:1000 - 
WB: o/N at 4°C in 5% 
BSA/PBS 
FN Chemicon Ab 2033 rabbit 1:400 1:400 1:20000 -   
FN 
M. 
Humphries - chicken 1:300 1:300 - -   
GAPDH Calbiochem CB 1001 mouse - - 1:25000 -   
Lamin A 
Cell 
signaling #2032 rabbit - - 1:1000 -   
LTBP-1 C. Heldin - rabbit 1:300 - 1:20000 -   
Pecam (CD 
31) PharMingen 01951D rat 1:300 1:200 -  -   
phalloidin 
Alexa 488  Invitrogen A12379  - 1:400 -  -  -   
phalloidin 
Alexa 647  Invitrogen A22287  - 1:400 -  -  -   
pHiston3 Upstate 16-189 rabbit - 1:100 - - 
treat sections 30 min in 2 
M HCl at 60°C 
pSmad2/3 Santa Cruz sc-11769-R rabbit -  -  1:1000 -  
WB: o/N at 4°C in 5% 
BSA/PBS 
Smad2/3 Santa Cruz sc-8332 rabbit -  -  1:1000 -    
Smad4 Epitomics #1676-1 rabbit -  -  1:5000 -    
tubulin Chemicon Mab1864  rat - - 1:10000 -    
sec. 
antibodies                 
anti-mouse 
HRP BioRad 170-6516 goat - - 1:20000 -    
anti-rabbit 
HRP BioRad 170-6515 goat - - 1:20000 -    
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anti-rat HRP Jackson 712/035/150 donkey - - 1:20000 -    
streptavidin-
HRP Vector Lab. SA-5004 - - - - - 
1:1000 in solid-phase 
binding assay 
anti- rabbit 
Alexa 488 Invitrogen A11008 goat 1:400 1:300 - -   
anti-rabbit 
Alexa 547 Invitrogen A11010 goat 1:400 1:300 - -   
anti-rabbit 
Alexa 647 Invitrogen A21244 goat 1:400 1:300 - -   
anti-chicken 
Cy3 Jackson 
703-165-
155 donkey 1:400 1:300 - -   
anti-rat 
Alexa 488 Invitrogen A11008 goat 1:400 1:300 - -   
anti-rat 
Alexa 647 Invitrogen A21247 goat 1:400 1:300 - -   
Were indicated, a 5 min staining with 4’, 6-Diamidino-2-phenylindole (DAPI, 1:10000 
in PBS) was made prior to the final steps of washing and mounting in order to visualize 
the nuclei. 
LabTek chamber slide: Nunc, #177402 
Pap pen: Kisker-Biotech, #MKP-1 
Elvanol: 12 g Mowiol 4 – 88 (Roth, #0713) dissolved in 30 ml 87% glycerol, 60 ml 
Tris-HCl pH 8.5 and 30 ml H2O 
DAPI: Sigma, Biochemica, #32670 
2.4.2 Immunohistochemistry (IHC) 
2.4.2.1 Preparation of sections for IHC 
Prior to staining, paraffin sections were de-paraffinized and re-hydrated as mentioned 
above (2.3.2.3). Cryo–sections were thawed at RT for 10 min and subsequently rinsed 
two times for 1 min each in ddH2O to remove all remnants of cryo–matrix. After short 
rinsing with PBS, each specimen was circled with a hydrophobic barrier pen (Pap pen) 
in order to minimize the required volume of staining solutions.  
2.4.2.2 Immunofluorescence staining of sections 
For detection of intracellular proteins, prepared (2.3.2.3) sections were permeabilized 
with 0.1% Triton X-100 in PBS for 10 min at RT prior to blocking in blocking buffer 
(3% BSA in PBS) for 1 h at RT. After blocking, overnight incubation of the sections 
with the indicated primary antibodies (diluted in blocking buffer) was performed at 4°C 
in a humidified chamber. Next day, slides were washed 3 x 10 min in PBS and 
subsequently incubated with the appropriate secondary antibodies (diluted in blocking 
buffer) for 2 h at RT in the dark. After three final washes with PBS (10 min each, in the 
dark), the sections were mounted with Elvanol (2.4.1).  
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2.4.2.3 3, 3’-Diaminobenzidine (DAB) staining of sections 
3, 3’-Diaminobenzidine is a substrate for peroxidase that forms a brown precipitate 
when it reacts with this enzyme. Based on this reaction, epitopes bound by peroxidase-
conjugated antibodies can be specifically stained by application of DAB. Since 
endogenous peroxidases are prevalent in most tissues, it is necessary to block the 
activity of those enzymes by a H2O2 treatment prior to the DAB staining procedure. In 
order to perform a DAB staining on sections, slides were prepared as mentioned above 
(2.3.2.3) and subsequently incubated for 10 min in a 0.3% H2O2 / methanol solution to 
block endogenous peroxidases. After a 5 min wash in PBS, the sections were blocked in 
blocking buffer (5% goat serum in PBS-T) for 1 h at RT. Subsequently the indicated 
primary antibody (diluted in blocking buffer) was added for overnight incubation at 4°C 
in a humidified chamber. Next day, the slides were washed 3 x 10 min with PBS-T prior 
to incubation with the appropriate peroxidase-conjugated secondary antibody (diluted in 
blocking buffer) for 1 h at RT. Consecutively, 3 x 10 min washes with PBS were 
performed and DAB solution containing 0.03% H2O2 was added to start the staining-
reaction. After a satisfactory staining intensity was reached (takes ~ 1–2 min), the 
reaction was stopped by extensive washes with tap water. Finally, a Hematoxylin 
counter-stain (2.3.2.3) was performed (~ 30 sec) to improve the contrast of the 
specimen, before the slides were subjected to dehydration and mounting with Entellan 
(2.3.1).  
PBS-T: 0.1% Tween-20 in PBS 
DAB solution: 0.3 mg DAB in 0.5 M Tris-HCl pH7.6   
2.4.3 Whole mount staining of embryos 
2.4.3.1 Whole mount immunofluorescence staining 
Staged embryos (2.2.2) were dissected in PBS and fixed overnight at 4°C in Dent’s 
fixative. Next day, embryos were sequentially re-hydrated in methanol / PBS-T 
solutions with decreasing methanol contents (75%, 50%, 25% methanol) for 1 h each. 
Subsequently, re-hydrated embryos were blocked 2 x 1 h in blocking buffer (5% goat 
serum in PBS-T) before the primary antibodies (diluted in blocking buffer) were added 
for overnight incubation at 4°C. Embryos were washed extensively for 5–8 h in TBS-T, 
and subsequently incubated with the appropriate secondary antibodies (diluted in 5% 
BSA / TBS-T) overnight at 4°C in the dark. Finally, after extensive washes in TBS-T 
(5–8 h, in the dark at RT), the embryos were carefully mounted in Elvanol (2.4.1).  
Dent’s fixative: 20% DMSO in methanol 
TBS: 150 mM NaCl in 50 mM Tris-HCl pH 7.5 
TBS-T: 0.1% Tween-20 in TBS 
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2.4.3.2 Whole mount DAB staining 
Staged embryos (2.2.2) were dissected in PBS and fixed overnight at 4°C in Dent’s 
fixative. In order to block endogenous peroxidases, the embryos were transferred to a 
methanol / DMSO / 30% H2O2 (4:1:1) solution for 5 h at RT. Next, re-hydration was 
performed as mentioned previously (2.4.3.1) and the embryos were subsequently 
transferred to a PBS-MT blocking solution for 2 x 1 h at RT. After blocking, the 
primary antibody (diluted in PBS-MT) was applied for overnight incubation at 4°C. The 
embryos were washed for 2 x 1 h at 4°C and 3 x 1 h at RT in PBS-MT before an 
overnight incubation at 4°C with the appropriate secondary antibody (diluted in PBS-
MT) was performed. In order to achieve a low background signal, the embryos were 
subjected to extensive washes: 2 x 1 h in PBS-MT at 4°C, 3 x 1 h in PBS-MT at RT and 
20 min in PBS-BT at RT. Subsequently, embryos were incubated in a defined volume 
of DAB solution (2.4.2.3) for 30 min at RT. To develop the DAB precipitate, H2O2 was 
added to a final concentration of 0.03% and the staining-reaction was monitored under a 
stereomicroscope (2.9.5) until the stained structures became visible (duration: ~ 10 
min). As soon as the desired staining intensity was reached, the reaction was stopped by 
repeated washes with PBS. To further optimize the imaging results, the embryos were 
cleared. To achieve clearance, the embryos were dehydrated (inverse procedure as 
mentioned in (2.4.3.1)) and subsequently transferred into a glass vial containing the 
clearance solution (1:2 mixture of benzyl alcohol and benzyl benzoate). Cleared 
embryos were stored at 4°C. 
PBS-MT: 2% skim milk powder and 0.1% Triton X-100 in PBS 
PBS-BT: 0.2% BSA and 0.1% Triton X-100 in PBS 
2.4.4 Immunostaining of adherent cells 
All immunostainings of adherent cells were performed on pre-coated LabTek chamber 
slides. Coating was performed overnight at 4°C with proteins and protein-
concentrations indicated. Next day, slides were washed once with PBS and 1 - 8 x 10
4
 
cells - dependent on the type of assay performed - were seeded into one well (final 
volume: 400 µl medium). After indicated times of culture in a cell incubator, cells were 
washed once with PBS and fixed with freshly prepared, ice–cold PFA (2.3.2) for 10 min 
at RT. Subsequently, slides were washed in PBS and incubated for 1 h in blocking 
solution. After blocking, the indicated primary antibodies (diluted in blocking buffer) 
were added and incubated for 2 h at RT. Next, 3 x 10 min washing steps with PBS were 
performed, followed by incubation with the appropriate secondary antibodies (diluted in 
blocking buffer) for 1 h at RT. Finally, slides were washed three times 10 min each in 
PBS and mounted in Elvanol (2.4.1).   
2.4.5 Flow cytometry (FACS) 
Flow cytometry is a widely used fluorescence-based technique that allows the 
discrimination of different cell populations in a heterogeneous cell suspension. Before a 
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FACS run is performed, cell-surface proteins are either directly or indirectly labelled 
with antibodies conjugated to different fluorochromes (e.g. FITC, PE or Cy5). During 
the FACS run, the labelled cell suspension is sucked up into a capillary and subjected to 
a liquid flow that only allows single cells to pass a cuvette. There, a laser excites the 
fluorochromes linked to the cell and the emitted fluorescence and scattered light of each 
individual cell is measured simultaneously. The so-called forward scatter signal (FSC) 
provides information about the cell size, whereas the side scatter signal (SSC) is 
proportional to the granularity of the cells. The light-signals are detected by a 
photomultiplier, are integrated and online displayed in a cumulative curve diagram.  
2.4.5.1 FACS of surface antigens 
In order to determine the expression level of integrins on the cell-surface, FACS 
analysis was performed: 5 x 10
5
 – 1 x 106 cells were pelleted and re-suspended in 200 µl 
FACS buffer and transferred into a U-bottom well of a 96 well plate. Next, cells were 
spun down (5 min at 4°C, 1500 RPM) and the pellet was subsequently re-suspended in 
50 µl of the primary antibody solution (Antibody in FACS buffer). The cell suspension 
was left on ice in the dark for 30 min. After a washing step with 150 µl FACS buffer, 
cells with un-conjugated primary antibodies were incubated (15 min, on ice, in the dark) 
with 50 µl of secondary antibody solution; whereas cells with fluorochrome coupled 
primary antibodies were simultaneously incubated in FACS buffer w/o antibodies. After 
a final washing step, cells were re-suspended in 200 µl FACS buffer and transferred to 
FACS tubes. Until measurement, all samples were kept on ice in the dark. Shortly 
before application on the flow cytometer, dead cells in the cell suspension were stained 
with propidium-iodine. Therefore, a propidium-iodine solution (1 mg/ml, working 
concentration 1:400) was mixed with the cells in order to allow distinction between 
living and dead cells. The obtained data was processed using CellQuest
TM
 software. 
Flow cytometer: Becton Dickinson, FACSCalibur 
FACS tubes: Alpha Laboratories, #QS845 
FACS buffer: 2% FBS and 2 mM EDTA in PBS, sterile filtered 
Propidium-iodine: Roth GmbH, #CN74.1 
2.5 Cell culture methods 
2.5.1 Material cell culture 
5, 10, 25 ml pipettes: Corning, Costar Stripette, #4487, #4488, #4489 
Multi-well plates (Corning): 96 well: #3799, 24 well: #3524, 6 well: #3046 
15, 50 ml tubes: Corning, CentriStar, #430791, #430829 
Cryogenic vial: Corning, #430489 
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60, 100 mm dishes: Falcon, Easy Grip, #353004, #353003 
140 mm dish: NUNC, #168381 
Cell growth media: Gibco, DMEM (#31966-021), DMEM/F-12 (#31331), AIM-V 
Medium (#12055), RPMI 1640 (#31870) 
Non-essential amino acids (NEAA): Gibco, MEM NEAA x 10, #11140 
Foetal bovine serum (heat inactivated: 15 min at 65°C): Gibco, #10270-106 
Trypsin: Gibco, Trypsin / EDTA (x 10), #15400-054 
P/S: PAA, Penicillin / Streptomycin (x 100), #P11-010 
Endothelial cell growth supplement: Sigma, #E2759 
Heparin: Sigma, #H1027 
Fibronectin: Calbiochem, bovine plasma, #341631 
Vitronectin: BD, human, #354238 
Laminin 111: gift from Prof. Dr. Rainer Deutzmann, University of Regensburg, 
Germany 
2.5.2 Isolation and culture of primary embryonic fibroblasts 
Fibroblasts were isolated from E9.5 staged embryos. Each embryo was dissected in PBS 
(2.2.2) and shortly after transferred in 50 µl of 0.5 x Trypsin / EDTA solution. Release 
of fibroblasts from the tissue was achieved by up and down pipetting, followed by a 3 
min digestion step in the Trypsin solution. Finally, the digest was mixed with 1.5 ml 
growth medium and was transferred into a 24 well cell culture dish. Primary fibroblasts 
were maintained in growth medium in a humidified atmosphere (5% CO2, 95% H2O) at 
37°C. 
Growth medium: DMEM supplemented with 10% FBS and 1 x P/S  
2.5.3 Immortalization and cloning of primary embryonic fibroblasts 
The large T antigen of the simian virus 40 (SV40) is capable to immortalize primary 
cells in culture through binding and stabilization of the tumor-suppressor p53 (O'Reilly 
1986). Large T is a valuable tool to immortalize primary cells, since its expression does 
not result in major changes of the cell-morphology and anchorage dependent cell-
growth. In this study, primary embryonic fibroblasts were immortalized by retroviral 
transduction of SV40 large T antigen. Therefore, a cell line producing a retrovirus 
containing the large T gene and a resistance cassette to neomycin (Brown, McCormack 
et al. 1986) was cultured in growth medium until the cells reached ~ 80% confluency. 
At this stage, the medium was exchanged against fresh growth medium and cells were 
further incubated for 16 h to maximize the virus-titer in the medium. Next day, the virus 
containing medium was spun down (3 min at 900 RPM) and sterile filtered (0.45 µm 
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filter pore-size) to remove residual cells. Shortly after, primary cells (2.5.2) were 
covered with a thin layer of the obtained virus-soup and incubated for 1 h at 37°C (5% 
CO2, 95% H2O). The infection was repeated 2 more times after 8 and 24 h, respectively. 
Infected cells harbouring the large T antigen could be isolated by virtue of resistance to 
0.5 mg / ml neomycin during ~ 5 days of selection. In order to isolate single clones, the 
resistant cell population was trypsinized (2.5.4.1) and low cell numbers (~ 200–500) 
were plated on a 100 mm cell culture dish.  1-2 weeks later, single colonies could be 
visualized under the microscope. Single colonies were scratched - and sucked off using 
a pipette and re-plated in a 24 well in 1 ml growth medium. Once cells reached 
confluency, they were trypsinzed and 50% were frozen down (2.5.4.3), while the rest 
was further expanded.  
2.5.4 Cell culture of immortalized mouse cell lines 
2.5.4.1 Passaging of cells 
Prior to trypsinization, layers of adherent cells were washed once with 1xPBS. To 
achieve detachment of the cells form the culture dish, the cell layer was subsequently 
incubated for 2-3 min at 37°C with a 1x Trypsin – EDTA solution. To stop the trypsin 
treatment, detached cells were re-suspended in fresh cell growth medium and spun 
down for 3 min at 900 RPM. The cell pellet was re-suspended in fresh medium and cells 
were seeded with the desired density on a new culture dish. 
2.5.4.2 Culture of fibroblast cell lines in serum-replacement medium 
Foetal bovine serum (FBS) is a widely used supplement in most cell growth media and 
contains large amounts of fibronectin (FN). Given that assays with self-produced FN 
critically depend on the absence of serum-derived FN, it was necessary to perform all in 
vitro experiments in the present study with fibroblasts grown in serum replacement 
medium. In order to adapt the cell metabolism to serum replacement medium, the serum 
content in the growth media was reduced with each passage (10% - 5% - 2% - 1% - 
0.5% - 0.1% - 0%) by diluting DMEM (supplemented with 10% FBS and P/S) with 
serum replacement medium.  
Serum replacement medium: AIM-V, DMEM, RPMI, NEAA (47.5: 47.5: 5: 1)   
2.5.4.3 Cryo-preservation of mouse cell lines 
For long-term storage, cells were trypsinized as mentioned in (2.5.4.1). After 
centrifugation (3 min at 900 RPM), the cell pellet was re-suspended in ice cold freezing 
medium. Aliquots of the cell suspension were filled into cryogenic vials and frozen at -
80°C. For prolonged storage, cryo-cultures were stored in liquid nitrogen at -196°C. 
 Freezing medium: FBS : DMEM : DMSO (5 : 4 : 1) 
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2.5.4.4 Thawing of cryo-preserved cells 
Cryo-cultures were thawed at 37°C. Immediately after the freezing medium had thawed, 
the cells were added to pre-warmed growth medium (~ 10 times the volume of the 
freezing medium) and centrifuged for 3 min at 900 RPM. The cell pellet was re-
suspended in growth medium and cells were plated on culture dishes of appropriate 
size.   
2.6 Cell biological assays 
All assays were performed with cells cultured in serum replacement medium or EC 
growth medium supplemented with 0.1% FN-stripped FBS (2.5.1). 
2.6.1 Fibronectin fibrillogenesis assay 
To analyze the assembly of FN matrix by fibroblast cell lines, 8 x 10
4
 cells in serum 
replacement medium were seeded on pre-coated LabTek chamber slides. Cells were 
typically incubated for 16 h up to 5 days at 37°C (5% CO2 and 95% H2O). Coating 
substrates and incubation times are indicated in the respective experiment. At the end of 
the incubation time, the medium was removed and cells were subjected to 
immunostaining (2.4.4) with the indicated antibodies. 
2.6.1.1 FN fibrillogenesis inhibitor assay 
Analysis of FN matrix assembly was performed a described previously (2.6.1). Apart 
from that, cells were incubated for 2 h before inhibitory peptides and proteins were 
added with indicated concentrations. Subsequently, cells were incubated for additional 
14 h until they were subjected to immunostaining (2.4.4) with the indicated antibodies. 
 cycloRGDfV: biomol, #AM-100 
 cycloRADfV: biomol, #AM-101 
cyclicRGD-2C, cyclicRGE-2C, cyclicNGR-2C, linRGD, linRGE: gift from Prof. 
Dr. H. Kessler, Technical University Munich 
2.7 Biochemical methods 
2.7.1 Material Biochemistry 
Protease inhibitor cocktail: Roche, Complete Mini / EDTA free, #12740900 
Phosphatase inhibitor cocktails 1 & 2: Sigma, #P2850, #P5726 
N-Ethylmaleimide (NEM): Sigma, #E3876 
Microtip Sonifier: Branson, #B-12 
Precision Plus Protein
TM
 Caleidoscope
TM
 Standards: BioRad, #161-0375 
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2.7.2 Preparation of protein lysates 
2.7.2.1  Preparation of total protein lysates from adherent cells 
The adherent cells were once washed with ice-cold PBS prior to addition of the 
appropriate amount of cell lysis buffer. Cell lysis was allowed to occur within 10 min 
incubation time on ice. Thereafter, cells were scraped off the dish using a cell scraper 
and transferred into a microcentrifuge tube. Cell lysates were briefly sonified on ice (1 
sec at intensity 4) using a microtip and were subsequently spun down at 15000 x g for 1 
min at 4°C. Next, the protein concentration of the supernatant was determined using a 
BCA protein assay kit (2.7.5.1). After protein concentrations had been adjusted, lysates 
were either snap-frozen in liquid N2 and stored at -80°C, or directly processed to 
perform SDS-PAGE (2.7.6). 
2.7.2.2 Preparation of total protein lysates from mouse embryonic tissue 
Embryos were dissected in PBS (2.2.2) and tissue was subsequently transferred into 50–
100 µl of the appropriate lysis buffer. The embryonic tissue was mechanically 
disintegrated by pipetting up and down and by sonification (1 sec, intensity 4, on ice) 
using a microtip sonifier. Lysates were briefly spun down (30 sec at 15000 x g, 4°C) 
and the protein concentration of the supernatant was determined using a BCA protein 
assay kit (2.7.5.1). Further processing of the lysates was performed as indicated for each 
experiment. 
Cell lysis buffer (RIPA): 150 mM NaCl, 1 mM EDTA, 1% Na-deoxycholate, 
0.1% SDS, 1% Triton X-100, 10 mM NaF, 1 mM Na3VO4 in 50 mM Tris-HCl pH 
7.8, protease inhibitor cocktail 1 tablet / 10 ml 
4 x SDS sample buffer (SDS-SB): 16 ml 20% SDS, 0.32 ml 0.5 M EDTA, 16 ml 
87% glycerol, 0.001% bromphenol blue in 50 mM Tris-HCl pH 6.8 (optional: 
4% mercaptoethanol)  
2.7.2.3 Nuclear fractionation of lysates from adherent cells 
Proteins that trans-locate into the nucleus upon activation are involved in a vast number 
of signaling events. In order to assess the intracellular distribution of signaling proteins, 
nuclear fractionation is an applicable preparative method to separate a cell lysate into its 
nuclear- and cytosolic-fraction. The fractionation was performed after 1.5 x 10
5
 cells 
had been cultured in a 100 mm cell culture dish for 3 and 6 days, respectively. Cells 
were harvested and subjected to nuclear fractionation using a NE-PER
®
 Nuclear and 
Cytoplasmic Extraction Kit according to the manufacturer’s instructions. Protein 
concentrations of obtained fractions were determined (2.7.5.1) and adjusted. Samples 
were snap-frozen in liquid N2 and stored at -80°C until SDS-PAGE (2.7.6) was 
performed. 
NE-PER
®
 Nuclear and Cytoplasmic Extraction Reagents: Pierce, #78833 
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2.7.3 Deoxycholate extraction of soluble and insoluble FN matrix fractions 
Increasing fibronectin depositions on cells lead to an enhanced complexity of the fiber-
network. As a consequence, the network becomes gradually insoluble in the detergent 
deoxycholate (DOC) (Hynes and Destree 1977; Keski-Oja, Mosher et al. 1977). The 
method of DOC extraction facilitates the separation of DOC soluble- and insoluble FN 
matrix fractions. In order to compare the DOC solubility properties of mutated FN and 
wild-type FN, extractions of DOC-soluble and DOC-insoluble fractions were 
performed.  
2.7.3.1 Deoxycholate extraction of FN matrix fractions from adherent cells 
1.5 x 10
5
 cells were grown in a 100 mm cell culture dish for 4 – 6 days. The cell layer 
was washed twice with ice-cold PBS prior to addition of 300 µl DOC lysis buffer. Lysis 
was performed on ice for 10 min. Thereafter, cells were scraped off the dish using a cell 
scraper and the lysate was passed several times through a 26G syringe-needle. 
Subsequently, the lysate was centrifuged at 20000 x g for 10 min at 4°C. The 
supernatant (DOC soluble fraction) was carefully removed and collected, while the 
pellet (DOC insoluble fraction) was washed twice in 500 µl ice-cold PBS. Finally, the 
pellet was re-suspended in 100 µl PBS and briefly sonified (2 sec, intensity 3, on ice). 
The protein concentrations of both samples were determined using a BCA protein assay 
kit (2.7.5.1). After protein concentrations had been adjusted, lysates were either snap-
frozen in liquid N2 and stored at -80°C, or directly processed to perform SDS-PAGE 
under non-reducing conditions (2.7.6). 
DOC lysis buffer: 2% DOC, 2 mM EDTA, 2 mM N-Ethylmaleimide in 20 mM 
Tris-HCl pH 7.8 
2.7.3.2 Deoxycholate extraction of FN matrix fractions from embryos 
Staged embryos (E9.5) were dissected in PBS (2.2.2). 3–4 embryos of the same 
genotype were transferred into 200 µl DOC lysis buffer and mechanically disintegrated 
by pipetting up and down and by sonification (2-3 sec, intensity 4, on ice) using a 
microtip sonifier. Subsequently, the embryo lysate was centrifuged at 20000 x g for 10 
min at 4°C. The supernatant (DOC-soluble fraction) was carefully removed and 
collected, while the pellet (DOC-insoluble fraction) was washed in 500 µl ice-cold PBS. 
The pellet was finally re-suspended in 100 µl PBS and briefly sonified (2 sec, intensity 
3, on ice) before the protein concentrations of both fractions were determined using a 
BCA protein assay kit (2.7.5.1). To release LTBP from DOC-insoluble fractions, a 
plasmin digest was performed. To this end, 0.3 U / ml plasmin were added to the DOC-
insoluble fraction, and the sample was subsequently incubated for 1.5 h at 37°C. Shortly 
after protein concentrations had been adjusted, lysates were either snap-frozen in liquid 
N2 and stored at -80°C, or directly processed for SDS-PAGE (2.7.6) under non-reducing 
conditions.  
 Plasmin: Sigma, #P1867 
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2.7.4 In vitro assays on three dimensional FN matrix (FN 3D) 
In order to mimic the three dimensional (3D) environment of cells in vivo, 3D 
fibronectin matrices were prepared in vitro. Thereby it was possible to perform in vitro 
analyses of cell signaling events that are triggered by 3D fibronectin–cell interactions.  
2.7.4.1 Preparation of cell-free FN 3D matrices 
3 x 10
5
 cells were plated on a pre-coated 6 well cell culture plate and incubated at 37°C 
for 4–5 days (5% CO2, 95% H2O) to produce sufficient amounts of FN matrix. 
Afterwards, the cells were selectively removed by sequential washes and incubations 
with hypo- and hyper-osmotic solutions, while the matrix remained unaffected. To this 
end, the medium was removed and cells were washed twice with wash buffer I prior to 
incubation with 3D lysis buffer for 15 min at 37°C. Subsequently, the 3D lysis buffer 
was replaced with fresh lysis buffer, followed by 45 min incubation at 37°C. Next, 3D 
matrices were washed twice with wash buffer II, 4 x with ddH2O and were finally 
stored at 4°C in PBS.   
3D lysis buffer: 1% NP-40 in 8 mM Na2HPO4 pH 9.6 
Wash buffer I: 2 mM MgCl2, 2 mM EGTA in 100 mM Na2HPO4 pH9.6 
Wash buffer II: 300 mM KCl in 10 mM Na2HPO4 pH 7.5 
2.7.4.2 Cell signaling assays on FN 3D matrices 
In order to study the effects of cell – 3D FN interactions on selected cell signaling 
pathways in vitro, cells were starved in DMEM (w/o supplements) for 6 h. Next, cells 
were trypsinized (2.5.4.1) and washed once with Trypsin–Inhibitor solution (50 µg / ml 
in PBS) to block the trypsin activity. Subsequently, the cells were re-suspended in 
DMEM, transferred into a polystyrene tube and incubated in suspension for 1 h at 37°C 
(5% CO2 and 95% H2O). Starving and incubation of cells in suspension causes 
extensive inactivation of signaling pathways related to cell adhesion. The cell signaling 
activity increases again, when cells are replated. Aliquots of the cell suspension (~ 5 x 
10
4
 cells / aliquot) were seeded on prepared 3D FN matrices (2.7.4.1), were incubated 
for indicated times at 37°C and subsequently lysed in 100 µl cell lysis buffer (RIPA) 
(2.7.2.2) on ice. After lysis, samples were spun down briefly, followed by determination 
of the protein concentration in the supernatant using a BCA protein assay kit (2.7.5.1). 
Finally the lysates were snap-frozen in liquid N2 and stored at -80°C, or directly 
prepared for SDS-PAGE (2.7.6). 
Trypsin Inhibitor (from soybean): Roche, #10-109-886-001 
2.7.5 Determination of the protein concentration 
2.7.5.1 BCA protein assay 
Proteins are able to reduce Cu
2+
 to Cu
+
 under alkaline conditions (Biuret-reaction). Cu
+
 
is readily chelated by bicinchoninic acid, forming a complex with high spectro-
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photometric absorbance at 562 nm. The assay was performed according to the 
manufacturer’s instructions. 
BCA Protein Assay Kit: Pierce, #23225 
2.7.5.2 UV spectroscopic protein determination 
The concentration of purified proteins in solution in this study was determined with 
sufficient accuracy by measurement of their photometric absorbance A280 at 280 nm. 
Aromatic side chains of proteins, such as tryptophan, tyrosine and phenylalanine, 
absorb light at this particular wavelength. The concentration of a protein is related to the 
amount of light absorbed by the protein solution by the Beer-Lambert Law:   
A = ε c l 
In this equation, A is absorbance, ε is the molar extinction coefficient (L / mol x cm), l 
is the path length of the sample cuvette (cm) and c is the concentration of the protein 
solution. Notice, that ε and l must be known to directly calculate c from A. The specific 
value of ε for each protein sequence was obtained by using the Peptide Property 
Calculator (www.basic.northwestern.edu/biotools/proteincalc.html). 
2.7.6 SDS-polyacrylamide-gelelectrophoresis (SDS-PAGE) 
SDS-PAGE is probably the most commonly used method to separate proteins under 
denaturizing conditions. The negatively charged detergent sodium dodecyl sulphate 
(SDS) becomes associated with the proteins and promotes their solubilisation. Thus, the 
proteins become negatively charged and can be electrophoretically separated in the 
meshwork of a polyacrylamide-gel according to their individual molecular size and 
shape. Defined protein standards are used as a reference to determine the size of the 
separated proteins. In order to prepare proteins for SDS-PAGE, a boiling step in 
presence of SDS has to be performed. Where indicated, 2-mercaptoethanol or di-
thiothreitol (DTT) was added in some experiments to reduce disulfide bonds. After 
separation, proteins in a gel can be visualized by means of protein dyes, silver staining 
or western blotting. All SDS-PAGE protein separations in this study were performed 
with the so called discontinuous method. Here, a stacking gel is poured on top of a 
resolving gel. Both gels differ in terms of pH and acrylamide concentration. The 
stacking gel, which is passed first by the proteins, facilitates the concentration of all 
proteins at the interface between the two gels, whereas the resolving gel allows the 
separation of proteins according to their molecular size and shape. The content of 
acrylamide in the resolving gel is considered to be inversely proportional to the size of 
proteins to be separated. Proteins were separated using a mini-gel system featuring the 
measures 73 x 83 x 1.5 mm. Samples were mixed with 4 x SDS sample-buffer (4 x 
SDS-SB), boiled 3–5 min at 95°C and subsequently chilled on ice. After a brief 
centrifugation step, the samples were loaded on the stacking gel. The electrophoresis 
module was filled with 1 x SDS running buffer and the electrophoresis carried out at 20 
mA (stacking gel) to 40 mA (resolving gel), respectively. 
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Resolving gels ................................ 6.5% ................ 9% ....................... stacking gel 4% 
30% acrylamide ............................ 4.34 ml ............. 6 ml ........................... 1.33ml 
1.5 M Tris-HCl pH 8.8 .................... 5 ml ................ 5 ml .................... 2.52 ml (pH 6.8) 
10% SDS ........................................ 0.2ml ............. 0.2 ml ........................... 0.1ml 
10% APS ....................................... 0.2 ml ............ 0.2 ml ........................... 0.1ml 
TEMED .......................................... 16 µl .............. 20 µl ............................. 10 µl 
ddH2O .......................................... 10.24 ml .......... 8.6 ml .........................5.94 ml 
for 4 mini-gels 
Mini-gel system: BioRad, Mini Protean III System, #165-3301 
10 x SDS running buffer: 144 g Glycine, 33.3 g Tris, 10 g SDS 
N,N,N’,N’-Tetramethylethylenediamine (TEMED): Serva, #35925 
2.7.7 Western blotting and Immunodetection 
Western blotting is a very sensitive method to detect and quantify specific proteins by 
means of antibodies. Proteins are first resolved by SDS-PAGE (2.7.6) and subsequently 
electrophoretically transferred on a PVDF membrane. Proteins tightly bound to this 
membrane can then be visualized applying immunodetection reagents. After SDS-
PAGE (2.7.6) the stacking gel was removed, and the resolving gel, together with a 
methanol-activated PVDF membrane, was assembled into a transfer-sandwich. Thereby, 
air bubbles between the layers, especially between gel and membrane, were thoroughly 
removed. Proteins were electrically transferred on the membrane overnight at 4°C and 
55 mA / gel, or for 3 h at 4°C and 150 mA / gel, with the gel side of the transfer-
sandwich connected to the cathode. After the transfer, the membrane was removed from 
the transfer-sandwich and blocked for 1 h in blocking buffer (see table of antibodies, 
2.4.1). Blocking, as well as all subsequent washing and antibody incubation steps were 
performed under continuous shaking on a laboratory rocker (ELMI, Shaker S-4, and 20 
RPM). Next, the membrane was incubated with the primary antibody (2.4.1) diluted in 
blocking buffer for either 3 - 4 h at RT, or overnight at 4°C. Subsequently, the 
membrane was washed 3 x 10 min with TBS-T (2.4.3) before the appropriate secondary 
antibody (2.4.1) in blocking buffer was added for 1–2 h incubation. After 3 further 
washes (2 x TBS-T, 1 x TBS (2.4.3) the membrane was subjected to a 
chemoluminiscence-based detection kit (ECL kit). 
Western blotting transfer buffer: 10 mM Na2B4O7 * 10 H2O in H2O 
Blocking buffer: 5% Skim milk powder in TBS-T or 5% BSA in TBS-T  
ECL kit: Millipore, Immobilon
TM
 Western, #WBKLS0500 
PVDF membrane: Millipore, Immobilon
TM
 Transfer membranes, #IPVH00010 
Materials and Methods 
41 
2.7.8 Expression of FN fragments in E.coli 
The expression of recombinant FN fragments was performed in the E.coli strain 
BL21(DE3) (2.8.2.1) using the pET-15b expression vector (2.8.8). Transformations of 
bacteria with the desired expression vectors were routinely performed one day in 
advance. All incubation steps to grow the bacteria were performed in LBAmp medium 
(2.8.2) at 37°C in a bacterial shaker (200 RPM). In order to start the protein expression, 
a bacterial colony was inoculated in 2 ml LBAmp medium and incubated for 8–9 h. 
Subsequently, 50 µl of this starter culture were transferred into 100 ml of LBAmp 
medium for overnight incubation. Next day, 20 ml of the overnight culture were mixed 
with 230 ml fresh LBAMP medium and incubated until an optical density at 578 nm 
(OD578) of 0.8 was reached (collect sample: - IPTG). Shortly after, the protein 
expression was induced by addition of isopropyl-β-D-thiogalactopyranoside (IPTG) to a 
final concentration of 0.4 mM. Following IPTG induction, the culture was further 
incubated for ~ 3 h (final OD578: ~ 1.8; collect sample: + IPTG). Next, bacteria were 
pelleted by 10 min centrifugation at 5000 x g (4°C), and the obtained pellet was re-
suspended in 200 ml ice-cold pellet wash buffer. Subsequently, the bacterial suspension 
was spun down again (5000 x g, 10 min, at 4°C) and the obtained pellet re-suspended in 
the appropriate amount of lysis buffer (10 ml lysis buffer / g pellet). Lysis was allowed 
to occur during 30 min with continuous stirring at 4°C. Afterwards, the lysate was 
sonified for 3 x 15 sec. (intensity 5, on ice) to further improve the lysis efficiency 
(collect sample: crude lysate). The obtained crude lysate was cleared by 30 min 
centrifugation at 20000 x g (at 4°C). To adjust the ionic-strength of the cleared lysate 
for Mn
2+
-NTA affinity chromatography, NaCl and MgCl2 were added to final 
concentrations of 150 mM and 2 mM, respectively (collect sample: cleared lysate). In 
order to purify the expressed protein, 2 ml of Mn
2+
- NTA resin was equilibrated with 2 
x 10 ml column wash buffer and shortly after added to the cleared lysate. The resin was 
allowed to bind the protein for 20 min at RT in a rotating tube. Thereafter, the resin was 
spun down for 3 min at 1500 RPM, the supernatant was removed and the resin was 
washed with 2 x 10 ml column wash buffer (collect sample: wash 1 & 2). Finally, the 
resin was packed on a column and washed with 5 ml column wash buffer before 5 ml of 
elution buffer were applied to elute the protein. The eluate was collected in 500 µl 
fractions and protein concentrations of all fractions were determined by UV 
spectrophotometric means (2.7.5.2). Most concentrated fractions were pooled and 
dialysed twice against 500 ml TBS overnight at 4°C.  
Isopropyl-β-D-thiogalactopyranoside (IPTG):Sigma, #I-6758 
Pellet wash buffer: 150 mM NaCl, 1 mM EDTA in 20 mM Tris-HCl pH 8.0 
Lysis buffer: 1 mM PMSF, 0.1 mg/ml Lysozyme, 1 mM EDTA in 20 mM Tris-
HCl pH 8.0 
Lysozyme: Sigma, #L-6876 
PMSF (Phenylmethanesulfonyl fluoride): Sigma, #P-7626  
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Column wash buffer: 150 mM NaCl, 10 mM Imidazole in 20 mM Tris-HCl pH 
8.0 
Elution buffer: 150 mM NaCl, 200 mM Imidazole in 20 mM Tris-HCl pH 8.0 
2.7.9 Solid phase binding assay 
The solid phase binding assay is a highly sensitive method to detect protein–protein 
interactions. The functional principle is similar to an ELISA assay: A protein is 
absorbed on a microtiter plate, whereas its supposed interaction partner is washed over 
the plate and is allowed to bind specifically. Finally, the binding complexes can be 
detected using antibodies. In order to map integrin binding sites on FN, various FN 
fragments of indicated concentration were absorbed on a microtiter plate overnight at 
4°C. Next day, the plate was blocked with SP blocking buffer for 1 h at RT. After 
blocking, serial dilutions of biotinylated integrins were added (50 µl / well, diluted in 
SP binding buffer) and incubated for 5 h at RT. The plate was subsequently washed 3 x 
with SP washing buffer (200 µl / well) prior to application of a Streptavidin–HRP 
solution (50 µl / well, diluted 1:1000 in SP binding buffer) for 15 min at RT. Finally, 
the plate was washed 4 times with SP washing buffer and bound integrins were detected 
using ABTS reagent. Therefore, ABTS solution (100 µl / well) was added to the plate 
and incubated for 45 min. Subsequently, the absorbance at 405 nm was measured in a 
spectrophotometer.  
 
Fig 2.1. Schematic depiction of FN fragments utilized in solid phase binding assays. The full-
length FN is shown on top. Type I domains are depicted as orange rectangles, Type II domains 
as grey ovals and type III domains as white circles. Domain FN-III9 (pink) contains the synergy 
region; FN-III10 (red) the RGD motif. The v-region is depicted in yellow. Note that in two FN-
III7-10 fragments the RGD motif was either mutated to RGE or completely removed, respectively. 
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Peroxidase Substrate Kit 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) 
(ABTS): Vector Laboratories, #SK-4500 
Microtiter plate: Nunc, MaxiSorp
TM
, #439454 
SP blocking buffer: 1% BSA, 150 mM NaCl in 20 mM Tris-HCl pH 7.5 
SP binding buffer: 0.1% BSA, 1 mM MgCl2, 150 mM NaCl in 20 mM Tris-HCl 
pH 7.5 
SP washing buffer: 1 mM MgCl2, 150 mM NaCl in 20 mM Tris-HCl pH 7.5 
Rec. biotinylated αvβ3 and α5β1 integrins: Gift from Junichi Takagi, Osaka 
University, Japan 
2.7.10 Luciferase based TGF-β reporter assay 
A major fraction of TGF-β is bound to the ECM in a so called latent form, which can be 
experimentally released and activated by a heat step. Cells stably transfected with a 
Luciferase gene fused to the Plasminogen Activator Inhibitor I promoter provide a very 
sensitive tool to assay the amount of active TGF-β (Abe, Harpel et al. 1994) in 
conditioned medium. Addition of active TGF-β to these cells induces the expression of 
the reporter enzyme firefly luciferase. This enzyme catalyses a luminescent reaction, in 
which light is produced through oxidation of beetle luciferin to oxyluficerin. 
Quantification of the emitted photons by means of a luminometer allows the indirect 
determination of the amount of active TGF-β. In this study, conditioned medium from 
equal amounts of fibroblasts (150000 fibroblasts / 6 cm dish) was analysed for TGF-β 
activity. To perform the assay, Mink lung epithelial cells (MLEC), stably transfected 
with the reporter construct p800neoLuc, were seeded on a 96 well plate (~ 20000 / well) 
and incubated overnight at 37°C (5% CO2, 95% H2O) in growth medium supplemented 
with 1 mg / ml neomycin. Next day, the MLECs were washed once with PBS and 
conditioned medium from fibroblasts after 3, 4 and 5 days in culture (100 µl / well) was 
added. Subsequently, the fibroblasts were incubated for 10 min at 80°C in order to 
release all latent TGF-β (heat-step) and cooled to RT. Aliquots of this heat-treated 
conditioned medium (100 µl / well) were also added to controlswells with MLECs and 
incubated for 24 h at 37°C (5% CO2, 95% H2O). Finally, a luciferase assay was 
performed according to the manufacturer’s instructions.  
 
 
Materials and Methods 
44 
 
Fig 2.2. Map of p800neoLuc. The construct contains a plasminogen activator inhibitor I 
promoter fused to the luciferase reporter gene. A neomycin resistance cassette allows positive 
selection of transfectants (Taken from Abe et al.1994).  
Luciferase assay: Promega, Bright-Glo
TM
 Luciferase Assay System, #TM052 
Luminometer: Promega, GloMax
TM 
Luminometer 96 well plates: Nunc, Nunclon Delta white, #136101 
Neomycin (G-418 sulphate): PAA, #P31-011 
TGF-β inhibitor, SB 431542: BIOTREND, #BS0216  
2.8 Molecular Biological Methods 
2.8.1 Material Molecular Biology 
Autoclave: KSG, KSG-12 
Centrifuge: Eppendorff, 5417C  
Centrifuge: Beckmann Coulter, Avanti J-25 with rotors J 14 and J 25.50 
Microwave: Daewoo, KOR 63D7 
Thermocycler: BioRad, DNAEngine 
Thermomixer: Eppendorff, 5350 
2.8.1.1 Phenol / Chloroform extraction of tail DNA 
In order to isolate murine genomic DNA for genotyping, ~ 5 mm of a tail tip biopsy 
were subjected to an overnight digestion with proteinase K (100 µg / ml) in 250 µl lysis 
buffer at 55°C in a shaker. Next day, 250µl Phenol/Chloroform (1:1) was added to the 
digest. After brief mixing, the DNA solution was spun down for 5 min at 15000 x g. 
The upper phase was collected and carefully mixed with 1 ml of 100% ethanol and 20 
µl of 3 M sodium acetate and spun down again (2 min at 15000 x g). The obtained 
pellet was washed once with ~ 200µl of 70% ethanol, air-dried and finally dissolved in 
50 – 150 µl ddH2O. 
Phenol / Chloroform / Isoamyl Alcohol (25 : 24 : 1): Calbiochem, #KP31757 
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2.8.1.2 Preparation of yolk sac DNA for genotyping 
Small pieces of yolk sac tissue were transferred to 25 µl of 1 x PCR buffer and digested 
overnight at 55°C with 400 µg / ml proteinase K. Next day, 1 µl of the digest was used 
for the genotyping PCR (2.8.5.2). 
2.8.2 Bacteriological tools 
Two Escherichia coli (E.coli) strains were used in this study: For all cloning steps the 
strain XL-1 blue was utilized, whereas the strain BL21(DE3) was used for recombinant 
protein expression purposes. Both strains were grown in lysogeny broth (LB) rich 
medium at 37°C in a bacteria shaker (Buchner Laboratories). The medium was 
autoclaved for 20 min at 120°C shortly after preparation. If indicated, antibiotics were 
added to the autoclaved, cooling medium after a temperature below 50°C was reached.  
For preparation of LB plates, about 20 ml of a sterile, ~ 50°C warm LB–Agar mixture 
was poured into 100 mm plates (Greiner bio-one) and stored at 4°C after gelling had 
occurred. 
LB medium: 10 g NaCl, 10 g trypton, 5 g yeast extract filled up to 1 l with 
ddH2O, autoclaved and stored at 4°C 
Agar: 15 g of Agar in LB, autoclaved and poured into 100 mm dishes, stored at 
4°C 
Concentration of antibiotics used: 12.5 µg / ml Tetracycline; 75 µg / ml 
Ampicillin 
2.8.2.1 Preparation of competent E.coli strains 
One colony of the E.coli strain XL-1 blue was inoculated in 10 ml LB, supplemented 
with Tetracycline, and incubated overnight at 37°C under shaking (185 RPM). Next, 2 
ml of the overnight culture were inoculated in 100 ml LB + Tetracycline and grown 
until an optical density of 0.5 at 550 nm (OD550) was reached.  The culture was chilled 
on ice for 10 min, and subsequently spun down for 15 min at 4°C with 1000 x g. The 
pellet was re-suspended in 10 ml TSS and 2.9 ml Glycerol (87%) and shortly after 
frozen on dry-ice in 100 µl aliquots. Aliquots of competent bacteria were stored at -
80°C until usage. 
TSS: 50 g polyethylenglycol, 5 g tryptone, 2.5 g yeast extract, 2.5 g NaCl, 25 ml 
DMSO, 25 ml MgCl2 (1 M) filled up to 500 ml with ddH2O and sterile filtered. 
Store at 4°C 
To prepare competent bacteria of the E.coli high-efficiency protein expression strain 
BL21(DE3),  a starter culture was inoculated in 5 ml LB, supplemented with 0.02 M 
MgCl2 and 0.01 M KCl. After overnight incubation at 37°C in a shaker (180 RPM), the 
bacteria were transferred into 150 ml LB + 0.02 M MgCl2 + 0.01 M KCl and grown at 
37°C until an OD550 of 0.3–0.4 was reached. After 10 min incubation on ice, the 
bacteria were pelleted (15 min, 4°C, 1000 x g) and re-suspended in an equal volume of 
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ice-cold TFB1 and incubated on ice for further 10 min. Subsequently, the bacteria were 
spun down again, the pellet was re-suspended in 1/10 volume of TFB2 and shortly after 
snap-frozen on dry-ice in 200 µl aliquots. Competent bacteria were stored at -80°C until 
usage. 
TFB1: 1 ml KAc (5 M), 10 ml MgCl2 (1 M), 20 ml RbCl (1 M), 2 ml CaCl2, 132 
ml ddH2O, the solution was sterile filtered and 34.5 ml of 87% glycerol was 
added 
TFB2: 0.5 ml MOPS (1 M), 3.75 ml CaCl2 (1 M), 0.5 ml RbCl (1 M), 8.75 ml 
87% glycerol, filled up to 40 ml with ddH2O and autoclaved 
2.8.2.2 Transformation of competent E.coli 
Shortly after the competent bacteria had thawed, 10-50 ng of desired DNA was added. 
The bacteria / DNA suspension was mixed by gently flicking the tube and was then 
incubated on ice for 30 min. Next, a heat-shock (90 sec at 42°C) was performed to 
promote the up-take of DNA. After the heat shock, bacteria were again placed on ice for 
at least 2 min before 1 ml of LB medium (w/o antibiotics) was added. The bacterial 
suspension was incubated at 37°C for 1 h in a shaker (200 RPM). Finally, bacteria were 
spun down (30 sec at 3000 x g) and re-suspended in 100 µl of LB medium and 
immediately spread on LB plates. Plates were incubated overnight at 37°C. Successful 
transformation was indicated by the appearance of colonies after 10–14 h. 
2.8.3 Preparation of plasmid DNA from bacterial cultures 
A single colony grown on a plate after transformation (2.8.2.2) was picked and 
inoculated in 2–5 ml LB medium (2.8.2) and bacteria were grown for 8–16 h (37°C, 200 
RPM). Next, ~ 2 ml of the culture was spun down for 30 sec at 15000 x g. The bacterial 
pellet was used for plasmid DNA isolation using the Qiagen Plasmid Mini Kit following 
the manufacturer’s instructions. For preparations of larger amounts of plasmid DNA (up 
to 500 µg), a larger volume of bacterial culture (~ 100 ml) was processed using a 
Qiagen Plasmid Maxi Kit. Purified plasmid DNA was photometrically quantified at 260 
nm and stored at -20°C. 
Qiagen Plasmid Mini Kit, Qiagen, #12125 
Qiagen Plasmid Maxi Kit, Qiagen, #12162 
2.8.4 Molecular cloning of DNA 
Restriction enzymes are commonly used tools for the generation of DNA constructs. 
These enzymes are able to specifically bind to mainly palindromic recognition 
sequences within the DNA and cut it by hydrolysation of two phosphodiester bonds. 
Thereby, they leave a phosphate group in 5’ prime and a hydroxyl group in 3’ prime of 
the cleaved DNA, which allows the ligation with other DNA fragments cleaved by the 
same enzyme.   
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2.8.4.1 Enzymatic digestion of DNA with restriction enzymes 
The restriction enzymes used in this study were all purchased form New England 
Biolabs (NEB). All digestion-reactions were performed according to the manufacturer’s 
instructions. In general, a total volume of 20–30 µl containing 10 U enzyme / µg DNA 
dissolved in ddH2O was incubated at 37°C in presence of the appropriate buffer 
recommended by the manufacturer. In some cases, the reaction-mix was supplemented 
with BSA to improve the restriction efficiency of certain enzymes.  
2.8.4.2 Dephosphorylation of plasmid DNA 
Digestion of plasmids with restriction enzymes creates a reactive phosphate group in 5’-
prime of the linearized plasmid, which readily ligates with the corresponding 3’- 
hydroxyl group of the same plasmid during subsequent ligation reactions. In most cases, 
this self-ligation competes with the insertion of the insert during a ligation reaction and 
thus strongly reduces the yield of the desired ligation product. To prevent self-ligation 
of linearized plasmids, the 5’ –phosphate group can be removed by utilization of 
alkaline phosphatases. In this study, shrimp alkaline phosphatase was used for this 
purpose (sAP). Dephosphorylation was achieved by incubating 3–5 µg linearized 
plasmid DNA with 5 U sAP in 1 x sAP reaction buffer in a total volume of 30 µl for 60 
min at 37°C. After the reaction, sAP was heat inactivated for 15 min at 65°C according 
to the manufacturer’s instructions. 
Shrimp Alkaline Phosphatase: Roche, #11 758 250 001 
2.8.4.3 Ligation of DNA fragments 
The ligation reaction generates a phosphodiester bond between the 5’- phospho - and 3’ 
– hydroxyl groups of two DNA segments that have been cut with the same restriction 
enzyme. Usually, the following protocol for ligation was used: ~ 100 ng of linearized 
and dephosphorylized vector were mixed with ~ 50 ng of the insert, 1.5 µl ATP (10 
mM), 1.5 µl Fast-Link Ligase buffer and 1 µl Fast-Link Ligase. The reaction was filled 
up to 15 µl with ddH2O and incubated for 30 min at RT. 1–5 µl of the reaction were 
used for DNA transformation (2.8.2.2). 
Fast-Link DNA Ligation Kit: Epicentre Biotechnologies, #LK6201H 
2.8.4.4 Sequencing of DNA 
To verify the sequence of cloned plasmid DNA,  ~ 500 ng DNA was mixed with 2 µl 
Big Dye terminator mixture and 1 µl of an appropriate sequencing primer (10 pmol) in a 
total volume of 10 µl. Subsequently, the sample was subjected to a PCR (2.8.5.2). The 
PCR product was stored at 4°C prior to sequencing at the core-facility of the Max-
Planck-Institute (Martinsried, Germany). The sequence data was processed by using 
Chromas Lite 2.01 software (www.technelysium.com.au). 
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2.8.5 Polymerase chain reaction (PCR) 
PCR is the method of choice for enzymatic DNA amplification. Typically, a PCR 
reaction mix contains five components: The DNA strand to be amplified (template), two 
primers, dNTPs and a heat-stable DNA polymerase (Taq or high fidelity polymerase). 
The reaction starts with DNA denaturation at 95°C, which is followed by annealing of 
the primers to the DNA template at lower temperatures (55°C – 68°C, depending on the 
primers), and finally ends with DNA synthesis at 68°C – 72°C. 
2.8.5.1 Oligonucleotides (primer) 
All oligonucleotides were synthesised and purified by Metabion international 
(Martinsried, Germany). Those used for cloning of siRNA constructs were 5’-prime 
phosphorylated and HPLC purified by the manufacturer. 
 
Name 5' - 3' sequence application 
Rb2 GTG GAG ATT TGT GTC ACA GGT G 
genotyping 
FN
CC>SS
 
Fb (HpaI 
BamHIF) CGG GAT CCG CTC ATG AAC AAA GCA GAC AGC 
genotyping 
FN
CC>SS
 
RGEGeno 
f CAA AGA AGA CCC CAA GAG CA 
genotyping 
FN
RGE/RGE
 
RGEGeno 
R ACA AGCCCTGGCCTTTAGTT 
genotyping 
FN
RGE/RGE
 
RGD>RGE 
ki fw CAC TGG CCG TGG AGA GAG CCC CGC AAG CAG 
FN III 7-10 
mutagenesis 
RGD>RGE 
ki rev CTG CTT GCG GGG CTC TCT CCA CGG CCA GTG A 
FN III 7-10 
mutagenesis 
deltaRGD 
ki fw GTG TAT GCT GTC ACT GGC AGC CCC GCA AGC AGC AAG C 
FN III 7-10 
mutagenesis 
deltaRGD 
ki rev GCT TGC TGC TTG CGG GGC TGC CAG TGA CAG CAT ACA C 
FN III 7-10 
mutagenesis 
Int av 
kdown 1fw 
GAT CCC CCA ACA GGC AAT CGA GAT TAT TCA AGA GAT AAT 
CTC GAT TGC CTG TTG TTT TTA 
cloning αv 
integrin-siRNA 
Int av 
kdown 
1rev 
AGC TTA AAA ACA ACA GGC AAT CGA GAT TAT CTC TTG AAT 
AAT CTC GAT TGC CTG TTG GGG 
cloning αv 
integrin-siRNA 
Int av 
kdown 2fw 
GAT CCC CCG GAC TGC ACA AGC AAT TTT TCA AGA GAA AAT 
TGC TTG TGC AGT CCG TTT TTA 
cloning αv 
integrin-siRNA 
Int av 
kdown 
2rev 
AGC TTA AAA ACG GAC TGC ACA AGC AAT TTT CTC TTG AAA 
AAT TGC TTG TGC AGT CCG GGG 
cloning αv 
integrin-siRNA 
Int av 
kdown 3fw 
GAT CCC CGC TTC AAT GAT ATT GCA ATT TCA AGA GAA TTG 
CAA TAT CAT TGA AGC TTT TTA 
cloning αv 
integrin-siRNA 
Int av 
kdown 
3rev 
AGC TTA AAA AGC TTC AAT GAT ATT GCA ATT CTC TTG AAA 
TTG CAA TAT CAT TGA AGC GGG 
cloning αv 
integrin-siRNA 
Int av 
kdown 4fw 
GAT CCC CGC AGG CTC ATA TTC TAC TTT TCA AGA GAA AGT 
AGA ATA TGA GCC TGC TTT TTA 
cloning αv 
integrin-siRNA 
Int av 
kdown 
4rev 
AGC TTA AAA AGC AGG CTC ATA TTC TAC TTT CTC TTG AAA 
AGT AGA ATA TGA GCC TGC GGG 
cloning αv 
integrin-siRNA 
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Int av 
kdown 5fw 
GAT CCC CCG TTA GGG CAA TTA GGA TTT TCA AGA GAA ATC 
CTA ATT GCC CTA ACG TTT TTA 
cloning αv 
integrin-siRNA 
Int av 
kdown 
5rev 
AGC TTA AAA ACG TTA GGG CAA TTA GGA TTT CTC TTG AAA 
ATC CTA ATT GCC CTA ACG GGG 
cloning αv 
integrin-siRNA 
>pET 11 
seq  fw GGA TAA CAA TTC CCC TCT AG sequencing 
>pET 11 
seq  rev GTT ATG CTA GTT ATT GCT CAG sequencing 
2.8.5.2 PCR reactions 
The following PCR reactions were performed in this study: 1) genotyping PCR using 
tail or yolk sac DNA and 2) cloning PCR using purified plasmid DNA (2.8.3) and high 
fidelity polymerase featuring proof reading activity.  
Genotyping PCR (1) 
Isolated tail or yolk sac DNA  ................................. 1 µl 
Primer 1 (100 pM) ............................................... 0.5 µl 
Primer 2 (100 pM) ............................................... 0.5 µl 
dNTPs (10 mM) .................................................... 0.5 µl 
MgCl2 (50 mM): ................................................ 0.75 µl 
10 x PCR buffer: .................................................. 2.5 µl 
Taq polymerase: .................................................. 0.5 µl 
Filled up to 25 µl with ddH2O and subjected to PCR 
Cloning PCR (2) 
Plasmid DNA (~ 200 ng) ........................................ 1 µl 
Primer 1 (100 pM) .................................................. 1 µl 
Primer 2 (100 pM) .................................................. 1 µl 
dNTPs (10 mM) ....................................................... 1 µl 
MgCl2 (50 mM): ................................................... 1.5 µl 
10 x PCR buffer: ..................................................... 5 µl 
High fidelity polymerase: ........................................ 1 µl 
Filled up to 50 µl with ddH2O and subjected to PCR 
2.8.5.3 PCR programs 
The following PCR programs were used in this study: 
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Genotyping FN
RGE/RGE 
and FN
CC>SS 
PCR:  Cloning PCR: 
 
Step ....... time (sec.) ....... temp. (°C) Step ....... time (sec.) ....... temp. (°C) 
1 ................... 30 ..................... 95 1 ................. 300 ..................... 95 
2 ................... 30 ..................... 95 2 .................. 30 ...................... 95 
3 ................... 30 ..................... 58 3 .................. 30 ...................... 63 
4 ................... 45 ..................... 72 4 ................. 120 ..................... 72 
5 .................. 300 .................... 72 5 .................. 30 ...................... 95 
6 ................... ∞ ........................ 4 6 .................. 30 ...................... 58 
 7 ................. 120 ..................... 72 
 8 ................. 420 ..................... 72 
 9 ................... ∞ ........................ 4 
Genotyping PCR’s were performed for 35 cycles (step 2 – 4). Cloning PCR’s were 
performed for 27 cycles (step 5-7), including 8 additional cycles with higher annealing 
temperature (63°C, step 2 – 4). 
Pwo SuperYield DNA Polymerase: Roche, #04 340 868 001 
2.8.6 PCR based Site directed mutagenesis 
Site directed mutagenesis is a commonly used approach to study protein functions. This 
method allows the selective introduction of point mutations into the coding DNA 
sequence of a gene of interest. As a result, deletion, insertion or swap of amino acids in 
the translated protein is achieved. In the present work, point mutations were introduced 
into FN fragments utilizing a QuikChange Site-Directed Mutagenesis kit. In order to 
perform a site directed mutagenesis, the gene of interest must be inserted in a circular 
DNA vector, which is used as template for the mutagenesis PCR reaction. Two 
oligonucleotide primers, encoding for the desired mutation, are extended during this 
PCR, thereby generating a mutant plasmid in vitro. Unlike the E.coli derived template 
DNA, the mutant plasmid lacks DNA methylations. Final application of an 
endonuclease (DpnI), which only targets methylated DNA, allows selective digestion of 
the template DNA, whereas the mutant plasmid remains unaffected. 
 
Fig 2.3. Principle of site directed mutagenesis. A. Gene in a plasmid with target site for 
mutation. B. Annealing with oligonucleotides containing the desired mutation. C. PCR 
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generated extension of the mutagenic primers, resulting in a mutant plasmid. D.  Digestion of 
the methylated, parental plasmid with Dpn I. E. Mutant plasmid, ready for transformation 
(Taken from the QuikChange Site-Directed Mutagenesis Kit manual (Stratagene) and modified).    
QuikChange
®
 Site-Directed Mutagenesis Kit: Stratagene, #200518   
2.8.6.1 Design of mutagenesis primers 
All primers used for mutagenesis were HPLC purified and designed according to the 
manufacturer’s instructions (Stratagene, QuickChange Site-Directed Mutagenesis Kit). 
The desired mutational sequence was flanked by 10–15 nucleotide bases of the correct 
sequence at both ends of the oligonucleotide. The maximum length of the designed 
primers was limited by their calculated melting temperature Tm (see formula below), 
which was not allowed to exceed 78°C.  
Tm = 81.5 + 0.41 (x % GC content) – 675 / N - % mismatch 
N: primer length in bases 
2.8.6.2 Mutagenesis PCR reactions 
Mutagenesis Mix 1: Mutagenesis Mix 2: 
Plasmid DNA (~ 25 ng) ........ 0.5 µl  Plasmid DNA (~ 25 ng) ......... 0.5 µl 
Primer 1 (100 pM) ................... 1 µl Primer 2 (100 pM) ................... 1 µl 
dNTPs (25 mM) ........................ 2 µl dNTPs (25 mM) ........................ 2 µl 
10 x PCR buffer ........................ 5 µl 10 x PCR buffer ........................ 5 µl 
PfuTurbo DNA polymerase ...... 1 µl PfuTurbo DNA polymerase ...... 1 µl 
Each mix was filled up to 50 µl with ddH2O and subjected to mutagenesis PCR 
(2.8.6.3). 
2.8.6.3 Mutagenesis PCR program 
The following PCR program was used for site directed mutagenesis 
Step ............. time (sec.) ....... temp. (°C) 
1 ....................... 30 ..................... 95 
2 ....................... 30 ..................... 95 
3 ....................... 60 ..................... 65 
4 ...................... 420 .................... 72 
5 ........................ ∞ ........................ 4 
6 ....................... 30 ..................... 95 
7 ....................... 30 ..................... 95 
8 ....................... 60 ..................... 63 
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9 .......................900..................... 72 
10 ...................... ∞ ........................ 4 
The mutagenesis PCR was performed for 10 cycles (step 2 – 4) for each mutagenesis 
mix separately. At step 5, 25 µl of both mixes were combined and subjected to the next 
PCR (step 7 – 9) for 18 cycles. Subsequently, 1 µl of DpnI was added to 50 µl of the 
PCR product and incubated for 1 h at 37°C. 5–20 µl of the digest were used for DNA 
transformation (2.8.2.2). 
2.8.7 Agarose gel electrophoresis 
In this study, agarose gel electrophoresis was routinely used for separation, purification 
and identification of DNA fragments. In order to prepare an agarose gel, 1–3 mg of 
Ultra pure Agarose was added to 150 ml 1 x TAE buffer (final agarose concentration 
0.07-2%, dependent on the sizes of separated DNA fragments) and boiled in a 
microwave. As soon as the agarose was dissolved, 10 µl of ethidium bromide solution 
was mixed with the hot solution to allow visualization of DNA under UV-light. The 
melted agarose was poured into a casting mould and allowed to gel at RT. After gelling 
had occurred, the agarose gel was placed in an electrophoresis chamber containing 1 x 
TAE buffer. The DNA sample solution was mixed with 6 x DNA loading buffer and 
loaded on the agarose gel. Electrophoresis was performed at 70 – 120 V at RT. As a size 
reference, the 1 kb DNA Ladder was regularly used. DNA fragment bands were 
visualized by means of UV-light of 366 nm wavelength. 
TAE x 50: 242 g Tris-base, 57.1 ml glacial acetic acid, 100 ml  EDTA (0.5 M, 
pH 8.0) filled up to 1 l with H2O 
Agarose: Invitrogen, UltraPureTM Agarose, #15510-027 
Ethidium bromide: Roth, #2218.1 
1 kb Ladder: Invitrogen, #15615-016  
2.8.7.1 Extraction of DNA from agarose gels 
For cloning purposes, it was necessary to extract the desired DNA bands from agarose 
gels after separation. Therefore, the corresponding DNA band was excised from the gel 
under UV-light with a scalpel and extracted from the agarose block using a Qiagen Gel 
Extraction Kit according to the manufacturer’s instructions. 
Qiagen Gel Extraction Kit, Qiagen, #20021  
2.8.8 Generation of FN fragment expression constructs 
FN-III7-10 RGE, FN-III7-10 ΔRGD: A fragment of the FN-III7-10 cDNA (inserted in 
pET-15b) was released by digestion with BamHI and subcloned into pBS that was cut 
before with the same enzyme and dephosphorylated. Site directed mutagenesis was 
performed (2.8.6) and the correct mutation was checked by sequencing. Subsequently, 
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the FN fragment was released form pBS by BamHI digest and inserted back into 
BamHI cut and dephosphorylated pET-15b FN-III7-10. The orientation was checked by 
PCR using a primer pair annealing 3’-prime in pET-15b and 5’-prime in the cDNA. 
Finally, correctness of the mutated cDNA was verified by sequencing.  
 
Fig 2.4. Map of the cloning / expression vector pET-15b. The cDNAs of the FN fragments were 
cloned into the vector by Nde I / BamH I sites. Recombinant FN fragments exhibit a N-terminal 
His-Tag (Taken from the pET-15b map (Novagen)and modified).  
2.8.9 Generation of siRNA constructs 
Small synthetic interfering RNAs (siRNAs) are a highly specific tool to silence genes 
on the post-transcriptional level. The effect of many RNAi mediated gene silencing 
approaches is short-lived, since many of them utilize only transiently transfected 
expression systems. To overcome this problem, a stably transfected siRNA expression 
system (pSuper RNAi vector) was used in this study to provide permanent and effective 
silencing of the gene of interest. The pSuper RNAi (Brummelkamp, Bernards et al. 
2002) system facilitates the transcription of RNA transcripts that readily form pair stem 
loop structures. These structures are rapidly cleaved within the cell, thereby producing a 
functional siRNA.  
    
Fig 2.5. Principle of pSuper driven siRNA expression. A. Annealed primers containing the 
targeting sequence, the hairpin loop, a termination signal (T5) and pSuper compatible 
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overhangs (Bgl II and Hind III). B. The RNA transcript forms a pair stem loop structure. C. Cell 
mediated processing of the RNA transcript results in a functional siRNA.(Modified from the 
pSuper.Retro Instruction manual, OligoEngine. Shown here: Construct #5 for αv integrin 
knockdown, which produced a highly efficient knockdown. 
2.8.9.1 Design of siRNA constructs 
siRNA constructs were designed according to the protocols of (Ui-Tei, Naito et al. 
2004) and (Naito, Yamada et al. 2004). The constructs had to meet the following 
requirements: The sense-strand should contain G/C nucleotides in 5’- prime and an A/T 
rich region ending with A/T must be located at its 3’-prime end. There should be no 
G/C stretches longer than 9bp and the overall G/C content should not exceed 60%. 
Appropriate 19mers matching these requirements were identified through processing the 
target gene’s full length mRNA sequence with siDirect software. For each knockdown, 
five different knockdown constructs were designed and subsequently cloned into the 
pSuper.Retro vector. 
2.8.9.2 Cloning of knockdown constructs 
In order to prepare the knockdown insert for pSuper.Retro, the forward and reverse 
strands of the oligonucleotides (5’-prime phosphorylated and HPLC purified) had to be 
annealed. Therefore, 3 µg of each, the forward and the reverse strand were combined 
and filled up to 50 µl with annealing buffer. Primer denaturation was achieved through a 
heat-step. Subsequently the solution was allowed to cool down slowly to allow proper 
annealing of both strands. The denaturation and annealing procedure was performed as 
listed in the table below:  
Step ................... time (sec.) ........... temp. (°C) 
1 ........................... 240 ....................... 90 
2 ........................... 600 ....................... 70 -1°C / min 
3 ........................... 900 ....................... 15 
4 ............................. ∞ ........................ 10 
Annealed oligonucleotides were kept on ice until ligation was performed. In order to 
prepare pSuper.Retro for ligation, the vector was digested with Bgl II and Hind III 
(2.8.4.1), followed by dephosphorylation (2.8.4.2). Finally, 4 µg of linearized 
pSuper.Retro were ligated (2.8.4.3) with 2 µl of the annealed oligonucleotides. 
Successful ligation results in destruction of the Bgl II restriction site. To reduce the 
amount of re-ligated vector, a additional Bgl II digest (2.8.4.1) of the ligation reaction 
was performed. 2 µl of the reaction were used for transformation. 
 Annealing buffer: 100 mM NaCl in 50 mM HEPES pH 7.4   
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2.8.10 Preparation of retrovirus 
Retrovirus preparations were done in collaboration with Prof. Dr. Alexander Pfeiffer 
(University of Bonn, Germany). For production of vesicular stomatitis virus G (VSV-G) 
pseudo typed retroviral vectors, human embryonic kidney cells (HEK293T) were 
transfected with the pSuper.Retro knockdown construct, packaging plasmids (encoding 
HIV gag, pol and rev) and a plasmid encoding for the envelope of VSV-G by a calcium-
phosphate method. Supernatant containing the VSV-G pseudo typed retrovirus was 
harvested, enriched by centrifugation and directly used for infection of FN
RGE/RGE 
fibroblasts. 
2.8.11 Plasmids and cDNAs 
cDNA ....................... backbone ............................ provided by ........................ reference 
FN-III1-5 (human) ...... pET-15b  ........................... H.P. Erickson ....... (Ohashi et al., 2005) 
FN-III4-7 (human) ...... pET-15b  ........................... H.P. Erickson ....... (Ohashi et al., 2005) 
FN-III7-10 (human) ..... pET-15b ............................ H.P. Erickson ....... (Ohashi et al., 2005)  
FN-III7-10RGE (human) pET-15b ........................ H.P. Erickson ....... (Ohashi et al., 2005) 
FN-III7-10ΔRGD (human) pET-15b  .................... H.P. Erickson ....... (Ohashi et al., 2005) 
FN-III10-12 (human) .... pET-15b  ........................... H.P. Erickson ....... (Ohashi et al., 2005) 
FN-III13-15 (human) .... pET-15b  ........................... H.P. Erickson ....... (Ohashi et al., 2005) 
2.9 Microscopy 
2.9.1 Confocal microscopy 
Confocal images were taken using a confocal microscope (Leica, DMIRE2) with 
immersion oil objectives HCX PL APO 100 x/1.4-0.70, HCX PL APO 63 x/1.4-0.60 
and a HC PL 40 x/0.70 dry objective at RT. Images were acquired, processed and 
evaluated using Leica Confocal Software (version 2.5, Build 1227).   
2.9.2 Epifluorescence microscopy 
Fluorescence images were taken at RT with an epifluorescence microscope (Leica, 
DMRA2) equipped with a NPLAN 40/0.65 NA objective and a CCD camera 
(Hamamatsu, ORCA-ER). 
2.9.3 Light microscopy of living cells 
Images of living cells were taken using an inverted light microscope (Zeiss, Axiovert 40 
CFL) equipped with a A – PLAN 10 x / 0.25 objective and a LCD camera (Prosilica). 
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Images were acquired and evaluated using the software Fire wire recorder (SVS – 
Visitek GmbH). 
2.9.4 Light microscopy of histological sections 
Images of histological sections were taken using a light microscope (Zeiss, Axioskop) 
equipped with a 5 x / 0.15 and 10 x / 0.30 objective (Zeiss, Plan-NEOFLUAR) 
equipped with a LCD camera (Leica, DCC500).  
2.9.5 Stereo microscopy of macroscopic structures 
Embryos were dissected and visualized using a stereomicroscope (Leica, MZFLIII) 
equipped with a LCD camera (Jenoptik, ProgRes C14).  
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3 Results 
3.1 Functional analysis of FN’s RGD motif in vivo and in vitro 
The generation of the FN RGD>RGE targeting construct as well as the generation of 
FN
RGE/+ 
knockin ES cells was done by Drs. Fässler and Seiichiro Takahashi. Mouse-
blastocyst injection of selected ES cells to obtain germ line chimeras was performed by 
Dr. Bösl (Max-Planck-Institute of Biochemistry, Martinsried, Germany). The in vivo 
analysis of FN
RGE/RGE 
mice described in this study was performed in cooperation with 
Dr. Seiichiro Takahashi. 
3.1.1 Generation of FNRGE/RGE knockin mice 
Murine fibronectin is encoded by a single gene (Fn1) that consists of 46 exons located 
on chromosome 1. Translation of its ~ 8.3 kbps long transcript gives rise to a protein 
composed of 2477 amino acid residues. The RGD motif is located in exon 30. 
Substitution of the aspartate (D
1616
) to glutamate (E) leads to abrogation of integrin 
binding (Pierschbacher and Ruoslahti 1984). In order to study the impact of the 
RGD>RGE mutation in vivo, mice with the corresponding mutation in the fibronectin 
gene were generated using homologous recombination techniques. Therefore, a 
fragment of the FN gene containing exon 30 was cloned into a pKS vector backbone. 
The amino acid substitution was achieved by site directed mutagenesis, resulting in a 
change of the aspartate (D) encoded by the codon GAC to GAG, which codes for 
glutamate (E). The C>G nucleotide change additionally created a novel HinfI restriction 
site in the mutant FN gene, which was used to identify mice carrying the mutated allele. 
(Fig 3.2). The resultant targeting construct FN-RGE
neo
 was used for gene targeting (Fig 
3.1). 
 
 
Results 
58 
 
Fig 3.1. Schematic representation of the FN-RGE knockin strategy. Depicted is the cloned FN 
fragment containing exon 30, which was targeted by the point mutation (*). Additionally, a loxP 
flanked neomycin resistance (Neo
R
) cassette was inserted into intron 30 to allow positive 
selection of ES cell clones that incorporated the mutated allele by recombination. The resultant 
targeted allele is depicted as FN-RGE
neo
. The removal of the selection cassette from the 
targeted allele was later achieved by intercrossing heterozygous mice with a strain expressing 
deleter-Cre recombinase. B marks BamHI restriction sites. (Modified from Takahashi et al.). 
Electroporation of the targeting construct
 
into ES cells (derived form 129/Sv mice) and 
subsequent selection with neomycin yielded two clones whose chromosomal DNA had 
incorporated the mutant allele by homologous recombination. Both clones were 
identified by Southern blot analysis. Therefore, genomic ES cell DNA was subjected to 
a BamHI digest and hybridized with an external probe which recognized the wild-type 
(6.3 kbps) and the mutant allele (4.2 kbps). In order to generate germ-line chimeras, the 
two ES cell clones carrying the FN-RGE allele were injected into blastocysts, which 
were subsequently transferred into foster mice. Highly chimeric male offspring were 
mated to female C57BL6 mice to assess germ-line transmission and to obtain FN-RGE 
heterozygous mice (FN
RGE/+
). The FN
RGE/+ 
progeny were viable and of normal 
appearance. In order to remove the neomycin selection cassette, FN
RGE/+ 
males were 
mated to deleter-Cre expressing C57BL6 females. The successful introduction of the 
FN-gene mutation in mice was finally confirmed by Southern blot analysis of DNA 
derived from tail biopsies as previously described for the ES cells. In addition, the mice 
were genotyped by PCR, which facilitated the detection of the mutant and the wild-type 
allele with the corresponding amplicon-sizes of 380 bps and 330 bps, respectively (Fig 
3.2).    
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Fig 3.2. Confirmation of the FN-RGE mutation in mice. A. Sequenced amplicon of a 
genotyping PCR: Confirmation of the knockin mutation. B. HinfI digest of amplicons, derived 
from genotyping PCR using the primer pair genoRGE fw and genoRGE rev (2.8.5.1), results in 
the expected fragmentation of the mutant amplicon. (Taken from Takahashi et al. and modified). 
Intercrossings of FN
RGE/+ 
mice revealed no viable homozygous (FN
RGE/RGE
) progeny. 
Out of 157 viable offspring, 65% heterozygous and 35% wild-type, but no homozygous 
were obtained (Fig 3.3). This clearly indicates that the FN-RGE mutation represents a 
recessive embryonic lethal trait. In order to assess the time point of lethality, embryos 
derived from heterozygous intercrosses were dissected at different stages of embryonic 
development. Each dissected embryo was genotyped by PCR of DNA-extracts from 
yolk sac biopsies or embryonic tissue. Until E10.5, all embryos were alive and the 
determined genotypes showed normal Mendelian distribution. Beyond E10.5, no 
FN
RGE/RGE 
embryo survived, which was indicated by lacking heartbeat. One day later 
(E11.5), all homozygous mutants were already partially disintegrated and started to 
become resorbed. 
 
Fig 3.3. Genotypes of progeny derived from heterozygous intercrosses. The genotypes show 
Mendelian distribution. Homozygous mutants die around E10.5. (
a) assigns embryos without 
beating heart. (Taken from Takahashi et al. and modified). 
3.1.2 FNRGE/RGE embryos display multiple abnormalities 
To analyse the cause of lethality and the defects caused by the FN-RGE mutation, 
embryos derived from heterozygous intercrosses were dissected at different 
developmental stages. FN
RGE/RGE 
embryos displayed the first subtle defects at E8.5, 
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which was manifested in a slightly shorter anterior–posterior axis. With respect to the 
development of the neural tube, the head fold and the number of present somites (three 
to four pairs), FN
RGE/RGE 
embryos were indistinguishable from their wild-type 
littermates. The defects caused by the FN mutation became explicitly evident at E9.5. 
While wild-type embryos at this stage completed turning (Fig 3.4) into the fetal 
position, FN
RGE/RGE 
mutants were only partially turned, the limb buds were missing and 
their neural tube exhibited a notable kink. Furthermore, FN
RGE/RGE 
embryos had a 
shortened posterior trunk whose appearance differed markedly from the elongated and 
C-shaped trunk of wild-type embryos.   
 
Fig 3.4. Turning of the embryo. Between E8.5 (A) and E9.0 (B), embryos turn by rotation 
around their longitudinal axis. FN
RGE/RGE 
mice fail to complete this rotation in time. (Pictures 
taken from emap Edinburgh mouse atlas project and modified). 
A characteristic feature of all FN
RGE/RGE 
embryos at E9.5 was the complete absence of 
somite blocks in the severely shortened posterior trunk, which resulted in a low total 
number of only 12 – 13 somite pairs compared to ~ 21 in wild-type littermates. At 
E10.5, FN
RGE/RGE 
embryos displayed some further progression in heart and head 
development. However, the formation of somite blocks in FN
RGE/RGE 
embryos stopped 
around E9.0 with a number of 12 – 13 pairs, which did not increase any further at later 
stages.  
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Fig 3.5. Whole-mount images of wild-type and FN
RGE/RGE 
embryos. A and B. Side view of E8.5 
embryos, both with four pairs of somites and a well developed allantois (al). The FN
RGE/RGE 
embryo is slightly smaller. C and D. The wild-type embryo has turned into fetal position and 
contains 21 pairs of somites (C). The E9.5 FN
RGE/RGE 
embryo has not completed turning, has a 
kinked neural tube and a shortened posterior trunk region with only 13 pairs of somites (D). 
The inset shows the anterior somites in higher magnification. The headregion of the mutant 
embryo is normally developed. E and F. Side view of an E10.5 wild-type embryo with 29 somite 
pairs (E) and an FN
RGE/RGE 
embryo with 13 (F). The fore limb buds and the first branchial arch 
are developed, but the second branchial arch is missing (F). al, allantois; fl, fore limb bud; h, 
heart; nt, neural tube; s, somites; Scale bars: (B, D, F) 500 µm. (Taken from Takahashi et al. 
and modified). 
The observed defects in FN
RGE/RGE 
embryos suggested implications of aberrant 
apoptotic and cell proliferation processes. In order to test this assumption, markers for 
cell apoptosis and proliferation were analysed by immunohistochemistry. Analysis of 
the apoptotic markers TUNEL and cleaved Caspase 3 revealed, that FN
RGE/RGE 
embryos 
exhibited markedly elevated levels of apoptotic cell death, particularly in tail bud 
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derived mesodermal cells located in the posterior trunk region. In contrast, cell 
proliferation tested by Ki67 staining was similar in wild-type and FN
RGE/RGE 
embryos.  
 
Fig 3.6. Analysis of apoptotic cell death and cell proliferation in E9.5 embryos. A to D. 
TUNEL and cleaved form of caspase-3 staining reveal massive apoptosis in the posterior trunk 
region of FN
RGE/RGE 
embryos in comparison with very few positive cells in the wild-type control 
embryo. Sites of co-localization of TUNEL (green) and cCasp3 (red) are colored in yellow. E 
and F. Analysis of cell proliferation by staining for the cell proliferation marker Ki67 revealed 
no notable difference between controls and FN
RGE/RGE 
embryos. nt, neural tube; Scale bars: (D 
and F) 100 µm (Taken from Takahashi et al. and modified).   
3.1.3 FN-RGE is normaly distributed and assembled in vivo 
It is a widely accepted notion, that FN’s RGD motif is essential for FN matrix assembly 
to occur (Schwarzbauer 1991). Thus it was obvious to expect that mutation of this motif 
abrogates FN fibril assembly. To determine whether FN-RGE was assembled into a 
fibrillar matrix, immunostaining and Western blot analysis of E9.5 embryos were 
performed.  Immunofluorescence staining for FN of parasagittal paraffin-sections from 
PFA fixed E9.5 embryos revealed a wide expression of FN-RGE. FN
RGE/RGE 
embryos 
exhibited a strong FN-RGE matrix surrounding large vessels, the nervous tissue and 
somite blocks. A fine meshwork was visible within the heart, somites, tail bud 
mesoderm and the developing facial and trunk mesenchyme (Fig 3.7.A). There was no 
detectable difference of the FN immunosignal between FN
RGE/RGE 
and wild-type control 
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embryos. The apparently normal expression levels of FN-RGE assessed by 
immunofluorescence could be confirmed by a comparative Western blot analysis of 
whole embryo lysates (Fig 3.7.B).   
 
Fig 3.7. FN-RGE expression in FN
RGE/RGE 
embryos. A. Sagittal paraffin sections of E9.5 
embryos stained with hematoxylin-eosin (H&E, top) and anti-serum against FN (bottom). 
FN
RGE/RGE 
embryos display a notably shortened posterior trunk region. B. Western blot of E8.5 
embryo lysates shows similar levels of FN expression levels in wild-type and FN
RGE/RGE 
littermates. Scale bars: 500 µm (Taken from Takahashi et al. and modified). 
In vitro studies reported that α4 integrin is capable to trigger FN fibril formation in an 
RGD independent manner (Sechler, Cumiskey et al. 2000). Thus, the unexpected 
finding of apparently normal FN-RGE fibrils could be explained by the possibility of 
α4β1 integrin dependent assembly or, alternatively, by a cross-linking artefact induced 
by PFA fixation. In order to test these possibilities, native cryo-sections derived from 
E9.5 embryos were immunostained for FN and α4 integrin expression. The FN staining 
revealed a similar amount and distribution of FN fibrils in FN
RGE/RGE 
embryos and wild-
type controls. Integrin α4 was expressed at low levels and signals were only detectable 
in the cranial region, the epicardium and the proepicardial serosa of controls and 
FN
RGE/RGE embryos. Importantly, α4 integrin positive cells in the cranial region or in the 
heart did not co-localize with FN signals, suggesting the existence of a novel, RGD and 
α4 integrin independent FN fibrillogenesis mechanism (Fig 3.8.A). In order to test 
Results 
64 
whether the absence of RGD-integrin interactions leads to a compensatory up-
regulation of non-RGD binding α4 integrin expression, fluorescence activated cell 
sorter (FACS) analysis of single cell suspensions derived from collagenase treated E9.5 
embryos was performed. It revealed that both, FN
RGE/RGE 
and control embryos exhibited 
only a small population of α4 integrin positive cells of indistinguishable size and similar 
expression levels, demonstrating that α4 integrin expression was not altered in 
FN
RGE/RGE 
mice (Fig 3.8.B).  
 
Fig 3.8. FN-RGE fibrillar network in FN
RGE/RGE 
embryos. A. Native cryosections of unfixed 
E9.0 embryos were stained for FN and α4 integrin. Image of the heart ventricle (top): Note that 
α4 integrin immunosignals are not co-localizing with FN signals. Higher magnifications show 
similar FN fibril-thickness and ramifications in wild-type and FN
RGE/RGE 
embryos (bottom and 
inset). B. FACS analysis of single cell suspensions derived from E9.5 embryos shows 
comparable levels of α4 integrin expression. ep, epicardium; ps, proepicardial serosa; Scale 
bars: 100 µm. (Taken from Takahashi et al. and modified). 
3.1.4 FNRGE/RGE cells assemble FN-RGE in an αv integrin-dependent manner 
In order to identify the mechanism underlying FN-RGE matrix assembly, several clonal 
fibroblast-like cell lines derived from E9.5 FN
RGE/RGE 
and control embryos were 
established. The obtained cell lines were assayed for the cell surface expression levels 
of α2, α5, α6, αv, α4, β1 and β3 integrin by FACS analysis (Fig 3.9.A). Only cell lines 
with comparable integrin expression levels were chosen for subsequent assays. To rule 
out α4 integrin mediated FN assembly, only clones lacking α4 integrin were used. 
Addition of labelled wild-type plasma FN (pFN) to FN
RGE/RGE 
cells in serum 
replacement medium resulted in the assembly of a normal fibrillar network with α5 
integrin co-localized in fibrillar adhesions (Fig 3.9.B). This preliminary test confirmed 
that FN binding integrins on the surface of FN
RGE/RGE 
clones were fully functional.     
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Fig 3.9. Integrin expression profile and plasma FN assembly assay. A. Integrin expression 
profile of a selected wild-type and FN
RGE/RGE 
clone determined by flow cytometry. Cell lines 
were incubated with antibodies to α2, α4, α5, αv, α6, β1 and β3 integrin subunits (blue 
histogram). Note that α5, αv, β1 and β3 integrins are expressed at comparable levels, while 
both clones lack α4 integrins. (Isotype controls are depicted in black). B. Wild-type and 
FN
RGE/RGE 
cells cultured in presence of exogenous plasma FN (60 nM). Note that FN
RGE/RGE 
cells 
are capable to assemble exogenously added pFN. Scale Bar: 15 µm (Taken from Takahashi et 
al. and modified).  
In order to test whether FN
RGE/RGE 
cells were also capable to assemble their 
endogenously produced mutant FN-RGE, it was necessary to grow them in serum-
replacement medium to avoid contaminations with exogenous FN derived from serum. 
Serum is a widely used supplement of most cell growth media and a major source for 
exogenous FN. Assembly assays of endogenous FN critically depend on the absence of 
serum-derived FN. As cells in serum-replacement medium lack ECM components 
usually provided by the serum, they had to be seeded on defined substrates, such as 
Laminin 111 (LM111) or Vitronectin (VN). Wild-type and FN
RGE/RGE 
cells plated on 
LM 111 adhered via their laminin binding α6β1integrin. Thus, α5β1 integrin, as well as 
αv integrins, were left unoccupied to the assembly of the secreted FN. In contrast to the 
previously mentioned notion that FN’s RGD motif is essential for the initiation of FN 
matrix assembly, FN
RGE/RGE 
cells were found to initiate and complete the assembly of 
FN-RGE into a dense network of fibrils on their cell-surface. The morphology of the 
fibrillar FN-RGE network was similar to that observed in FN
RGE/RGE 
embryos. Although 
the kinetics of fibril formation was comparable between wild-type and FN
RGE/RGE 
cells, 
the size and the distribution of the fibrils differed between the two cell lines. Wild-type 
cells produced an elaborate network of long and thin fibers, while the appearance of 
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FN-RGE fibrils assembled by FN
RGE/RGE 
cells was rather short and thick (Fig 3.10.A). 
To determine which integrin, α5 or αv, mediates the assembly of FN-RGE, cells were 
plated on VN. On VN, wild-type and FN
RGE/RGE cells adhered via their αv integrins. A 
previous study has shown that this depletes αvβ3 integrins from the apical cell surface 
but leaves α5β1 integrin diffusely distributed on the cell surface and presumably free to 
participate in FN matrix assembly (Fath, Edgell et al. 1989). When plated on VN, 
control cells developed a regular FN network, while FN
RGE/RGE 
failed to form FN-RGE 
fibrils (Fig 3.10.B). This suggests that αv, but not α5β1 integrin, mediates the assembly 
of FN-RGE into a matrix network.  
 
Fig 3.10. FN-RGE fibril assembly on LM111 and VN. A and B. Wild-type and FN
RGE/RGE 
cells 
grown in serum replacement medium and either plated on LM111 (A) or VN (B). Cells were 
fixed after 48, 72 and 96 h and stained for FN (red, DAPI stained cell-nuclei are depicted in 
blue). Note that FN
RGE/RGE 
cells are able to form FN-RGE fibrils on LM111 (A, bottom), but not 
on VN (B, bottom). Scale bar: 15 µm (Taken from Takahashi et al. and modified).  
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3.1.5 αv integrins can trigger an RGD-independent FN assembly pathway 
Since the data obtained with FN
RGE/RGE 
cells on VN (shown in Fig 3.10. B) suggested 
that αv integrins play an essential role in FN-RGE fibril formation, it was further 
investigated whether α5β1 integrins were indeed not involved in this process. Therefore, 
wild-type and FN
RGE/RGE 
cells were grown on LM111 and stained with antibodies 
against FN and the α5 integrin subunit. Fig 3.11.A demonstrates that wild-type cells 
showed co-alignment of α5 integrin with the thin and elaborate FN network. In contrast, 
FN
RGE/RGE cells failed to align α5 integrin with FN-RGE fibrils. Instead, the α5 signal on 
FN
RGE/RGE 
cells was diffusely distributed over the whole cell surface further indicating 
that this integrin was not able to bind to FN-RGE (Fig 3.11.A). Unfortunately, due to 
the poor quality of available anti-αv antibodies, it was not possible to directly 
demonstrate the co-localization of αv integrin with FN-RGE. To further corroborate the 
particular importance of αv integrins for FN-RGE fibril formation, a knockdown of the 
αv subunit in FNRGE/RGE cells was performed. The depletion was achieved by retroviral 
transduction of a construct expressing αv specific siRNAs, and yielded a ~80% down-
regulation of αv expression as determined by FACS (Fig 3.11.C).  As a negative 
control, FN
RGE/RGE 
cells were transduced with a construct expressing scrambled siRNA. 
In order to assess the consequences of the knockdown on FN-RGE assembly, the αv-
depleted FN
RGE/RGE 
cells were plated on LM111 and cultured in serum-replacement 
medium for up to 96 h. Despite the availability of free α5β1 integrins, the αv-depleted 
FN
RGE/RGE 
cells were unable to form FN-RGE fibrils (Fig 3.11.B). Only after longer 
culture periods a few thick fibers could be occasionally observed, which was likely due 
to the remaining low levels of αv integrin expressed on αv-depleted FNRGE/RGE cells.  
 
Fig 3.11. Distribution of α5 integrin and siRNA mediated depletion of αv integrin in 
FN
RGE/RGE 
cells. A. Distribution of α5 integrin and FN fibers on wild-type and FNRGE/RGE cells 
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cultured on LM111 for 24 h in serum-replacement medium. Note that α5 and FN co-localize in 
fibrillar adhesions (white arrowheads) of wild-type cells, whereas α5 is diffusely distributed on 
FN
RGE/RGE 
cells. B. αv integrin depletion in FNRGE/RGE cells by retroviral transduction of anti-αv 
siRNA and control siRNA (scr.-siRNA) expression cassettes. Cells were cultured for 48, 72 and 
96 h on LM111 in serum-replacement medium and stained for FN-RGE. Note that FN-RGE 
fibril formation is largely abrogated in αv-depleted FNRGE/RGE cells. C. Determination of αv 
integrin knockdown efficiency by FACS analysis. The siRNAs against αv integrins cause ~80% 
depletion (thin black histogram). The bold black histogram indicates normal expression levels 
of αv integrin in FNRGE/RGE cells expressing scrambled siRNAs. (red histogram: isotype-control). 
Scale bars: 15 µm. (Taken from Takahashi et al. and modified). 
To assess the importance of αv integrin’s RGD-binding pocket for FN-RGE fibril 
formation, I performed FN assembly assays in presence of RGD containing peptides. 
The linear Gly-Arg-Gly-Asp-Ser-Pro (linRGD) peptide is a widely used compound to 
disrupt the interaction of RGD binding integrins, such as α5β1 and αvβ3, with their 
ligands. The more constrained cyclic cycRGD (cyclo [-Arg-Gly-Asp-D-Phe-Val-]) was 
reported to preferentially bind to αvβ3 integrin (Pfaff, Tangemann et al. 1994). 
Incubation of wild-type and FN
RGE/RGE 
cells with linRGD extensively inhibited 
assembly of wild-type as well as FN-RGE fibrils. In contrast, presence of cycRGD had 
a strong inhibitory effect on the assembly of FN-RGE, while wild-type fibril formation 
was only marginally affected.  Treatment of wild-type and FN
RGE/RGE 
cells with control 
peptides, in which the RGD motif was mutated (linear Gly-Arg-Gly-Glu-Ser-Pro 
[linRGE] peptide or cyclic cyclo[-Arg-Ala-Asp-D-Phe-Val-] peptide [cycRAD]) had no 
effect on assembly of wild-type FN or FN-RGE (Fig 3.12). Since FN contains domains 
that facilitate binding to cell surface proteoglycans, such as members of the syndecan 
family, it was further tested whether these receptors were involved in the promotion of 
FN-RGE assembly. Heparin treatment, which blocks the binding of FN to cell surface 
proteoglycans, marginally inhibited wild-type FN assembly but had almost no effect on 
FN-RGE fibril formation (Fig 3.12). These data demonstrated that the RGD binding 
pocket of αv integrin is essential for FN-RGE matrix assembly. 
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Fig 3.12. Effect of heparin, linear RGD or cyclic RGD peptides on FN-RGE assembly. Wild-
type and FN
RGE/RGE 
cells were cultured on LM111 in serum-replacement medium for 2 h. 
Subsequently, heparin or peptides were added and cells were further incubated for 14 h. 
Finally, cells were stained with anti-FN antibodies (red signal) and DAPI to stain the nuclei 
(blue signal). The following compound concentrations were used: linRGD and linRGE 900 µM; 
cycRGD and cycRAD 410 µM; heparin 100 µg/ml; Scale bars: 15 µm. (Taken from Takahashi 
et al. and modified). 
3.1.6 The FN-I1-9 domains bind αvβ3 integrin with high affinity 
The previous data demonstrated that αv integrins are essential for the formation of FN-
RGE fibrils and suggested that these integrins are capable to bind to FN via a novel 
binding site. In order to map this novel αv binding / assembly site(s), wild-type and 
FN
RGE/RGE 
cells cultured on LM111 were treated with recombinant FN fragments 
spanning almost the entire length of the FN molecule. As expected, all fragments 
containing the RGD motif (FN-III7-10 and FN-III10-12) strongly inhibited the formation of 
wild-type FN as well as FN-RGE fibrils (Fig 3.13). In addition, a strong inhibitory 
effect was observed after treatment with FN’s N-terminally derived fragment FN-I1-9, 
which is generally recognized as a potent inhibitor of FN matrix assembly (Fig 3.13). 
The inhibitory effect of FN-I1-9 on FN matrix assembly is thought to be caused by its 
interaction with cell surface receptors. Another explanation for the inhibitory effect is 
its ability to bind to specific FN-III domains of other FN molecules, which results in 
lateral inhibition of FN self-association required for network formation (McKeown-
Longo and Mosher 1984; Aguirre, McCormick et al. 1994; Hocking, Sottile et al. 1994; 
Bultmann, Santas et al. 1998). In contrast to the previously mentioned results, no 
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inhibitory effect on FN assembly, neither on wild-type nor on FN-RGE, was observed 
after cells had been treated with FN-III1-5, FN-III4-7, FN-III13-15 and the control fragment 
FN-III7-10RGE (Fig 3.13). 
 
Fig 3.13. Effect of recFN fragments on FN assembly. A. Wild-type and FN
RGE/RGE 
cells were 
cultured on LM111-coated dishes in serum replacement medium for 2 h, recFN fragments were 
added (right) and cells were incubated for further 14 h. Finally, cells were PFA fixed and 
stained for FN using an anti-FN antibody. Note the strong inhibition of FN assembly when FN-
III7-10, FN-III10-12 and FN-I1-9 are applied. Final concentrations of recFN fragments: FN-I1-9, 2.5 
µM; FN-III7-10 and FN-III7-10RGE, 10 µM; all other fragments 25 µM. B. Schematic depiction of 
the modular domain composition of FN. Type I domains are depicted as orange rectangles, type 
II domains as grey ovals, and type III domains as circles. The integrin binding domains III9 and 
III10 have been highlighted in pink (synergy site) and red (RGD motif), respectively. The 
variable region is depicted as a yellow rectangle. Extradomains A and B are shown in green. 
Scale bars: 15 µm. (Taken from Takahashi et al. and modified). 
Treatment of wild-type and FN
RGE/RGE 
cells with recFN-I1-9 resulted in a strong 
inhibition on FN matrix assembly. Since assembly of FN-RGE depended on αvβ3 
integrin, it was further examined whether this integrin was capable of binding to the 
recombinant FN-I1-9 fragment. Therefore direct and competitive solid phase binding 
assays (2.7.9) were performed, in which the recombinant FN fragments were adsorbed 
to a microtiter plate and then incubated with serially diluted biotinylated αvβ3 integrins. 
Direct binding assays showed comparable binding of αvβ3 to FN-III7-10, FN-III10-12 and, 
surprisingly, to FN-I1-9 (Fig 3.14.A). No binding of αvβ3 to the other fragment tested 
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was observed (Fig 3.14.B). In a similar assay, α5β1 integrin was applied. Although 
α5β1 lacked the ability to assemble FN-RGE, it exhibited the capability to bind to FN-
I1-9 (Fig 3.14.C).  
 
Fig 3.14. Direct solid-phase FN and integrin binding assay. A. Titration curve of avb3 integrin 
bound to different recombinant FN fragments. FN fragments were adsorbed at 0.25 µM to 
microtiter plates. After blocking of non-specific binding with BSA, biotinylated αvβ3 was 
allowed to bind to immobilized FN fragments. In order to activate the integrins, the assay was 
performed in TBS buffer containing 1 mM MnCl2.  Note that αvβ3 bound with high affinity to 
FN-I1-9. Fragments containing the RGD motif (FN-III7-10 and FN-III10-12) served as positive 
controls. A FN-III7-10 fragment lacking the RGD motif served as negative control. B.αvβ3 
integrin showed no binding to other fragments than FN-III7-10, FN-III10-12 and FN-I1-9. C. Same 
experimental procedure as mentioned in A and B, this time using biotinylated α5β1 for titration. 
Note that α5β1 binds to FN-I1-9. D. Similarly to αvβ3, α5β1 did not bind to other fragments than 
FN-III7-10, FN-III10-12 and FN-I1-9. In all binding assays, the absorbance measured in BSA coated 
control wells was <15% relative to maximum absorbance values and was routinely subtracted. 
All binding was determined in duplicate. Mean ± SD (n = 3) (Taken from Takahashi et al. and 
modified). 
In order to reveal the role of the RGD binding pockets of the integrins αvβ3 and α5β1 
for FN-I1-9 binding, competitive solid phase binding assays in presence of linRGD 
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peptides were performed. Treatment with linRGD resulted in strong inhibition of both, 
αvβ3 and α5β1 binding to the FN-I1-9 fragment (Fig 3.15.A and B).  
 
Fig 3.15. Competitive solid-phase binding assay. FN-I1-9 was immobilized at 0.25 µM. The 
same experimental procedure was performed as mentioned in Fig 3.14. Integrins were allowed 
to bind in presence of 100 µg/ml heparin (triangles), 750 µM isoDGR-2C peptide (squares) or 
850 µM linRGD peptide (circles). The values plotted are normalized to the maximal binding 
value to give the yield of saturation. A. The maximal binding value of αvβ3 integrin to FN-I1-9 
corresponds to an OD (405 nm) of 1.08. Note that αvβ3 binding to FN-I1-9 is inhibited by both 
linRGD and isoDGR-2C peptides. B. Maximal binding of α5β1 corresponds to an OD (405 nm) 
of 1.04. Note that α5β1 binding to FN-I1-9 is inhibited by linRGD peptides but not by isoDGR-2C 
peptides.  
3.1.7 The GNGRG motif in FN-I5 represents a novel αvβ3 binding and assembly 
site for FN 
Structural studies have shown that murine FN contains four GNGRG motifs within the 
FN-I1-9 fragment that are well conserved in human, rat, bovine, amphibian and fish (Di 
Matteo, Curnis et al. 2006). In a more recent study it was demonstrated that a single 
GNGRG motif located in the FN-I5 domain can convert into GisoDGRG (where isoD is 
iso-aspartate) and GDGRG by spontaneously occurring deamidation of the asparagine 
and that particularly GisoDGRG exhibits a high binding affinity to αvβ3 integrin. This 
finding was further supported by structural studies, which revealed that this particular 
GNGRG motif extends in a loop like structure from the core of the FN-I5 domain into 
the peri-fibrillar space, were it should be easily accessible to integrins. To further 
examine the role of this motif as a potential αvβ3 binding site required for FN-RGE 
assembly, synthesised *Cys-Asn-Gly-Arg-Cys* (NGR-2C) and *Cys-isoAsp-Gly-Arg-
Cys* (isoDGR-2C) peptides were applied in competitive solid-phase binding and FN in 
vitro assembly assays. As indicated in Fig. 3.15, isoDGR-2C strongly inhibited binding 
of αvβ3, but not α5β1, to FN-I1-9. These data indicate that αvβ3 but not α5β1 can 
recognize the isoDGR motif. Treatment of FN
RGE/RGE 
cells with NGR-2C and isoDGR-
2C peptides resulted in effective inhibition FN-RGE fibril formation, whereas the 
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assembly of wild-type FN matrix was unaffected (Fig.3.16 A). The strong inhibition of 
FN-RGE assembly observed after treatment with NGR-2C peptides was unexpected, 
since GNGRG was reported to exhibit a lower binding affinity to αvβ3 integrins 
compared with GisoDGRG (Curnis, Longhi et al. 2006). NGR-2C’s inhibitory effect 
suggested that a fraction of the peptides had rearranged into isoDGR-2C during 14 h of 
incubation in cell culture, since rearrangement of GNGRG to GisoDGRG or GDGRG is 
a well-known reaction occurring spontaneously under physiological conditions 
(Robinson, Robinson et al. 2004). In order to assess the kinetics of the deamidation 
reaction, NGR-2C peptides were incubated for 35 h at 37°C at a physiological pH of 
7.2. HPLC analysis of peptide samples, taken at different time points during incubation, 
revealed that ~10% of purified NGR-2C had been converted to isoDGR-2C and DGR-
2C within 16 h (Fig 3.16.B). Therefore, when testing for inhibition of FN matrix 
assembly, only a small amount of isoDGR-2C would have accumulated during 14 h of 
incubation. These data suggest that the observed inhibition observed was most likely 
due to unmodified NGR-2C interacting with αvβ3. 
 
Fig. 3.16. Effect of NGR-2C and isoDGR-2C peptides on FN-RGE assembly. A. Wild-type and 
FN
RGE/RGE 
cells were cultured on LM111 coated dishes in serum-replacement medium for 2 h, 
incubated with 800 µM NGR-2C or isoDGR-2C for 14 h and stained with anti-FN antibodies. 
Note that both NGR-2C and isoDGR-2C peptides inhibit assembly of FN-RGE but not wild-type 
FN. Scale bar: 15 µm. B. Kinetics of NGR-2C deamination and rearrangement to isoDGR-2C 
and DGR-2C, respectively. NGR-2C peptides were incubated at 37°C and pH 7.2. Amounts of 
NGR-2C and the rearrangement products isoDGR-2C and DGR-2C were determined by HPLC 
analysis as percentage peak areas. Results were normalized against NGR-2C input. Note that 
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the concentration of isoDGR-2C is steadily increasing with time, reaching ~10% of the NGR-2C 
input after 16 h. 
Taken together, these results indicate that (1) FN-I1-9 contains novel αvβ3 binding / 
assembly sites, (2) binding sites on both integrins involve their RGD binding pocket, (3) 
FN-I1-9 contains a binding site for α5β1 that is not functional for FN matrix assembly, 
(4) the binding of αvβ3 to FN-I1-9 is of somewhat lower affinity than the RGD binding 
motif of wild-type FN, (5) the GNGRG motif in FN-I5 represents a novel, selective 
αvβ3 binding site that can function for FN fibril assembly in vitro and in vivo.  
3.2 Functional analysis of FN’s dimerization motif in vivo and in 
vitro 
The generation of the FN
CC>SS
 targeting construct as well as the generation of FN
CC>SS/+
 
knockin ES cells was done by Drs. Fässler and Takayoshi Miyazono. Mouse-blastocyst 
injection of selected ES cells to obtain germ line chimeras was performed by Dr. Bösl 
(Max-Planck-Institute of Biochemistry, Martinsried, Germany). 
3.2.1 Generation of FNCC>SS/CC>SS knockin mice 
Fibronectin is secreted as a disulfide-bonded dimer and it is believed that the 
dimerization is essential for assembly of a fibrillar FN matrix (Schwarzbauer 1991). 
However, this acceptance is solely based on in vitro studies, and a confirmation for the 
in vivo situation is missing so far. To directly test the importance of FN dimerization in 
vivo, a mouse strain was generated that is incapable of expressing FN in the dimeric 
form. To this end, two Cysteins residues (Cys
2458
 and Cys
2462
), located in Exon 45 at the 
very C-terminus of the FN-molecule, were changed to serines which should result in the 
abrogation of FN’s capability to dimerize. The generation of mice carrying the CC>SS 
mutation in one of their fibronectin alleles was achieved using a gene targeting 
approach. Therefore, a fragment of the FN gene containing exon 45 was cloned into a 
pKS vector backbone. Site directed mutagensis was performed in order to change the 
Cys ( C ) encoding codons TGC to TCC, which encode for Ser (S). The resultant 
targeting construct FN
CC>SSneo 
was used for gene targeting (Fig 3.17).  
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Fig 3.17. Schematic representation of the FN-monomer (FN
CC>SS
) knockin strategy. A 
fragment of the FN wild-type allele containing exon 45 was modified with the point 
mutations (**). A loxP flanked neomycin resistance (NeoR) cassette was inserted into intron 44 
to allow positive selection of ES cell clones that incorporated the mutated allele by 
recombination. The targeting vector FN
CC>SSneo 
contains the loxP flanked neomycin cassette and 
the mutated exon 45. Homologous recombination results in the depicted targeted allele. The 
removal of the neo selection cassette from the targeted allele was performed in vivo by 
intercrossing FN
CC>SS neo/+ 
heterozygous mice with deleter-Cre recombinase strain. Restriction 
sites: B, BamHI;  S, SpeI; RV, EcoRV. 
The targeting construct FN
CC>SSneo 
was electroporated into ES cells and the obtained 
transfectants were subsequently subjected to neomycin selection. Neomycin resistant 
ES cell clones were screened by Southern blot analysis to identify clones that had 
incorporated the mutant allele into their chromosomal DNA by homologous 
recombination. Therefore, genomic ES cell DNA was digested with BamHI restriction 
enzyme and hybridized with an external probe which recognized the wild-type (12.9 
kbps) and the mutant allele (8.8 kbps) (Fig.3.18.A). Two positive ES cell clones 
carrying the FN
CC>SS 
allele (Fig. 3.18.A) were identified and subjected to the same 
procedure as mentioned above (3.1.1) in order to obtain FN
CC>SS 
heterozygous mice. 
Finally, the successful introduction of the mutation in mice was confirmed by Southern 
blot analysis of DNA derived from tail biopsies and by PCR genotyping (Fig. 3.18.B, 
D).  
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Fig 3.18.  Confirmation of the FN
CC>SS 
mutation in ES cells and mice. A. Southern blot 
analysis of genomic ES cell DNA. DNA was hybridized with an external probe after BamHI 
digestion.  Insertion of the targeting vector by homologous recombination changes the wild-type 
genomic DNA fragment of 12.9 kbp to 8.8 kbp. B. Southern analyses of genomic DNA derived 
from tail-tip biopsies of mice as described in A. Note that heterozygous mice exhibit the wild-
type (12.9 kbp) and the targeted allele (8.8 kbp). C and D. PCR based genotyping of tail-tip 
DNA. Note that the targeted allele after neo deletion results in a band of 298 bp in size.  
In order to obtain homozygous mutant mice (FN
CC>SS/CC>SS
), heterozygous mice 
(FN
CC>SS/+
) were intercrossed. Genotyping of the resulting litters 3 weeks after birth 
(P21) revealed that no homozygous mutants were among the progeny. Out of 278 viable 
offspring, 49% heterozygous and 51% wild-type, but no homozygous were obtained 
(Fig 3.19), indicating that the FN-monomer mutation represents a recessive lethal trait. 
To determine the time point of lethality, embryos derived from heterozygous 
intercrosses were dissected at different stages of embryonic development. The genotype 
of each dissected embryo was determined by PCR, using DNA-extracts derived from 
yolk sac tissue. All embryos were alive until E11.5 and the distribution of the genotypes 
was according to the Mendelian law (Fig 3.19). No live FN
CC>SS/CC>SS 
embryos were 
recovered beyond E11.5. Only a single FN
CC>SS/CC>SS 
embryo had a beating heart, 
whereas all the mutant littermates were already dead and showed first indications of 
disintegration. At E12.5, all homozygous mutants were already partially absorbed. 
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Fig 3.19. Genotypes of progeny derived from heterozygous (FN
CC>SS/+
)
 
intercrosses. 
Homozygous mutants die around E11.5. (
a) assigns the only homozygous mutant embryo with 
beating heart at E11.5. 
3.2.2 FNCC>SS/CC>SS embryos display growth retardation and abnormal vascular 
development 
To investigate the reasons for the embryonic lethality of FN
CC>SS/CC>SS 
embryos, 
embryos derived from heterozygous intercrosses were isolated at different stages of 
development to compare mutant with control littermates. The morphology of mutant 
embryos isolated at E8.5 was undistinguishable from wild-type littermates; they 
exhibited well developed head folds, 5 – 6 somite pairs and a properly developed neural 
tube (Fig 3.20 A, B). First indications of impaired development became apparent at 
~E9.0. All FN
CC>SS/CC>SS 
embryos at E9.5 were developmentally retarded when 
compared with their wild-type littermates (Fig. 3.20 E, F). They were markedly reduced 
in size, displayed a retarded posterior development and rarely developed beyond 20 
pairs of somites. Another hallmark of mutant embryos at E9.5 was the appearance of 
oedema, indicated by a noticeably enlarged pericardial sac (Fig 3.20 F, H), which 
suggested that the FN mutation affected the development of the cardiovascular system. 
At E10.5, the growth arrest affecting mutant embryos became more evident and in some 
mutant hearts a cardiac-looping defect was observed (Fig 3.20 H).  
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Fig 3.20. Whole mount images of wild-type and FN
CC>SS/CC>SS 
embryos. A and B. Side view of 
E8.5 embryos. Wild-type and mutant embryos are comparable in size and exhibit well developed 
allantoises. C and D. Dorsal view of E8.5 embryos. Note that both, wild-type and mutant, 
exhibit 5 pairs of somite blocks. The insets shows properly shaped somite blocks at higher 
magnification. E and F. Side view of E9.5 embryos. FN
CC>SS/CC>SS 
embryos are severely growth 
retarded and underlie a growth arrest at the 20 - 25 somite pair stage. Note that mutants show 
oedema in the heart, as indicated by an enlarged pericardial sac (F and H). G and H. Side view 
of E10.5 embryos. The growth arrest in FN
CC>SS/CC>SS 
embryos leads to a pronounced difference 
in size as compared to the wild-type littermates. The arrowhead points to the markedly effused 
pericardial sac and the noticeable malformed heart, which is observed in most mutant embryos 
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(H). al, allantois; fl, fore limb bud; h, heart; pl, placenta; s, somites; ys, yolk sac; Scale bars: 
(D,F) 500 µm; (H) 1 mm. 
The effused pericardial sac and the growth arrest observed in FN
CC>SS/CC>SS 
embryos 
beyond E9.0 suggested that the cardiovascular development was affected by the 
mutation. Clear indications of abnormal vascular development were also visible in 
FN
CC>SS/CC>SS 
yolk sacs by E9.5. Compared to control yolk sacs, mutant yolk sacs were 
anemic and lacked a distinct branching network of vessels, which became even more 
pronounced by E10.5 (Fig 3.21.A). Some regions on the mutant yolk sac exhibited only 
small and disorganized vessels, whereas other regions completely lacked vessels. 
Furthermore, the presence of red blood cells in the mutant yolk sac cavity indicated 
leakiness of present small vessels, and suggested that the circulation would be impaired. 
To characterize these defects in more detail, the morphology of the vessel architecture 
in embryonic and extra-embryonic tissue was examined by means of 
immunohistochemistry. To this end, immunofluorescence stainings for the endothelial 
marker PECAM-1 (CD31) were performed on whole-mount yolk sacs. The analysis 
revealed that mutant yolk sacs failed to remodel their primitive vascular plexus by 
angiogenesis (Fig 3.21.C), which starts beyond E8.5 (Risau 1997) and results in 
formation of individual branched vessels through endothelial cell outgrowth and 
splitting of existing vessels.  
The observed abnormal vascular development in the yolk sacs of FN
CC>SS/CC>SS 
embryos
 
suggested that other parts of the extra-embryonic tissue, such as the ectoplacental plate, 
may also be affected. To test this, paraffin sections of E10.5 placentas were stained for 
the endothelial marker Endomucin. At this stage of development, chorioallantoic fusion 
has been accomplished and fetal blood vessels derived from the extra-embryonic tissue 
have already invaded the maternal labyrinthine layer of the placenta in control mice. 
Intermingling of embryonic and maternal vessels in this layer is essential for proper 
exchange of gases and nutrition between the two circulations. The analysis of 
Endomucin stained ectoplacental plates revealed that the allantoic blood vessels of 
FN
CC>SS/CC>SS 
mutants completely failed to invade the maternal labyrinthine layer. The 
mutant vessels residing in the embryonic part of the chorioallantoic plate were dilated or 
sometimes collapsed (Fig 3.21.F).  
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Fig 3.21. Abnormal vascular development in the extra-embryonic tissue of FN
CC>SS/CC>SS 
mice. 
A. Gross morphology of whole-mount yolk sacs of mutant embryos compared to those of wild-
type littermates at E10.5. FN
CC>SS/CC>SS 
yolk sacs exhibit severe defects in vascular development. 
Arrowheads show a defined and organized vessel structure in the wild-type yolk sac (left), 
whereas the mutant yolk sac exhibits  severely dilated and leaky blood vessels with bleedings 
into the yolk sac tissue (right arrowhead and inset). B and C. Yolk sacs at E9.5, stained with an 
antibody against the endothelial marker PECAM-1. In contrast to the large vessels developed in 
wild-type yolk sacs, the primitive vascular plexus in mutant yolk sacs is not remodelled into an 
organized network of larger vessels (C). E and F. Paraffin sections of placentas at E10.5 
stained with an antibody against the endothelial marker endomucin. Note that embryonic 
vessels of FN
CC>SS/CC>SS 
embryos fail to invade and sprout properly into the maternal 
labyrinthine layer (F) The arrowhead marks a vessel of collapsed appearance. ca, 
chorioallantoic plate; ll, labyrinthine layer; pl, placenta; ys, yolk sac; Scale bars: (A) 1 mm; (C, 
F) 100 µm.    
To analyse the vessel architecture in embryonic tissue, the vascular system of whole 
E9.5 embryos was also stained with antibodies against endothelial markers. Similar to 
the observations made in extra-embryonic tissues, whole-mount staining of embryos 
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with endomucin antibodies revealed a markedly impaired capability of FN
CC>SS/CC>SS 
embryos to develop a properly branched vascular system. In contrast to control embryos 
at this stage, FN
CC>SS/CC>SS 
embryos exhibited dilated small vessels of fragile 
appearance and notably reduced lumina. Some regions of the mutant embryo - particular 
in the head and in intersomitic regions of the posterior trunk - showed only a weak 
expression of endomucin, suggesting an abnormal endothelial differentiation (Fig 
3.22.A, C). Furthermore, immunofluorescence stainings with an antibody against 
PECAM-1 revealed that mutant vessels were irregularly shaped and showed numerous 
dilations. Some regions of the mutant embryo proper completely lacked a discernable 
organisation of vessels into a branched network (Fig 3.22.E).  
 
Fig 3.22. Abnormal vascular development in FN
CC>SS/CC>SS 
embryos. A. Image of whole-mount 
embryos at E9.5, stained with antibodies against endomucin. Mutant embryos (right) display a 
profoundly impaired vessel architecture as compared to control embryos (left). B and C. Higher 
magnification of embryo head-regions (from A). Note that FN
CC>SS/CC>SS 
embryos form fragile, 
disoriented vessels with markedly reduced lumina (C). D and E. Immunofluorescence image of 
the head region of E9.5 embryos stained with antibodies against PECAM-1. Note the dilated 
vessels with markedly diverse diameters in FN
CC>SS/CC>SS 
embryos (E), compared to control 
embryos (D). Arrowheads in D and E mark regions of normally developed vessels in the wild-
type (D), and a severly disoriented vessel architecture in the head of a mutant embryo (E), 
respectively. Scale bars: (A) 500 µm; (C) 250 µm; (E) 100 µm 
Together, the expression of FN-monomers results in a growth arrest at the 20-25 somite 
stage with an abnormal vascular development in both embryonic and extra-embryonic 
tissues. Defects in vascular development may explain embryonic lethality at the time-
point when the embryo starts to become dependent on placental supply. In the case of 
FN
CC>SS/CC>SS 
embryos, however, the growth is arrested around E9.5 (Fig 3.20.F) when 
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the embryo is not yet dependent on placental exchange of nutrients (Cross, Werb et al. 
1994).    
3.2.3 FNCC>SS/CC>SS mice display enhanced apoptotic cell death 
The early embryonic lethality of FN
CC>SS/CC>SS 
mice raised the question, whether the 
mutation caused abnormal apoptotis and/or cell proliferation. In order to address this 
question, paraffin sections from E9.5 embryos were stained with antibodies for the 
apoptotic marker cleaved caspase-3 and for the cell proliferation marker phospho- 
histone-3. Whereas phospho-histone-3 staining showed no difference between wild-type 
and FN
CC>SS/CC>SS 
embryos, stainings for cleaved caspase-3 revealed markedly elevated 
numbers of apoptotic cell-death in FN
CC>SS/CC>SS 
embryos, particularly in the developing 
facial and trunk mesenchyme and in the posterior trunk region (Fig 3.23.B, C). 
Furthermore, cleaved caspase-3 staining of sections through the chorioallantoic region 
of E10.5 placentas showed that mutant allantoic blood vessels derived from extra-
embryonic tissue did not only fail to invade the maternal part of the placenta 
(labyrinthine layer) (Fig 3.23.E, F), but also exhibited pronounced apoptotic cell-death 
in endothelial cells, as indicated by the strong immunofluorescence signal of cleaved 
caspase-3 staining (Fig 3.23.E to H). Together, these results show that the FN-monomer 
mutation accounts for elevated levels of apoptotic cell death events in the embryonic 
mesoderm and in endothelial cells of the extra-embryonic tissue.    
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Fig 3.23. Analysis of cell proliferation and apoptotic cell death in E9.5 embryos. A and B. 
Analysis of the cell proliferation marker phospho-histone-3 revealed no notable difference 
between FN
CC>SS/CC>SS 
and wild-type embryos. C and D. Cleaved caspase-3 staining on sections 
of E9.5 embryos revealed massive apoptosis in the posterior trunk region of FN
CC>SS/CC>SS 
embryos as compared to very few apoptotic cells in the wild-type control embryo. E and F. 
Analysis of apoptosis in the chorioallantoic region of E10.5 placenta sections. Note that mutant 
allantoic blood vessels (stained in red with the endothelial marker endomucin) derived from 
extra-embryonic tissue display markedly enhanced apoptotic cell-death. The boxed areas -
shown with higher magnification in G and H - show that mutant endothelial cells (red) of the 
extra-embryonic tissue are in  particular affected by apoptotic cell-death (green). Scale bars: (B 
and D) 500 µm; (H) 100 µm. 
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3.2.4 Monomeric FN is expressed and assembled into a fibrillar matrix-network  
According to the current model for the mechanism of FN fibrillogenesis, dimerization 
of FN is regarded as a prerequisite for the assembly of a fibrillar matrix (Wierzbicka-
Patynowski and Schwarzbauer 2003). Therefore, disruption of the dimer was expected 
to result in abrogation of FN fibril assembly. However, embryos exclusively expressing 
monomeric FN developed further than FN knock out mice, suggesting that monomeric 
FN was at least partially assembled into a functional network. To test this hypothesis, 
histological analyses of embryo sections and Western blot analyses of whole embryo 
lysates were performed to detect the amount and distribution of FN. FN 
immunofluorescence staining of parasagittal paraffin-sections from PFA fixed E9.5 
FN
CC>SS/CC>SS 
embryos revealed a strong FN-monomer deposition surrounding the 
somite blocks, nervous tissue and the large vessels, resembling the expression pattern in 
control embryos (Fig 3.24.A, bottom). Similar immunosignal intensities implied 
comparable expression levels of FN in FN
CC>SS/CC>SS 
embryos and control littermates. 
To confirm this data, a comparative Western blot analysis for FN of whole embryo 
lysates was performed which revealed similar FN levels expressed in mutant embryos 
and wild-type controls (Fig 3.24.B). The finding of apparently normal levels of FN-
monomer deposition raised the question, whether the chemical properties in terms of 
intermolecular cross-linking resembled those of a dimeric FN matrix in the control 
embryos. To address this question, FN derived from embryo lysates was extracted with 
the mild detergent deoxycholate (DOC). This procedure allows the separation of the FN 
matrix into two fractions; a DOC-soluble fraction of recently assembled FN, which is 
cross-linked to a lesser extent, and a DOC-insoluble fraction, represented by the mature 
and highly cross-linked proportion of the FN matrix (Sechler, Takada et al. 1996). 
Western blot analysis of DOC-fractions derived from mutant embryos and wild-type 
controls showed comparable amounts of FN in both fractions. This data indicated that 
FN-monomer - despite the lacking disulfide bonds - becomes normally deposited and 
cross-linked after secretion into the extra-cellular space.  
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Fig 3.24. FN-monomer expression and deposition in FNCC>SS/CC>SS embryos. A. Sagittal 
paraffin sections of E9.5 embryos stained with hematoxylin-eosin (H&E, top) and an antibody 
against FN (bottom). FN
CC>SS/CC>SS 
embryos are notably smaller than their wild-type littermates 
but express and deposit comparable levels of FN. B. Western blot of whole E8.5 embryo lysates 
shows similar amounts of FN expressed in wild-type and FN
CC>SS/CC>SS 
littermates. C. 
Deoxycholate fractionations of FN derived from E9.5 embryos. Comparable amounts of FN in 
both, DOC-soluble and DOC-insoluble fractions derived from wild-type and FN
CC>SS/CC>SS 
embryos indicate that FN-monomer is normally deposited and cross-linked. Scale bars: 500 µm  
To further analyse whether assembled FN-monomer effectively formed fibrils, 
immunofluorescence images of embryo sections stained with antibodies against FN 
were taken at higher magnifications. Closer examination of deposited FN on paraffin 
fixed E9.5 embryo sections revealed a similar morphology of the monomeric FN 
matrix-network in FN
CC>SS/CC>SS 
embryos as compared to FN networks in their wild-
type littermates (Fig 3.25.A, B). A fine, ramified FN meshwork was visible within the 
developing head-mesenchyme (Fig 3.25.C, D), as well as in the heart (Fig 3.25.E, F), 
somites, trunk mesenchyme and tail bud mesoderm. To rule out the possibility that the 
observed FN-monomer fibrils represent artefacts generated by PFA mediated cross-
linking during fixation, unfixed cryo-sections derived from E9.5 embryos were 
immunostained for FN. In line with the previous findings, this staining on native 
sections confirmed the presence of comparable amounts of normally distributed, 
delicate FN fibrils in FN
CC>SS/CC>SS 
embryos (Fig 3.25.E, F). 
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Fig 3.25. Fibrillar FN-monomer meshwork in FN
CC>SS/CC>SS 
embryos. A and B. PFA fixed 
paraffin sections of E9.5 embryos were stained for FN. Boxed areas in the head-mesenchyme 
were imaged at higher magnification. C and D. Higher magnification image of the head-
mesenchyme: FN is deposited in similar density, comparable FN fibril-shape and thickness in 
wild-type and FN
CC>SS/CC>SS 
embryos. E and F. Native cryo-sections of unfixed E9.5 embryos 
were stained for FN.  Note that similar amounts of FN are deposited in FN
CC>SS/CC>SS 
and 
control embryos. Higher magnification image of the heart (inset) shows similar FN fibril-
thickness and ramifications in the heart ventricle of wild-type and FN
CC>SS/CC>SS 
embryos. Scale 
bars: (B, F) 500 µm, (D) 50 µm. 
3.2.5 FNCC>SS/CC>SS cells assemble a morphologically distinct FN-monomer 
matrix in vitro  
The data above demonstrates normal expression, assembly and chemical properties of 
monomeric FN in FN
CC>SS/CC>SS 
embryos. Therefore, the reasons for the early 
embryonic lethality of FN
CC>SS/CC>SS 
mice must be attributed to impaired functionality 
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of the FN-monomer matrix. In order to facilitate more detailed in vitro examinations of 
the FN-monomer matrix properties, fibroblast-like cell lines were established from E9.5 
embryos. Clonal mutant and wild-type cell lines, which showed similar cell surface 
expression levels of α2, α5, α6, αv, α4, β1 and β3 integrin by FACS analysis,  were 
chosen for further analysis (Fig 3.26.A). The chosen clones lacked α4 integrin 
expression in order to exclude a potential contribution of this particular integrin to FN 
matrix assembly in vitro (Fig 3.26.A). To test the functionality of FN binding integrins 
on the surface of FN
CC>SS/CC>SS 
clones, labelled wild-type plasma FN (pFN) was added 
to the cells in serum replacement medium. Immunofluorescence imaging of 
FN
CC>SS/CC>SS 
cells stained with antibodies against α5 integrin and FN revealed that the 
mutant cells were capable to assemble normal FN into a fibrillar network. FN aligned 
with α5 integrins in fibrillar adhesions, confirming that FN binding integrins on the cell 
surface were fully functional (Fig 3.26.B). 
 
Fig 3.26. FN
CC>SS/CC>SS 
cell surface integrin expression profile and plasma FN assembly 
assay. A. Integrin expression profile of a selected wild-type and FN
CC>SS/CC>SS 
clone determined 
by FACS. Cell lines were incubated with antibodies to α2, α4, α5, αv, α6, β1 and β3 integrin 
subunits (blue histogram). Note that α5, αv, β1 and β3 integrins are expressed at comparable 
levels, while both clones lack α4 integrins. (Isotype controls are depicted in black). B. Wild-type 
and FN
CC>SS/CC>SS 
cells cultured in presence of exogenous plasma FN (60 nM). Note that 
FN
CC>SS/CC>SS 
cells are equally capable to assemble exogenous  pFN as the control cells. Scale 
Bar: 15 µm 
In vitro FN assembly assays provide the opportunity to study the kinetics of initiation 
and completion of FN fibril formation. They facilitate the detection of delays and 
variations in early fibril formation which might affect the development of the embryo 
Results 
88 
but are impossible to observe in vivo. To determine (i) whether the FN
CC>SS/CC>SS 
cell 
line was capable to assemble endogenously produced FN-monomer into fibrils; (ii) 
whether the kinetics of the assembly process were comparable between wild-type and 
mutant cells; and (iii) which sort of integrin heterodimer was required for the FN-
monomer assembly, cells were seeded either on laminin 1 (LM111) or vitronectin (VN) 
and were cultured for indicated lengths of time in serum-replacement medium. As 
previously mentioned (3.1.4), cells preferentially adhere to VN via their αvβ3 integrins 
and to LM111 via their α6β1 integrins. Only the latter integrin does not bind to FN and 
thus should not affect the FN assembly process. In contrast, adhesion of cells on VN 
should result in depletion of FN binding αvβ3 integrins from the apical cell surface, 
leaving only α5β1 integrins available to participate in FN matrix assembly (Fath, Edgell 
et al. 1989). FN
CC>SS/CC>SS 
cells were found to initiate and complete the assembly of a 
dense FN-monomer network equally well on both substrates, indicating that α5β1 
integrin alone was sufficient to facilitate the assembly of a FN-monomer matrix. While 
both cell lines showed similar kinetics of fibril formation, a clear difference in matrix 
morphology was evident between the FN networks on control and FN
CC>SS/CC>SS 
cells. 
In contrast to the long and ramified fibrils produced by the control cells (Fig 3.27.A, B, 
top), FN-monomer fibrils were more numerous, appeared to be thinner and shorter with 
only few ramifications (Fig 3.27.A, B, bottom) Unfortunately, it was not possible to test 
whether the distinct morphology of the FN-monomer matrix was caused by a time delay 
in fibril formation, since the postconfluent cells tended to detach during the prolonged 
incubation times necessary to answer this question.    
 
Fig 3.27. FN-monomer assembly kinetics on LM111 and VN. A and B. Wild-type and 
FN
CC>SS/CC>SS 
cells grown in serum replacement medium and either plated on LM111 (A) or VN 
(B). Cells were fixed after 48 and 72 h and stained for FN (red, DAPI stained cell-nuclei are 
depicted in blue). Note that FN
CC>SS/CC>SS 
cells are capable to assemble FN-monomer on both 
substrates,
 
but the fibrils appear shorter and thinner (A and B, bottom) as compared to fibrils 
on wild-type cells (A and B, top).  Scale bar: 15 µm 
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3.2.6 FN-monomer leads to altered α5β1 integrin distribution but largely 
unaffected “outside-in” signaling  
Among all FN binding integrins, α5β1 is one of the most important cell surface 
receptors to initiate and complete FN fibril formation. FN aligned α5β1 integrins are 
trans-locating along actin stress fibers forming fibrillar adhesions (Geiger, Bershadsky 
et al. 2001). The movement of α5β1 integrins induces the stretching of FN fibers on the 
cell surface which facilitates the exposure of additional cryptic binding sites on FN. 
These binding sites in turn allow interactions with a variety of other ECM components. 
The comparably thin and short morphology of FN-monomer fibrils observed on 
FN
CC>SS/CC>SS cells suggested that FN aligned α5β1 integrins might be differently 
clustered when assembling monomeric FN. To test whether this was the case, 
FN
CC>SS/CC>SS 
and wild-type control cells grown on LM 111 and in serum-replacement 
medium were fixed and stained with antibodies against the α5 integrin subunit and FN. 
Fluorescently labelled phalloidin was used to facilitate the detection of cytoskeletal F-
actin, along which fibrillar adhesion structures form. As demonstrated in Fig 3.28, wild-
type cells showed elongated, streak-like fibrillar adhesions in which long FN fibrils 
were aligned with α5β1 integrins and F-actin (Fig 3.28.top). In contrast, fibrillar 
adhesions on FN
CC>SS/CC>SS 
cells were markedly shorter with accordingly shortened FN-
monomer fibrils (Fig 3.28.bottom). 
 
Fig 3.28. Altered morphology of fibrillar adhesions on FN
CC>SS/CC>SS 
cells . Distribution of α5 
integrin, F-actin and FN fibers in wild-type and FN
CC>SS/CC>SS 
cells cultured for 18 h on LM111 
and in serum-replacement medium. Note that F-actin, α5β1 integrin and FN co-localize in 
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elongated fibrillar adhesions of wild-type cells (white arrowheads, top), whereas fibrillar 
adhesions on FN
CC>SS/CC>SS 
cells
 
(white arrowheads, bottom) are reduced in length which 
presumably causes the shortened morphology of FN-monomer fibers. Scale bar: 15 µm. 
The activated and ligand-bound integrins clustered in fibrillar adhesions are able to 
transmit a vast array of intracellular changes referred to as “outside-in” signaling via the 
recruitment of intra-cellular signaling complexes. Previous studies have shown that FN-
bound active α5β1 integrin triggers “outside-in” signals required for early 
vasculogenesis and angiogenesis processes (Francis, Goh et al. 2002). The abnormal 
vascular development observed in FN
CC>SS/CC>SS 
mice and the comparably short streaks 
of α5β1 integrins clustered in fibrillar adhesions on FNCC>SS/CC>SS cells suggested that 
α5β1 integrin mediated “outside-in” signaling may be affected in mutant mice. To test 
this hypothesis, a biochemical analysis of selected signaling molecules which act 
downstream of α5β1 integrin was performed using an in vitro cell culture assay. In most 
situations in vivo, however, “outside-in” signaling is triggered through integrin 
interactions with components of a three-dimensional (3D) extracellular matrix network. 
In order to mimic the 3D extracellular environment of cells in vivo, mutant and wild-
type 3D networks were generated in cell culture (Fig 3.29.A) (2.7.4) (Mao and 
Schwarzbauer 2005). FN-null cells were seeded into these matrices and the levels and 
phosphorylation states of two important downstream effectors of α5β1 integrin, the 
focal adhesion kinase (FAK) and the extracellular signal related kinases 1&2 (ERK1/2), 
were analysed.   
FAK plays a central role in cell migration and proliferation and has been shown to 
function as an early mediator of integrin-mediated signaling. Its activity is regulated in 
response to integrin engagement by phosphorylation at multiple tyrosine and serine 
residues (Abedi and Zachary 1997). A recent study reported that number and bond-
strength of α5β1-FN interactions correlate with levels of FAK specifically 
phosphorylated at tyrosine residue Y397 (Shi and Boettiger 2003). Further, it was 
shown that increased matrix stiffness results in increased resistance to integrin mediated 
pulling forces generated by the cytoskeleton. The emerging tension between 
extracellular matrix and cytoskeleton controls the mechanical, switch-like activation of 
α5β1 tethered to FN, which in turn regulates the phosphorylation of FAK Y397 
(Friedland, Lee et al. 2009). For this reason, semi-quantitative analysis of FAK Y397 
phosphorylation levels provides information about number and strength of FN-α5β1 
interactions and an indirect measure for matrix stiffness.  
ERK is a member of the mitogen-activated protein kinase family and has been shown to 
promote cell growth and cell cycle progression. The initial ERK activation is largely 
dependent on growth-factor signaling, whereas elevated levels of active ERK require 
signals triggered by integrin mediated cell adhesion, implicating activated FAK as an 
intermediate  effector (Hughes, Renshaw et al. 1997; Giancotti and Ruoslahti 1999; 
Danen and Yamada 2001). In order to perform a biochemical analysis of integrin 
“outside-in” signaling on 3D matrices, a FN knock out cell line was used (Sakai, 
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Johnson et al. 2001). This cell line offered two advantages; firstly, FN knock out cells 
would not deposit endogenous FN into the 3D matrix during the assay, and secondly, 
results obtained from assays on wild-type and FN-monomer 3D matrix could be readily 
compared when one and the same cell line is used. Prior to the experiment, the cells 
were starved in serum-free medium for several hours and subsequently incubated in 
suspension for an additional hour. Starving and suspension culture leads to inactivation 
of cell adhesion dependent kinases. Subsequently, the cells were seeded on the mutant 
and wild-type 3D matrices and incubated for indicated periods of time to allow integrin 
signaling to occur. Western blot analysis of the cell lysates probed with site-specific 
anti-phospho antibodies against pERK1/2 (Thr 202/Tyr 204) revealed similar activation 
kinetics and comparable levels of phospho-ERK in cells plated on wild-type and FN-
monomer 3D matrices (Fig 3.29.B). This result indicated that the FN-monomer 
mutation did not affect ERK1/2. Immunoblotting with anti-pFAKY397 antibodies 
showed slightly reduced levels of pFAKY397 on FN-monomer 3D matrices as 
compared to the control fibrilar network (Fig 3.29.B). This finding suggests that the 
monomeric FN matrix differs from control fibrils with regard to its mechanical 
pliability and the number and bond-strength of α5β1-FN interactions. However, it is 
unclear to which extent these rather subtle changes in “outside-in” signaling contribute 
to the severe defects observed in FN
CC>SS/CC>SS 
mice and therefore suggest that changes 
in other signaling pathways may be primarily responsible for the FN
CC>SS/CC>SS 
phenotype. 
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Fig 3.29. Biochemical analysis of “outside-in” signaling on FN 3D matrices. (A, top). 
Confocal stack image of cell free FN 3D matrices, stained with antibodies against FN. 
Confluent layers of wild-type and FN
CC>SS/CC>SS 
cells were grown on gelatine for 5 days in 
serum-replacement medium to allow endogenous FN-derived matrix assembly to occur. (A, 
bottom). Subsequently, the cells were lysed and cell remnants were washed out, leaving a ~ 6 - 
10 µm thick layer of 3D extracellular matrix behind. Note that the morphology of the FN-
monomer matrix differs markedly from the wild-type matrix. (A and B). Western blot analysis of 
selected signaling molecules activated by integrin mediated cell adhesion. B. ERK1/2 (p44/42 
MAPK) activation on 3D matrices. The immunoblot was probed with site-specific anti-phospho-
ERK1/2 antibodies. Note that cells on both matrices exhibit a comparable pERK1/2 profile (B, 
top). Reprobing with anti-ERK1/2 antibodies revealed equal protein loading per each lane (B, 
bottom). C. Determinatining integrin-dependent FAK activation using anti-Y397-FAK 
antibodies. Cells on FN-monomer matrices exhibited a slightly reduced amount of pFAK Y397 
as compared to cells on the control matrix (C, top). Reprobing with anti-FAK antibodies 
revealed equal protein loading per each lane (C, bottom). Scale bar: 100 µm 
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3.2.7 Monomeric FN matrices fail to deposit latent TGF-β in vitro 
An interesting feature of all FN
CC>SS/CC>SS 
embryos is that the severely defective 
vascular development resembles the abnormalities reported in mice with compromised 
transforming growth factor-β (TGF-β) signaling (Dickson, Martin et al. 1995; Oshima, 
Oshima et al. 1996; Goumans, Zwijsen et al. 1999; Oh, Seki et al. 2000; Larsson, 
Goumans et al. 2001). Growth factor binding to the ECM is a major mechanism for 
regulation of growth factor activity and plays a crucial role in tissue morphogenesis and 
repair (Taipale and Keski-Oja 1997). FN has been shown to store latent TGF-β secreted 
by fibroblasts (Dallas, Sivakumar et al. 2005). TGF-βs are deposited as inactive 
complexes containing the TGF-β, its propetide, the so called latency-associated protein 
(LAP) and the latent TGF-β binding proteins (LTBP-1, -4). The LTBPs are playing a 
functional role in the integrin dependent activation of latent TGF-β, since LTBPs are 
tightly anchored to FN (Annes, Rifkin et al. 2002). How LTBPs are incorporated into 
the FN matrix is still unknown (Chen, Sivakumar et al. 2007). This raised the question, 
whether the monomeric FN matrix fails to assemble FN-LTBP-complexes, which in 
turn affects TGF-β signaling. To address this question, I first investigated how LTBP-1 
is distributed in the control and mutant FN matrix. To this end, cells were grown on 
LM111 in serum-replacement medium for 3, 4 and 5 days. The cells were subsequently 
fixed and immunostained with anti-FN and anti-LTBP-1 antibodies. A distinct network 
of fibrilar LTBP-1 was already visible on the control cells after 3 days, which became 
more pronounced after 4 and 5 days, respectively (Fig 3.30.A). Shape and co-
distribution of FN fibers and LTBP-1 indicated that FN served as a scaffold for initial 
LTBP-1 fibril formation (Koli, Hyytiainen et al. 2005). In sharp contrast, FN
CC>SS/CC>SS 
cells largely failed to deposit LTBP-1. Hardly any fibrilar LTBP-1 was visible on cells 
after 3 days. Even after 5 days only few and short LTBP-1 fibrils were deposited on the 
FN-monomer matrix (Fig 3.30.A). In order to compare the total amounts of LTBP-1 
secreted by FN
CC>SS/CC>SS 
and control cells, a Western blot analysis of ECM derived 
LTBP-1 levels after plasmin-release was performed (2.7.3.2). It revealed slightly 
reduced amounts of LTBP-1 in the ECM of two FN
CC>SS/CC>SS 
clones as compared to the 
control cells (Fig 3.30.B). This finding suggests that non-incorporated LTBP-1 was 
either degraded or released into the medium. The latter hypothesis was confirmed by 
immunoblotting showing increased amounts of LTBP-1 in conditioned medium of 
FN
CC>SS/CC>SS 
cells (Fig 3.30.C). To analyse the amount of LTBP-1 cross-linked to the 
matrix in vivo, DOC-insoluble fractions derived from E9.5 embryos were plasmin 
digested and the amount of released LTBP-1 was determined by immunoblotting. 
Comparable amounts of deposited LTBP-1 in both, mutant and control embryos were 
detected (Fig 3.30.D).  
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Fig 3.30. Impaired deposition of LTBP-1 on FN-monomer matrices. A. Time course of FN 
and LTBP-1 assembly on cells plated on LM111 and cultured in serum-replacement medium. 
Note that FN
CC>SS/CC>SS 
cells fail to properly assemble fibrillar LTBP-1. B. Western blot analysis 
of LTBP-1 levels reveals decreased amounts deposited in the ECM of FN
CC>SS/CC>SS 
cells. C. 
Impaired deposition of LTBP-1 by mutant cells leads to increased amounts of unbound LTBP-1 
in conditioned medium. D. Analysis of LTBP-1 deposition in the ECM of E9.5 embryos. Note 
that the amount of ECM-cross-linked LTBP-1 is similar in mutant and control embryos. Scale 
bar: 25 µm  
These in vivo findings are contradictory to the results in vitro. However, the in vitro 
assays demonstrate the kinetics of FN facilitated LTBP assembly, whereas the in vivo 
result merely represents a snap-shot. Since the development of a complex organism 
requires a tightly timed control of ongoing processes, it is conceivable that small delays 
might cause major defects. To further examine possible implications of altered TGF-β 
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signaling in FN
CC>SS/CC>SS 
mice, analyses of TGF-β downstream effectors were 
performed.  
3.2.8 Impaired deposition of LTBP-1 results in increased activation of TGF-β  
A recent study reports that ECM displaced LTBP results in increased activation of TGF-
β (Chaudhry, Cain et al. 2007). The increased amounts of latent TGF-β in the 
conditioned medium of FN
CC>SS/CC>SS 
cells suggested that elevated levels of active TGF-
β were present. To check whether this was indeed the case, the activation status of TGF-
β downstream effectors was tested by means of Western blot analysis. Smad proteins 
transmit TGF-β signals from the cell-surface into the nucleus. Receptor-regulated (R-
Smads) Smads 2 and 3 are specifically phosphorylated in response to TGF-β receptor I 
& II activation. Upon phosphorylation, they associate with the so called common 
mediator (co-Smad) Smad 4 and translocate into the nucleus to facilitate the 
transcriptional activation of TGF-β target genes. Immunoblotting for pSmad 2/3 in 
nuclear fractions of cells after 3 and 5 days in culture revealed increased levels of 
phosphorylated Smad 2 and 3 in the nuclei of FN
CC>SS/CC>SS 
cells compared to control 
cells (Fig 3.31.A). This data could be confirmed by immunodetection of 
correspondingly enhanced nuclear translocation of Smad 4 into nuclei of mutant cells 
(Fig 3.31.A). To address whether this altered signaling could also be detected in vivo, a 
Western blot analysis of pSmad2/3 levels in E9.5 embryonic and extra-embryonic tissue 
was performed. It revealed elevated levels of pSmad 2/3 in yolk sacs (Fig. 3.31.B) and 
FN
CC>SS/CC>SS 
embryo proper (Fig. 3.31.C), confirming that the mutation increased 
TGF-β signaling both in vitro and in vivo. The previous in vitro experiments 
corroborated the notion that impaired deposition of LTBP-1 by FN
CC>SS/CC>SS 
cells 
resulted in enhanced levels of active TGF-β in conditioned medium. To test the 
significance of this finding, an active TGF-β reporter assay was performed to exactly 
measure the amount of active TGF-β present in conditioned medium of FNCC>SS/CC>SS 
and control cells. To this end, conditioned medium from control and FN
CC>SS/CC>SS 
cells 
was collected after indicated days in culture and added on top of Mink lung epithelial 
cells (MLECs) stably transfected with an expression construct containing a TGF-β 
sensitive promotor fused to the firefly luciferase reporter gene. Levels of active TGF-β 
were found to be significantly higher in conditioned medium of FN
CC>SS/CC>SS 
cells 
compared to medium from control cells (Fig 3.31.D). In agreement with the results of 
previous studies, a decrease of active TGF-β amounts in conditioned medium during 
extended culture (3, 4 and 5 days) was observed (Koli, Hyytiainen et al. 2005) in both 
cell lines. To test the specificity of the assay, a control experiment utilizing the specific 
TGF-β receptor I inhibitor SB 431542 was performed in parallel, which resulted in the 
expected inhibition of TGF-β induced luciferase expression (Fig 3.31.E). 
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Fig 3.31. Analysis of TGF-β signaling in vitro and in vivo. A. Nuclear fractions of 
FN
CC>SS/CC>SS 
and control cells after 3 and 5 days in culture. A. Immunoblot analysis for nuclear 
translocation of pSmad 2/3 and Smad 4. (A, top) The immunoblot was probed with anti-phospho 
Smad 2/3 and anti-Smad 4 antibodies. Note that mutant cells exhibit an increased amount of 
pSmad 2/3 in the nuclei as compared to wild-type cells. (A, bottom) Enhanced levels of Smad 4 
detected in the nuclei of FN
CC>SS/CC>SS 
cells correspond with increased pSmad 2/3 levels. 
Reprobing with anti-Smad 2/3 and anti-Lamin A antibodies revealed equal protein loading per 
each lane. Equal expression of Smad protein levels in both cell lines was confirmed by 
immunoblotting of total cell lysates. B. TGF-β signaling in vivo. Levels of pSmad 2/3 in 
FN
CC>SS/CC>SS 
yolk sacs are increased as compared to control yolk sacs. C. Comparison of 
pSmad 2/3 levels in whole embryo lysates at E9.5. Note the increased amounts of pSmad 2/3 in 
mutant embryos. (B and C) Reprobing with anti-GAPDH antibodies revealed equal protein 
loading per each lane. D. Luciferase based active TGF-β reporter assay. Conditioned medium 
of cells cultured for 3, 4 and 5 days was added to the reporter cell line and incubated for further 
24 h prior to detection of TGF-β induced luciferase expression. Shown are ratios of active TGF-
β in conditioned medium versus total ECM-bound TGF-β after its release into the medium by a 
10 min heat-step at 80°C. Note that FN
CC>SS/CC>SS 
cells fail to deposit latent TGF-β in their 
ECM, resulting in a significantly higher ratio of active versus total ECM-bound TGF-β. E. 
Specificity test to validate the reporter assay. Addition of the TGF-β receptor I inhibitor SB 
431542 at 200 nM markedly reduced the TGF-β induced luciferase expression.  
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The in vivo role of altered TGF-β signaling during development of FNCC>SS/CC>SS mice 
requires more detailed analyses in future. This tests should include in utero TGF-β 
inhibitor assays in FN
CC>SS/CC>SS 
embryos. Through application of endothelial cells 
derived from mutant embryos in 3D gels, the effect of altered TGF-β signaling on 
angiogenesis will be tested. Furthermore, the mechanical activation of integrin 
dependent signaling in cells on FN 3D matrices and the phosphorylation levels of α5β1 
integrin downstream effectors should be analysed in more depth.  
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4 Discussion 
4.1 Mutational analysis of the RGD motif in FN 
4.1.1 The RGD motif in FN is dispensable for fibril formation 
The RGD binding motif in FN is thought to play a central role in FN matrix assembly 
and RGD-mediated integrin signaling. In the first part of the present study, this role was 
assessed by creating a non-functional RGE site in the FN gene of mice. The phenotype 
of the FN
RGE/RGE 
mice is identical in type and quality to the defects reported for α5β1 
integrin-deficient mice (Yang, Rayburn et al. 1993), but much less severe than the 
phenotype of FN-null or α5/αv integrin double-null mice (George, Georges-Labouesse 
et al. 1993; Yang, Bader et al. 1999). This finding allows drawing several important 
conclusions. First, the mesodermal defects caused by absent α5β1 expression are solely 
based on disruption of α5β1 integrin binding to the RGD motif of FN and do not 
involve binding to other α5β1 ligands (Collagen XVIII, ADAMs, etc.). Second, the 
development of a less severe phenotype in FN
RGE/RGE mice than in α5/αv double-null 
mice indicates that αv integrin-FN interactions are either not required for early 
development or occur in an RGD-independent manner. Third, the direct observation of 
FN matrix in FN
RGE/RGE 
mice shows that the RGD motif must be dispensable for the 
formation of a fibrillar FN network. 
4.1.2 FN-RGE can assemble into a fibrillar network 
A large number of integrins can bind FN (Pankov and Yamada 2002; Leiss, Beckmann 
et al. 2008). Although FN fibrillogenesis can still proceed in mice carrying single gene 
deletions of FN binding integrins, double deficiencies for α5 and αv integrin 
dramatically reduce the amount of FN matrix, suggesting that the two integrins bind, 
activate, and assemble FN fibrils independently of each other (Yang, Bader et al. 1999). 
Based on this mouse work and previous assembly studies performed in vitro, one would 
have predicted that a non-functional RGD motif in FN would abrogate binding to both 
α5β1 and αv integrins and hence render fibrillogenesis equally impossible as in α5/αv 
double-null mice. However, this was not the case. Neither quantitative nor qualitative 
differences in the FN network of FN
RGE/RGE 
mice were found, irrespective of whether 
the embryo sections were treated with fixative or examined in native cryo-sections.  
One reason for this unexpected finding could have been that the D>E mutation was too 
conservative and hence would still permit binding to integrins. Such a possibility, 
however, was ruled out experimentally: the assembly of FN-RGE by FN
RGE/RGE 
cells 
grown on LM111 was inhibited by the addition of neither linear RGE peptides nor 
recombinant FN-III7-10 fragments, in which the RGD was converted into an RGE. 
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Moreover, the same recombinant FN-III7-10RGE fragment was unable to bind integrins 
in a highly sensitive solid-phase binding assay. 
4.1.3  FN-RGE is assembled by αv integrins 
FN assembly via the RGD motif can occur through either α5β1 or αv integrins. The αv 
integrin-mediated assembly, however, leads to a less dense network with shorter and 
thicker fibrils in vitro (Wennerberg, Lohikangas et al. 1996), which is thought to be due 
to the different subcellular localization and associated shape of αv versus α5β1 integrin 
clusters (α5β1 form thin fibrillar adhesions and αv arrowhead-like focal adhesions) 
and/or to the differential activation of small Rho GTPases such as RhoA, which occurs 
through FN binding to α5β1 but not to αv integrins (Danen, Sonneveld et al. 2000).  
The FN-RGE fibrils of FN
RGE/RGE 
cells displayed appearance and behaviour typical of 
αv-mediated fibrils: they were short and thick, whereas fibrils of wild-type cells were 
thin, long and ramified. Furthermore, the assembly of FN-RGE could be efficiently 
inhibited by cycRGD, which was shown to bind with higher affinity to αvβ3 than to 
α5β1 integrin (Pfaff, Tangemann et al. 1994). The interpretation that αv integrins 
mediate FN-RGE assembly was further supported by siRNA-mediated depletion of the 
αv integrin protein in FNRGE/RGE cells, which showed that αv integrin-depleted cells 
were unable to form a fibrillar FN-RGE network. The role of αv integrins was further 
confirmed by direct binding assays, with recombinant fragments spanning almost the 
entire FN molecule, which revealed a novel high-affinity binding interaction for αvβ3 
integrin and the N-terminal FN-I1-9 fragment. Moreover, the assembly of FN-RGE by 
FN
RGE/RGE 
cells was efficiently inhibited by FN-I1-9 and synthetic peptides comprising 
the novel αvβ3 integrin binding site.  
RGD-independent mechanisms for FN assembly have been observed with different cell 
culture systems. One report showed that binding of Mn
2+
 activated α4β1 integrin to the 
v-region can induce FN assembly in vitro (Sechler, Cumiskey et al. 2000). It is not 
clear, however, whether the α4β1-mediated mechanism also operates in vivo and, if so, 
whether its role is substantial during embryogenesis. In the E9.5 control and FN
RGE/RGE 
embryos, we observed a very restricted expression of α4β1 in the cranial region and the 
developing epicard. Thus, the abundant FN-RGE fibrils in sites without α4β1 
expressing cells must have been assembled using an α4β1-independent mechanism. 
This conclusion was further confirmed with FN
RGE/RGE cell lines that lacked α4 integrin 
but still efficiently assembled FN-RGE fibrils.  
A second RGD-independent FN assembly mechanism has been described for cells 
isolated from α5 integrin deficient mice (Sottile, Hocking et al. 2000). Incubation of 
FN-null cells grown in serum-replacement medium and on VN with recombinant FN 
lacking the RGD motif (FNΔRGD) assembled short stitch-like aggregates on the cell 
surface. A potential explanation for the development of the dot-like FNΔRGD 
aggregates could be that a view αvβ3 integrins failed to bind to the VN substrate and 
were available to recruit FNΔRGD to the cell surface by binding to the site in FN-I1-9. 
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Alternatively, the recruitment and aggregation of FNΔRGD may have been 
accomplished by syndecans, which also bind FN. Potential syndecan-FNΔRGD 
interaction would also explain why heparin treatment inhibited the formation of the 
stitch-like aggregates on the surface of FN-null cells. The potential involvement of such 
interactions with FN-RGE was also tested in this study by treatment of FN
RGE/RGE 
cells 
with heparin. Interestingly, heparin had no considerable effect on the assembly of FN-
RGE fibrils, indicating that in the FN
RGE/RGE 
system, proteoglycan binding to FN-RGE 
is not essential for FN fibril development. 
4.1.4 The GNGRG motif in FN-I5 is a novel αvβ3 binding site that can function 
for FN matrix assembly 
The FN-I1-9 fragment (also called 70 kDa N-terminal fragment) inhibits FN assembly 
with efficiencies similar to RGD containing peptides. It is generally believed that the 
inhibitory effect of FN-I1-9 is caused by high-affinity binding sites for FN, which block 
the FN-FN interactions required to align and cross-link FNs into fibrils (McKeown-
Longo and Mosher 1984; McDonald, Quade et al. 1987; Schwarzbauer 1991; Aguirre, 
McCormick et al. 1994; Hocking, Sottile et al. 1994; Sechler, Corbett et al. 1998). The 
fact that FN-RGE assembly could be inhibited with FN-I1-9 pointed to the possibility 
that FN-I1-9 may, in addition to its FN binding activity, contain a αv integrin binding 
site. This was confirmed in direct binding assays which revealed that FN-I1-9 bound 
αvβ3 integrin. Curnis et al. (2006) reported that the Asn-Gly-Arg (NGR) sequence of 
FN-I5 could be converted to a high-affinity binding site for αvβ3 integrin through the 
deamidation and rearrangement of the asparagine residue and the creation of an isoDGR 
sequence. Isoaspartate formation is a well-known, non-enzymatic process that can occur 
during ageing of ECM proteins (David, Orpiszewski et al. 1998; Lanthier and 
Desrosiers 2004) and during isolation and storage of proteins (Paranandi, Guzzetta et al. 
1994). The properties of the novel αvβ3 integrin binding sites in FN agreed with direct 
binding assay results, which showed that FN-I1-9 bound αvβ3 and offered a potential 
explanation for the αv integrin-dependent and FN-I1-9-sensitive assembly of FN-RGE. 
Indeed, an isoDGR peptide was found to efficiently inhibit the binding of αvβ3 to FN-
I1-9 in a direct binding assay, and it blocked the assembly of FN-RGE by FN
RGE/RGE 
cells.  
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Fig 4.1. Schematic representation of the NGR deamidation reaction. Asparagine deamidation 
occurs via hydrolysis of a succinimide intermediate, leading to formation of DGR and the 
biological active isoDGR (Modified from Curnis et al., 2006).  
Interestingly, the assembly of the FN-RGE matrix was equally inhibited by both, NGR-
2C and isoDGR-2C peptides. This suggests that the native NGR sequence itself may 
already be able to bind αvβ3 and function for FN-RGE matrix assembly. It is more 
likely, however, that the NGR motif was sufficiently modified to isoDGR in culture to 
inhibit FN-RGE assembly. Supporting this hypothesis is the fact that NGR peptides 
failed to block αvβ3 integrin binding to the FN-I5 module (Curnis, Longhi et al. 2006). 
Moreover, assembly of the FN-RGE matrix in both embryos and cell culture requires 
only a small fraction of isoDGR-modified FN molecules to bind cell surface integrins, 
whereas the remaining fractions becomes integrated into fibrils via FN-FN interactions, 
which proceeds independent of the isoDGR modification. 
Interestingly, α5β1 integrin also bound the FN-I1-9 fragment, but the isoDGR-2C peptide 
failed to inhibit this binding or assembly of wild-type FN. A likely explanation is that 
the interaction of α5β1 with FN-I1-9 is weaker than the interaction of αvβ3 with the 
isoDGR motif in FN-I5 and fails to provide a necessary binding strength to allow 
assembly of FN-RGE fibrils. Conversely, the findings in this study indicate that FN-I1-9 
inhibits FN assembly not only by affecting the FN-FN but also FN-αvβ3 integrin 
interactions, which has profound consequences for assembly of FN-RGE. Collectively, 
these results revealed, that the GNGRG loop (see Fig 4.1) in FN-I5 represents a novel 
and functional αvβ3 integrin binding and FN assembly site. Future experiments will be 
necessary to test whether additional motifs in FN-I1-9 can also provide functional 
integrin binding and FN assembly sites (Shpiro, Ellis et al. 2005).  
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Fig 4.2. Schematic depiction of selected FN-domain structures. Depicted in blue and cyan are 
the type I modules 4-5 and the NGR motif (shown in red). The type III modules 9-10 (coloured 
in green) harbouring the synergy site (PHSRN) and the RGD motif (both shown in red). Note 
that the proposed integrin binding GNGRG motif forms a exposed loop-like structure - 
comparable to the RGD loop in domain III10 -  which is likely accessible to water and receptors 
(Modified from Leiss et al., 2008).  
4.1.5 The integrity of FN’s RGD motif is essential for development 
The FN
RGE/RGE 
mice survive substantially longer than FN-null mice, indicating that FN-
RGE fibrils are biologically active. FN
RGE/RGE 
embryos display defects that are 
strikingly similar to those observed in α5-null mice (Yang, Rayburn et al. 1993), 
suggesting that high-affinity interactions of α5β1 with FN triggers unique functions 
during early development that can not be compensated by αv integrin-RGD, αv integrin-
NGR or α5β1-FN-I1-9 interactions. In both mouse mutants, the posterior trunk is 
shortened, underdeveloped and lacks somites. TUNEL assays and immunostaining for 
activated caspase-3 revealed diminished survival of posterior trunk mesoderm in 
FN
RGE/RGE mice, suggesting that RGD triggered α5β1 integrin signals inhibit caspase-3 
activation and anoikis.  
A consistent feature of all FN
RGE/RGE 
embryos analysed between E9.5 and E10.5 was 
that their somite number was limited to 12-13 somites. A plausible explanation for this 
finding could be that somites 12-13 represent the transition from the gastrulation- to 
tail-bud derived mesoderm (Wilson and Beddington 1996). This would indicate that the 
integrin-triggered survival signals are mainly required for the posterior trunk- and tail 
bud-derived mesoderm. Such a α5β1 integrin independency of the anterior, streak- 
derived mesoderm could be explained by expression and compensation of αv integrins. 
Unfortunately, it could not be tested in this study whether αv is high in the anterior and 
low or absent in the posterior mesoderm, because all available anti-αv antibodies 
produced only background staining.  
Zebrafish also require α5 integrin for somite development along the body axis. In 
contrast to the mouse, α5 integrin mutant zebrafish display anterior somite defects, 
suggesting that α5 integrin is indispensable for anterior somitogenesis, whereas the 
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posterior somites developed normally (Julich, Geisler et al. 2005; Koshida, Kishimoto 
et al. 2005). Interestingly, knockdown of fibronectin1 in α5 integrin mutant zebrafish, 
as well as knock down of fibronectin1 and fibronectin3, led to a more severe phenotype, 
suggesting that the restriction of defects in zebrafish to the anterior somites is probably 
due to functional redundancy (Julich, Geisler et al. 2005; Koshida, Kishimoto et al. 
2005). A further difference from the findings presented in this study is the absence of 
apoptosis in the anterior somites of α5 integrin-deficient zebrafish. It was even shown 
that the anterior somites develop perfectly well, but their boundaries can not be 
maintained because of the loss of FN fibrils that would normally surround somite 
boundaries. In about half of the FN
RGE/RGE 
mouse embryos, normal amounts of FN-RGE 
fibrils were observed at the boundaries of the anterior somites, whereas in the remaining 
half, the levels were reduced (unpublished data).   
In conclusion, this part of the thesis shows that FN-RGE can be assembled into fibrils in 
vivo and in vitro via αvβ3 binding to the isoDGR motif in FN-I5. The isoDGR site in 
FN-I5 is generated by NGR deamidation and, as previously demonstrated, can be readily 
reverted by the enzymatic action of the protein L-isoaspartyl methyl-transferase 
(Reissner and Aswad 2003; Lanthier and Desrosiers 2004). The ability of tissues to 
swiftly activate and deactivate binding of αvβ3 and likely other αv integrins to FN may 
represent a novel strategy to spatially and temporally trigger FN-mediated αv integrin 
signaling during development and disease.    
4.2 Functional in vivo analysis of the dimerization motif in FN 
It is widely accepted that the dimeric structure of FN is essential for the de novo 
formation of FN fibrils in vitro (Schwarzbauer 1991). However, it remained an open 
question whether this condition also applies to the in vivo situation. In the second part of 
this study, the role of the dimerization domain for FN fibrillogenesis and FN functions 
was tested in vivo. To this end, a mouse strain was generated that is exclusively 
expressing a monomeric form of FN. The mutation resulted in recessive embryonic 
lethality at around E11.0. The phenotype of FN
CC>SS/CC>SS 
mice, however, was much 
less severe than the phenotype observed in FN-null mice which die at E8.5. 
Furthermore, unlike in FN-null and α5 integrin-null mice (George, Georges-Labouesse 
et al. 1993; Yang, Rayburn et al. 1993), FN
CC>SS/CC>SS 
mice exhibit comparably mild 
defects in mesoderm-derived structures of the embryo proper. Surprisingly, the analysis 
of FN
CC>SS/CC>SS 
mice further revealed, that FN-monomer was normally expressed and 
assembled into a fibrillar matrix. Several conclusions can be drawn from these 
observations. First, in contrast to the current model, the dimerization of FN is not 
required for FN fibril formation. Second, the moderate severity of defects observed in 
the embryonic mesoderm of FN
CC>SS/CC>SS 
mice suggests that integrins interacting with 
the FN-monomer matrix are capable to trigger signals required for mesoderm 
development (e.g. somitogenesis in the posterior trunk region). Third, the embryonic 
lethality of FN
CC>SS/CC>SS 
mice indicates that the FN-monomer matrix lacks functions 
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required for normal development. The impairment is likely compromising the scaffold 
function of FN necessary for assembling other ECM components.   
4.2.1 FN-monomer can assemble into a fibrillar FN network in vivo 
Almost two decades ago it was demonstrated in in vitro studies that the carboxy-
terminal interchain bonds of FN, together with the N-terminal region (FN-I1-5), are 
indispensable for FN fibrillogenesis and its incorporation into the ECM (Schwarzbauer 
1991; Ichihara-Tanaka, Maeda et al. 1992). These observations led to the widely 
accepted concept that these two domains represent the minimal requirements for FN 
fibrillogenesis to occur. According to this concept, FN
CC>SS/CC>SS 
mice should not be 
capable of assembling a FN matrix network, and consequently should display a similar 
phenotype as FN-null mice. However, this was not the case. Although the FN-monomer 
mutation resulted in early embryonic lethality, FN
CC>SS/CC>SS 
mice developed beyond the 
stage at which FN-null embryos die, and their comparably moderate phenotype 
suggested that FN-monomer was assembled into an at least partially functional matrix 
network. Closer examination of native and fixed tissue sections of FN
CC>SS/CC>SS 
embryos revealed that FN-monomer was assembled into a morphological normal 
matrix. Furthermore, no difference in terms of FN quantity or cross-linking 
biochemistry was detectable between mutants and control embryos. These findings 
showed that the FN-monomer mutation allows normal secretion of the protein, although 
FN monomers are disulfide-bonded into dimers in the lumen of the endoplasmic 
reticulum shortly after synthesis (Choi and Hynes 1979), and hence FN-monomer is 
passing the protein quality control system of the cell before secretion. The apparently 
normal FN-monomer fibril morphology observed in vivo in turn was clearly in 
disagreement with the dogma that FN’s dimeric structure is essential for FN-
fibrillogenesis (Schwarzbauer 1991). These findings further show that the N-terminal 
region (FN-I1-5) of FN is the only fragment essential for FN fibril formation.  
4.2.2 FN-monomer fibrils align with abnormal adhesive structures 
The de novo generation of FN fibrils starts shortly after FN has bound integrins at sites 
of nascent focal adhesions. Acto-myosin contractile forces drive the translocation of 
FN-bound α5β1 integrins from the cell periphery towards the cell center. This 
movement applies tension to FN which promotes fibril formation through exposure of 
cryptic FN-self binding sites, and concurrently leads to formation of a new type of cell-
matrix adhesion in which FN, α5β1 integrin and F-actin filaments co-align with 
multiple signaling molecules. This adhesive structure, called fibrillar adhesion, is 
characterized by a typical streak-like appearance. Finally, when cells interact with a 3D 
extracellular matrix, they form a more complex adhesion structure called 3D-adhesion. 
Both adhesive structures are implicated in ECM remodelling processes and multiple 
integrin-mediated signaling events (Pankov, Cukierman et al. 2000; Zamir, Katz et al. 
2000; Ohashi, Kiehart et al. 2002). Cell interactions with a FN-rich 3D-matrix are 
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mediated primarily by α5β1 integrin and depend on matrix pliability, which results in 
FAK signaling and ERK activation (Yamada, Pankov et al. 2003). 
Immunocytochemical analysis of the FN matrices in cell culture revealed a markedly 
different FN fibril morphology between FN-monomer and wild-type control fibrils. 
While the latter contained an elaborated and ramified network of elongated fibrils, FN-
monomer fibrills were of short and thin appearance with only few ramifications. 
Furthermore, also α5β1 integrin and F-actin of FNCC>SS/CC>SS cells displayed markedly 
altered structures of fibrillar adhesions, suggesting that α5 integrin signaling might have 
been modified in response to FN-monomer binding. This notion could be confirmed 
experimentally. Western blot analysis revealed slightly decreased levels of p397FAK in 
cells adhering to FN
CC>SS/CC>SS 
matrices. FAK activation at tyrosine residue Y397 is 
regulated by acto-myosin contractility, integrin-mediated adhesion and matrix stiffness 
in a mechano-responsive manner (Tilghman and Parsons 2008). It is therefore 
conceivable that the FN-monomer matrix exhibits a differential mechanical pliability 
and rigidity when compared to the wild-type matrix, which leads to altered integrin 
signaling and to the defects observed in FN
CC>SS/CC>SS 
mice.  
Targeted inactivation of the FAK gene in mice results in a strikingly similar phenotype 
compared to FN-null mice. FAK-null mice display a severely defective development of 
mesoderm-derived structures, including the inability to form somites, and fail to 
develop an organized vascular system (Furuta, Ilic et al. 1995; Ilic, Furuta et al. 1995). 
The importance of FAK in vascular development is evident because of its abundant 
expression in the vasculature at the time of critical vascular development (Polte, 
Naftilan et al. 1994; Braren, Hu et al. 2006). However, the unaffected somite formation 
in FN
CC>SS/CC>SS 
mice suggests that the mesoderm is less sensitive to changes in FAK 
signaling than endothelial cells.   
Future experiments will be necessary to test to which extent the diminished FAK 
activation caused by the altered composition and mechanical properties of the FN-
monomer matrix is contributing to the severe vascular defects observed in the 
extraembryonic tissues of FN
CC>SS/CC>SS 
mice. 
4.2.3 FN dimers are essential for normal vascular development 
Targeted inactivation of the FN gene in mice has leads to impaired development of 
mesoderm-derived structures including somites, notochord, heart and embryonic 
vessels. FN
CC>SS/CC>SS 
mice develop posterior somites, although their posterior trunk 
region appears smaller. 
A hallmark of FN
CC>SS/CC>SS 
embryos was their anemic yolk sac, which completely 
lacked a distinct branching network of vessels. Areas of accumulated red blood cells in 
the yolk sac indicated leaky vessels and an impaired blood circulation. These circulation 
defects might lead to elevated intracardial pressure which could explain the enlarged 
pericardial sac observed in the hearts of FN
CC>SS/CC>SS 
embryos. Immunohistochemical 
analysis of the mutant yolk sacs revealed, that the formation of the primary capillary 
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plexus occurred (vasculogenesis; (Risau 1997)), but that remodelling (pruning) into a 
ramified network of vessels did not take place, indicating a defect in angiogenesis 
(Risau 1997). Similarly, in the embryo proper of E9.5 mutants, only fragile, 
disorganized and enlarged vessel-like structures were formed, probably exacerbating the 
circulation defect that possibly causes the growth arrest affecting FN
CC>SS/CC>SS 
embryos. This growth arrest commenced at 20-25 somite stage, which corresponds to 
E9.0 - E9.5 of embryonic development. Sections through the placenta indicated further 
defects of the mutant vascular system, which were characterized by the inability of 
embryonic vessels to properly sprout into the maternal labyrinthine layer, and by the 
pronounced apoptotic cell death in FN
CC>SS/CC>SS 
endothelial cells at E10.5. 
The vascular defects of FN
CC>SS/CC>SS 
mice are similar to those observed in mice with 
compromised TGF-β signaling. The cytokine TGF-β is an inhibitor of endothelial 
proliferation and migration (Muller, Behrens et al. 1987; Merwin, Newman et al. 1991), 
and can also induce growth arrest in a variety of other cell types including epithelial, 
hematopoietic, neural and certain types of mesenchymal cells (Massague and Gomis 
2006). Furthermore, TGF-β has also been shown to induce a number of pro-apoptotic 
responses (Siegel and Massague 2003). Targeted inactivation of the genes for the TGF-
β1 ligand, as well as for the TGF-β receptors ALK5, TGF-βRII, endoglin and the 
endothelial specific ALK1 result in severe angiogenesis defects that lead to embryonic 
growth arrest and early embryonic lethality around E10-11 (Dickson, Martin et al. 1995; 
Oshima, Oshima et al. 1996; Li, Sorensen et al. 1999; Oh, Seki et al. 2000; Larsson, 
Goumans et al. 2001). A major difference between the ALK1-null phenotype and the 
other TGF-β knock out phenotypes is identified by the vascular morphogenesis in the 
embryo proper around E9.5, which is only defective in ALK1-null mice. This difference 
is likely attributed to the fact that mutations of other TGF-β components disrupt both 
ALK1 and ALK5 pathways, whereas mutation of ALK1 disrupts only the endothelial 
specific ALK1 pathway (which signals through R-Smads 1/5) (Attisano, Carcamo et al. 
1993), leading to a dominance of the ubiquitous ALK5 mediated R-Smad2/3 signaling 
in the endothelial tissue (Oh, Seki et al. 2000). This finding indicates that ALK1 
signaling can inhibit ALK5 mediated functions in endothelial cells, and suggests that a 
balance between ALK1 and ALK5 signaling is an essential prerequisite for 
angiogenesis. In summary, the results of these studies suggest that the defects in 
FN
CC>SS/CC>SS 
embryos, which closely resemble the defects observed in ALK1-null 
mice, may be attributed to impaired endothelial functions in response to altered TGF-β 
signaling. 
Western blot analysis of lysates derived from FN
CC>SS/CC>SS 
embryos and yolk sacs for 
phospho-Smad2/3 levels confirmed increased levels of active TGF-β in vivo, suggesting 
that most parts of the defects observed in FN
CC>SS/CC>SS 
mice could be attributed to 
elevated levels of active TGF-β. This notion is supported by the study of Agah et al., 
which demonstrated that vasculature-specific over-expression of TGF-β in mice results 
in a phenotype that shares striking similarity with the phenotype observed in 
FN
CC>SS/CC>SS 
mice (Agah, Prasad et al. 2000). Moreover, it was reported that elevated 
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levels of active TGF-β can inhibit angiogenesis processes (Pepper 1997) and that 
overexpression of the type II TGF-β receptor (TGF-βRII) in murine extraembryonic 
mesoderm leads to impaired yolk sac vasculogenesis (Goumans, Zwijsen et al. 1999). In 
summary, these findings indicate that increased levels of active TGF-β in highly 
responsive tissue undergoing rapid morphogenesis, such as the developing yolk sac 
vasculature, is poorly tolerated.  
4.2.4 Enhanced levels of active TGF-β do not result in increased ECM 
production in FN
CC>SS/CC>SS 
mice 
Numerous studies have demonstrated that TGF-β is one of the most potent cytokines to 
induce ECM production in vivo (Taipale, Saharinen et al. 1996); reviewed in (Rahimi 
and Leof 2007). Furthermore, TGF-β is thought to be a master-regulator of FN 
production in the extraembryonic mesoderm (Goumans, Zwijsen et al. 1999). 
Surprisingly, no evidence for increased extracellular matrix deposition in response to 
increased levels of active TGF-β was observed in mice overexpressing TGF-β in the 
vasculature (Agah, Prasad et al. 2000) or in FN
CC>SS/CC>SS 
mice. Although R-Smads are 
clearly critical for increased ECM deposition induced by TGF-β, it remains unclear, 
whether they are differentially regulated in distinct cell types. 
4.2.5 The FN-monomer matrix fails to deposit latent TGF-β causing increased 
levels of active TGF-β 
The detection of increased levels of active TGF-β in FN-monomer mutants suggested 
that FN and TGF-β crosstalk with each other. Studies from Dallas et al. indicated that 
FN regulates the deposition of latent TGF-β into the matrix (Dallas, Sivakumar et al. 
2005) by controlling the assembly of the latent TGF-β binding proteins (LTBPs). 
LTBPs constitute a fibrillar component of the ECM and have been well established as 
major regulators of TGF-β functions (reviewed in (Hyytiainen, Penttinen et al. 2004)).  
Interestingly, initiation and sustained LTBP assembly into the ECM has been 
demonstrated to be critically dependent on a fibrillar FN matrix acting as a scaffold. 
There is conflicting data whether the FN-LTBP interaction is direct or indirect (Chen, 
Sivakumar et al. 2007; Kantola, Keski-Oja et al. 2008). However, studies with FN-null 
fibroblasts indicated that an absent FN matrix leads to a loss of LTBP-mediated TGF-β 
targeting to the ECM. As a result, soluble LTBPs accumulated, the levels of phospho 
Smad2/3 increased, suggesting that impaired deposition of LTBP leads to enhanced 
bioavailability of active TGF-β (Chaudhry, Cain et al. 2007; Kantola, Keski-Oja et al. 
2008). 
Unfortunately, it was not possible to analyse the fibrillar properties of LTBP deposits in 
embryo sections by immunohistochemistry. Therefore, it was sought to prove the 
hypothesis of impaired LTBP assembly on FN-monomer matrices in cell culture. 
In all FN
CC>SS/CC>SS 
clones tested, the FN-monomer matrix failed to properly assemble 
LTBP-1, a prototypic LTBP associated to TGF-β1. Western blot analysis of LTBP-1 
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released from cell derived matrices revealed that the absence of LTBPs on mutant cells 
was not due to lower expression levels, but that LTBPs rather accumulated in the 
medium. These data clearly indicate that FN-monomer fails to target LTBP-1 to the 
ECM. However, it still remains unanswered whether the impaired capability of FN-
monomer to deposit LTBPs into the ECM indeed resulted in increased levels of active 
TGF-β. To address this question experimentally, a luciferase-based TGF-β reporter 
system was used (Abe, Harpel et al. 1994) to comparatively analyse the levels of active 
TGF-β in conditioned medium of FNCC>SS/CC>SS and control cells. The assays revealed 
significantly increased levels of active TGF-β accumulated in the medium of 
FN
CC>SS/CC>SS 
cells, demonstrating that the FN-monomer matrix is not capable of 
regulating the bioavailability of TGF-β.  
In line with the previously mentioned studies, these data indicate that increased levels of 
active TGF-β may be responsible for the vascular defects observed in FNCC>SS/CC>SS 
mice. However, it can not be ruled out completely, that modified integrin signaling 
events additionally contribute to defects observed particularly in the extraembryonic 
tissues of FN
CC>SS/CC>SS 
mice. Future in vivo experiments applying TGF-β inhibitors in 
vivo should help to discriminate between these two defects and should demonstrate how 
diminished TGF-β signaling affects the development of FNCC>SS/CC>SS embryos in utero. 
It is tempting to speculate that FN-monomer probably does not completely fail to 
assemble ECM components such as LTBP-1, but rather delays FN dependent ECM 
assembly processes. This notion is substantiated by the observation of marked 
morphological differences between the FN-monomer matrix in vivo and in vitro. Further 
studies will be necessary to examine FN-monomers capabilities to assemble ECM 
components whose deposition into the ECM has been shown to be critically dependent 
on a fully functional FN matrix. 
In conclusion, the second part of the thesis shows that monomeric FN can be assembled 
into a matrix network in vivo and in vitro, but fails to deposit ECM components critical 
for the regulation of the growth factor TGF-β. The present mouse model exemplifies 
that the structural integrity of FN is of critical importance to properly fulfil its role as a 
master-organizer for ECM formation during development and tissue homeostasis. 
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